Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy   |   
enzyme (lysozyme)

 
Enzymes
  Enzyme classes:
  EC 1: Oxidoreductases
  EC 2: Transferases
    EC 2.1
    EC 2.2
    EC 2.3
    EC 2.4
    EC 2.5
    EC 2.6
    EC 2.7
      EC 2.7.1
      EC 2.7.2
      EC 2.7.3
      EC 2.7.4
      EC 2.7.5
      EC 2.7.6
      EC 2.7.7
      EC 2.7.8
      EC 2.7.9
      EC 2.7.10
      EC 2.7.11
        EC 2.7.11.1
        EC 2.7.11.2
        EC 2.7.11.3
        EC 2.7.11.4
        EC 2.7.11.6
        EC 2.7.11.7
        EC 2.7.11.8
        EC 2.7.11.9
        EC 2.7.11.10
        EC 2.7.11.11
        EC 2.7.11.12
        EC 2.7.11.13
        EC 2.7.11.14
        EC 2.7.11.15
        EC 2.7.11.16
        EC 2.7.11.17
        EC 2.7.11.18
        EC 2.7.11.19
        EC 2.7.11.20
        EC 2.7.11.21
        EC 2.7.11.22
        EC 2.7.11.23
        EC 2.7.11.24
        EC 2.7.11.25
        EC 2.7.11.26
        EC 2.7.11.27
        EC 2.7.11.28
        EC 2.7.11.29
        EC 2.7.11.30
        EC 2.7.11.31
      EC 2.7.12
      EC 2.7.13
      EC 2.7.14
    EC 2.8
    EC 2.9
  EC 3: Hydrolases
  EC 4: Lyases
  EC 5: Isomerases
  EC 6: Ligases
  General information:
  Catalytic mechanism
  Enzyme kinetics
  Inhibitors
  Enzymes in industry

EC 2.7.11.1 - ATP:protein phosphotransferase (non- specific) (non- specific serine/threonine protein kinase)



3D structures of EC 2.7.11.1 - non-specific serine/threonine protein kinase in Protein Data Bank

updated: 27 October 2021, 5:15

In total: 2620 PDB structures of EC 2.7.11.1 - non-specific serine/threonine protein kinase:
  1. 1e0a: Cdc42 Complexed with The Gtpase Binding Domain of P21 Activated Kinase
  2. 1h1w: High Resolution Crystal Structure of The Human Pdk1 Catalytic Domain
  3. 3p1a: Structure of Human Membrane-associated Tyrosine- and Threonine- Specific Cdc2-inhibitory Kinase Myt1 (pkmyt1)
  4. 3ow4: Discovery of Dihydrothieno- and Dihydrofuropyrimidines as Potent Pan Akt Inhibitors
  5. 3ot8: X-ray Crystal Structure of Compound 17r Bound to Human Chk1 Kinase Domain
  6. 3ot3: X-ray Crystal Structure of Compound 22k Bound to Human Chk1 Kinase Domain
  7. 3op5: Human Vaccinia-related Kinase 1
  8. 3omv: Crystal Structure of C-raf (raf-1)
  9. 3og7: B-raf Kinase V600E Oncogenic Mutant in Complex with Plx4032
  10. 3o96: Crystal Structure of Human Akt1 with an Allosteric Inhibitor
  11. 3o51: Crystal Structure of Anthranilamide 10 Bound to Auroraa
  12. 3o50: Crystal Structure of Benzamide 9 Bound to Auroraa
  13. 3ny5: Crystal Structure of The Rbd Domain of Serine/threonine-protein Kinase B-raf from Homo Sapiens. Northeast Structural Genomics Consortium Target HR4694F
  14. 3nrm: Imidazo[1,2-a]pyrazine-based Aurora Kinase Inhibitors
  15. 3nkx: Impaired Binding of 14-3-3 to Raf1 Is Linked to Noonan and Leopard Syndrome
  16. 3nay: Pdk1 in Complex with Inhibitor Mp6
  17. 3nax: Pdk1 in Complex with Inhibitor Mp7
  18. 3myg: Aurora a Kinase Complexed with Sch 1473759
  19. 3mvh: Crystal Structure of Akt-1-inhibitor Complexes
  20. 3mv5: Crystal Structure of Akt-1-inhibitor Complexes
  21. 3mop: The Ternary Death Domain Complex of Myd88, Irak4, and Irak2
  22. 3mn3: An Inhibited Conformation for The Protein Kinase Domain of The Saccharomyces Cerevisiae Ampk Homolog Snf1
  23. 1mry: Crystal Structure of an Inactive Akt2 Kinase Domain
  24. 3mfu: Cask-4m Cam Kinase Domain, Amppnp-mn2+
  25. 3mft: Cask-4m Cam Kinase Domain, Mn2+
  26. 3mfs: Cask-4m Cam Kinase Domain, Amppnp
  27. 3mfr: Cask-4m Cam Kinase Domain, Native
  28. 3mb7: Human Ck2 Catalytic Domain in Complex with a Difurane Derivative Inhibitor (amr)
  29. 3mb6: Human Ck2 Catalytic Domain in Complex with a Difurane Derivative Inhibitor (cpa)
  30. 3ma3: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Naphtho-difuran Ligand
  31. 3m9g: Crystal Structure of The Three-pasta-domain of a Ser/thr Kinase from Staphylococcus Aureus
  32. 3m2w: Crystal Structure of Mapkak Kinase 2 (mk2) Complexed with a Spiroazetidine-tetracyclic Atp Site Inhibitor
  33. 3lm5: Crystal Structure of Human Serine/threonine Kinase 17b (STK17B) in Complex with Quercetin
  34. 3lm0: Crystal Structure of Human Serine/threonine Kinase 17b (STK17B)
  35. 3lj2: Ire1 Complexed with Jak Inhibitor I
  36. 3lj1: Ire1 Complexed with Cdk1/2 Inhibitor III
  37. 3lj0: Ire1 Complexed with Adp and Quercetin
  38. 3lau: Crystal Structure of Aurora2 Kinase in Complex with a GSK3BETA Inhibitor
  39. 3kxn: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Inhibitor Tetraiodobenzimidazole (k88)
  40. 3kxm: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Inhibitor K74
  41. 3kxh: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Inhibitor (2-dymethylammino-4,5,6,7-tetrabromobenzoimidazol-1yl- Acetic Acid (k66)
  42. 3kxg: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Inhibitor 3,4,5,6,7-pentabromo-1h-indazole (k64)
  43. 3kud: Complex of Ras-gdp with RAFRBD(A85K)
  44. 3kuc: Complex of RAP1A(E30D/K31E)GDP with RAFRBD(A85K/N71R)
  45. 1o6y: Catalytic Domain of Pknb Kinase from Mycobacterium Tuberculosis
  46. 3knb: Crystal Structure of The Titin C-terminus in Complex with Obscurin- like 1
  47. 3kn6: Crystal Structure of The C-terminal Kinase Domain of Msk1
  48. 3kn5: Crystal Structure of The C-terminal Kinase Domain of Msk1 in Complex with Amp-pnp
  49. 3khf: The Crystal Structure of The Pdz Domain of Human Microtubule Associated Serine/threonine Kinase 3 (mast3)
  50. 3kgv: Crystal Structure of Human Dna-dependent Protein Kinase Catalytic Subunit (dna-pkcs)
  51. 3kga: Crystal Structure of Mapkap Kinase 2 (mk2) Complexed with a Potent 3-aminopyrazole Atp Site Inhibitor
  52. 3kc3: Mk2 Complexed to Inhibitor N4-(7-(benzofuran-2-yl)-1h-indazol-5-yl) Pyrimidine-2,4-diamine
  53. 3ka0: Mk2 Complex with Inhibitor 6-(5-(2-aminopyrimidin-4-ylamino)-2- Hydroxyphenyl)-n-methylbenzo[b]thiophene-2-carboxamide
  54. 3k5u: Identification, Sar Studies and X-ray Cocrystal Analysis of a Novel Furano-pyrimidine Aurora Kinase a Inhibitor
  55. 3k21: Crystal Structure of Carboxy-terminus of PFC0420W.
  56. 3k0e: Crystal Structure of The Phosphorylation-site Mutant T426N of The Kaic Circadian Clock Protein
  57. 3k0c: Crystal Structure of The Phosphorylation-site Double Mutant S431A/T432E of The Kaic Circadian Clock Protein
  58. 3k0a: Crystal Structure of The Phosphorylation-site Mutant S431A of The Kaic Circadian Clock Protein
  59. 3k09: Crystal Structure of The Phosphorylation-site Mutant S431D of The Kaic Circadian Clock Protein
  60. 3jzm: Crystal Structure of The Phosphorylation-site Mutant T432A of The Kaic Circadian Clock Protein
  61. 3jya: Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective and Orally Bioavailable Pim Kinases Inhibitors
  62. 3jy0: Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective and Orally Bioavailable Pim Kinases Inhibitors
  63. 3jxw: Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective and Orally Bioavailable Pim Kinases Inhibitors
  64. 3jvs: Characterization of The Chk1 Allosteric Inhibitor Binding Site
  65. 3jvr: Characterization of The Chk1 Allosteric Inhibitor Binding Site
  66. 3juh: Crystal Structure of a Mutant of Human Protein Kinase CK2ALPHA with Altered Cosubstrate Specificity
  67. 3jpv: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Pyrrolo[2,3-a]carbazole Ligand
  68. 3ixe: Structural Basis of Competition between Pinch1 and Pinch2 for Binding to The Ankyrin Repeat Domain of Integrin-linked Kinase
  69. 3iq7: Crystal Structure of Human Haspin in Complex with 5-iodotubercidin
  70. 3iop: Pdk-1 in Complex with The Inhibitor Compound-8i
  71. 3ion: Pdk1 in Complex with Compound 8h
  72. 3ii5: The Complex of Wild-type B-raf with Pyrazolo Pyrimidine Inhibitor
  73. 3iec: Helicobacter Pylori Caga Inhibits Par1/mark Family Kinases by Mimicking Host Substrates
  74. 3idp: B-raf V600E Kinase Domain in Complex with an Aminoisoquinoline Inhibitor
  75. 3i6w: Structure and Activation Mechanism of The Chk2 Dna-damage Checkpoint Kinase
  76. 3i6u: Structure and Activation Mechanism of The Chk2 Dna-damage Checkpoint Kinase
  77. 3hyh: Crystal Structure of The Protein Kinase Domain of Yeast Amp- Activated Protein Kinase Snf1
  78. 3hrc: Crystal Structure of a Mutant of Human Pdk1 Kinase Domain in Complex with Atp
  79. 3hdn: Crystal Structure of Serum and Glucocorticoid-regulated Kinase 1 in Complex with Compound 2
  80. 3hdm: Crystal Structure of Serum and Glucocorticoid-regulated Kinase 1 in Complex with Compound 1
  81. 3ha6: Crystal Structure of Aurora a in Complex with Tpx2 and Compound 10
  82. 3h9o: Phosphoinositide-dependent Protein Kinase 1 (pdk-1) in Complex with Compound 9
  83. 3h4j: Crystal Structure of Pombe Ampk Kdaid Fragment
  84. 3h30: Crystal Structure of The Catalytic Subunit of Human Protein Kinase Ck2 with 5,6-dichloro-1-beta-d- Ribofuranosylbenzimidazole
  85. 3h10: Aurora a Inhibitor Complex
  86. 3h0z: Aurora a in Complex with a Bisanilinopyrimidine
  87. 3h0y: Aurora a in Complex with a Bisanilinopyrimidine
  88. 3gub: Crystal Structure of DAPKL93G Complexed with N6-(2- Phenylethyl)adenosine
  89. 3gu8: Crystal Structure of DAPKL93G with N6-cyclopentyladenosine
  90. 3gu7: Crystal Structure of DAPKQ23V-ADP-MG2+
  91. 3gu6: Crystal Structure of DAPKQ23V-ADP
  92. 3gu5: Crystal Structure of DAPKQ23V-AMPPNP-MG2+
  93. 3gu4: Crystal Structure of DAPKQ23V-AMPPNP
  94. 3gre: Crystal Structure of Saccharomyces Cerevisiae Vps15 Wd Repeat Domain
  95. 3gok: Binding Site Mapping of Protein Ligands
  96. 3ggf: Crystal Structure of Human Serine/threonine-protein Kinase Mst4 in Complex with an Quinazolin
  97. 3g51: Structural Diversity of The Active Conformation of The N- Terminal Kinase Domain of P90 Ribosomal S6 Kinase 2
  98. 3fyk: Crystal Structure of a Benzthiophene Lead Bound to Mapkap Kinase-2 (mk-2)
  99. 3fyj: Crystal Structure of an Optimzied Benzothiophene Inhibitor Bound to Mapkap Kinase-2 (mk-2)
  100. 3fy0: Crystal Structure of Pak1 Kinase Domain with Ruthenium Complex Dw1
  101. 3fxz: Crystal Structure of Pak1 Kinase Domain with Ruthenium Complex Lambda-fl172
  102. 3fxw: High Resolution Crystal Structure of Mitogen-activated Protein Kinase-activated Protein Kinase 3/inhibitor 2 Complex
  103. 3fwq: Inactive Conformation of Human Protein Kinase Ck2 Catalytic Subunit
  104. 3fpm: Crystal Structure of a Squarate Inhibitor Bound to Mapkap Kinase-2
  105. 3fmd: Crystal Structure of Human Haspin with an Isoquinoline Ligand
  106. 3fl5: Protein Kinase Ck2 in Complex with The Inhibitor Quinalizarin
  107. 3fhr: High Resolution Crystal Structure of Mitogen-activated Protein Kinase-activated Protein Kinase 3 (mk3)-inhibitor Complex
  108. 3fe3: Crystal Structure of The Kinase Mark3/par-1: T211A-S215A Double Mutant
  109. 3fdn: Structure-based Drug Design of Novel Aurora Kinase a Inhibitors: Structure Basis for Potency and Specificity
  110. 3fbv: Crystal Structure of The Oligomer Formed by The Kinase- Ribonuclease Domain of Ire1
  111. 3f9n: Crystal Structure of Chk1 Kinase in Complex with Inhibitor 38
  112. 3f6q: Crystal Structure of Integrin-linked Kinase Ankyrin Repeat Domain in Complex with Pinch1 Lim1 Domain
  113. 3f69: Crystal Structure of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain in Complex with Kt5720
  114. 3f61: Crystal Structure of M. Tuberculosis Pknb LEU33ASP/VAL222ASP Double Mutant in Complex with Adp
  115. 3f5u: Crystal Structure of The Death Associated Protein Kinase in Complex with Amppnp and Mg2+
  116. 3f5g: Crystal Structure of Death Associated Protein Kinase in Complex with Adp and Mg2+
  117. 3f2n: Crystal Structure of Human Haspin with an Imidazo- Pyridazine Ligand
  118. 3f2a: Crystal Structure of Human Pim-1 in Complex with Dappa
  119. 3eha: Crystal Structure of Death Associated Protein Kinase Complexed with Amppnp
  120. 3eh9: Crystal Structure of Death Associated Protein Kinase Complexed with Adp
  121. 3efw: Structure of Auroraa with Pyridyl-pyrimidine Urea Inhibitor
  122. 3e8d: Crystal Structures of The Kinase Domain of Akt2 in Complex with Atp-competitive Inhibitors
  123. 3e88: Crystal Structures of The Kinase Domain of Akt2 in Complex with Atp-competitive Inhibitors
  124. 3e87: Crystal Structures of The Kinase Domain of Akt2 in Complex with Atp-competitive Inhibitors
  125. 3e7v: Crystal Structure of Human Haspin with a Pyrazolo- Pyrimidine Ligand
  126. 3e5a: Crystal Structure of Aurora a in Complex with Vx-680 and Tpx2
  127. 3e3b: Crystal Structure of Catalytic Subunit of Human Protein Kinase CK2ALPHA Prime with a Potent Indazole-derivative Inhibitor
  128. 3dvl: Crystal Structure of Full Length Circadian Clock Protein Kaic with Correct Geometry at Phosphorylation Sites
  129. 3dlz: Crystal Structure of Human Haspin in Complex with Amp
  130. 3dls: Crystal Structure of Human Pas Kinase Bound to Adp
  131. 3dj7: Crystal Structure of The Mouse Aurora-a Catalytic Domain (asn186->gly, Lys240->arg, Met302->leu) in Complex with Compound 130.
  132. 3dj6: Crystal Structure of The Mouse Aurora-a Catalytic Domain (asn186->gly, Lys240->arg, Met302->leu) in Complex with Compound 823.
  133. 3dj5: Crystal Structure of The Mouse Aurora-a Catalytic Domain (asn186->gly, Lys240->arg, Met302->leu) in Complex with Compound 290.
  134. 3dgk: Crystal Structure of a Glycine-rich Loop Mutant of The Death Associated Protein Kinase Catalytic Domain
  135. 3dfc: Crystal Structure of a Glycine-rich Loop Mutant of The Death Associated Protein Kinase Catalytic Domain with Amppnp
  136. 3dcv: Crystal Structure of Human Pim1 Kinase Complexed with 4-(4- Hydroxy-3-methyl-phenyl)-6-phenylpyrimidin-2(1h)-one
  137. 3dak: Crystal Structure of Domain-swapped Osr1 Kinase Domain
  138. 3dae: Crystal Structure of Phosphorylated Snf1 Kinase Domain
  139. 3d9v: Crystal Structure of Rock I Bound to H-1152p a Di- Methylated Variant of Fasudil
  140. 3d6t: Structure of The Roc Domain from The Parkinson's Disease- Associated Leucine-rich Repeat Kinase 2 Reveals a Dimeric Gtpase
  141. 3d4q: Pyrazole-based Inhibitors of B-raf Kinase
  142. 1ul7: Solution Structure of Kinase Associated Domain 1 of Mouse Map/microtubule Affinity-regulating Kinase 3
  143. 3d2k: Crystal Structure of Mouse Aurora a (asn186->gly, Lys240- >arg, Met302->leu) in Complex with [7-(2-{2-[3-(3-chloro- Phenyl)-ureido]-thiazol-5-yl}-ethylamino)-pyrazolo[4,3- D]pyrimidin-1-yl]-acetic Acid
  144. 3d2i: Crystal Structure of Mouse Aurora a (asn186->gly, Lys240- >arg, Met302->leu) in Complex with 1-{5-[2-(1-methyl-1h- Pyrazolo[4,3-d]pyrimidin-7-ylamino)-ethyl]-thiazol-2-yl}-3- (3-trifluoromethyl-phenyl)-urea
  145. 1unr: Crystal Structure of The Ph Domain of Pkb Alpha in Complex with a Sulfate Molecule
  146. 3d15: Crystal Structure of Mouse Aurora a (asn186->gly, Lys240- >arg, Met302->leu) in Complex with 1-(3-chloro-phenyl)-3- {5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)- Ethyl]-thiazol-2- Yl}-urea [sns-314]
  147. 3d14: Crystal Structure of Mouse Aurora a (asn186->gly, Lys240- >arg, Met302->leu) in Complex with 1-{5-[2-(thieno[3,2- D]pyrimidin-4-ylamino)-ethyl]- Thiazol-2-yl}-3-(3- Trifluoromethyl-phenyl)-urea
  148. 3d0e: Crystal Structure of Human Akt2 in Complex with Gsk690693
  149. 3cy3: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and The Jnk Inhibitor V
  150. 3cy2: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Beta Carboline Ligand II
  151. 3cxw: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Beta Carboline Ligand I
  152. 3cu8: Impaired Binding of 14-3-3 to Raf1 Is Linked to Noonan and Leopard Syndrome
  153. 1uwh: The Complex of Wild Type B-raf and Bay439006
  154. 1uwj: The Complex of Mutant V599E B-raf and Bay439006
  155. 3cqw: Crystal Structure of Akt-1 Complexed with Substrate Peptide and Inhibitor
  156. 3cqu: Crystal Structure of Akt-1 Complexed with Substrate Peptide and Inhibitor
  157. 3com: Crystal Structure of Mst1 Kinase
  158. 3coh: Crystal Structure of Aurora-a in Complex with a Pentacyclic Inhibitor
  159. 3ckx: Crystal Structure of Sterile 20-like Kinase 3 (mst3, Stk24) in Complex with Staurosporine
  160. 3ckw: Crystal Structure of Sterile 20-like Kinase 3 (mst3, Stk24)
  161. 3c4e: Pim-1 Kinase Domain in Complex with 3-aminophenyl-7- Azaindole
  162. 3c4c: B-raf Kinase in Complex with Plx4720
  163. 3c13: Low Ph-value Crystal Structure of Emodin in Complex with The Catalytic Subunit of Protein Kinase Ck2
  164. 3c0i: Cask Cam-kinase Domain- 3'-amp Complex, P212121 Form
  165. 3c0h: Cask Cam-kinase Domain- Amppnp Complex, P1 Form
  166. 3c0g: Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
  167. 3bwf: Crystal Structure of The Human Pim1 in Complex with an Osmium Compound
  168. 3bqr: Crystal Structure of Human Death Associated Protein Kinase 3 (dapk3) in Complex with an Imidazo-pyridazine Ligand
  169. 3bqc: High Ph-value Crystal Structure of Emodin in Complex with The Catalytic Subunit of Protein Kinase Ck2
  170. 3bhy: Crystal Structure of Human Death Associated Protein Kinase 3 (dapk3) in Complex with a Beta-carboline Ligand
  171. 3bgz: Human Pim-1 Kinase in Complex with Diphenyl Indole Inhibitor Vx3
  172. 3bgq: Human Pim-1 Kinase in Complex with an Triazolo Pyridazine Inhibitor Vx2
  173. 3bgp: Human Pim-1 Complexed with a Benzoisoxazole Inhibitor Vx1
  174. 3beg: Crystal Structure of Sr Protein Kinase 1 Complexed to Its Substrate Asf/sf2
  175. 3be9: Structure-based Design and Synthesis of Novel Macrocyclic Pyrazolo[1,5-a] [1,3,5]triazine Compounds as Potent Inhibitors of Protein Kinase Ck2 and Their Anticancer Activities
  176. 1wak: X-ray Structure of Srpk1
  177. 3b43: I-band Fragment I65-i70 from Titin
  178. 3akl: Crystal Structure of a Helicobacter Pylori Proinflammatory Kinase Ctka
  179. 3akk: Crystal Structure of a Helicobacter Pylori Proinflammatory Kinase Ctka
  180. 3akj: Crystal Structure of a Helicobacter Pylori Proinflammatory Kinase Ctka
  181. 3aad: Structure of The Histone Chaperone Cia/asf1-double Bromodomain Complex Linking Histone Modifications and Site-specific Histone Eviction
  182. 3a99: Structure of Pim-1 Kinase Crystallized in The Presence of P27KIP1 Carboxy-terminal Peptide
  183. 3a62: Crystal Structure of Phosphorylated P70S6K1
  184. 3a61: Crystal Structure of Unphosphorylated P70S6K1 (form Ii)
  185. 3a60: Crystal Structure of Unphosphorylated P70S6K1 (form I)
  186. 3a2c: Crystal Structure of a Pyrazolopyrimidine Inhibitor Complex Bound to Mapkap Kinase-2 (mk2)
  187. 2zjw: Crystal Structure of Human Ck2 Alpha Complexed with Ellagic Acid
  188. 2zej: Structure of The Roc Domain from The Parkinson's Disease- Associated Leucine-rich Repeat Kinase 2 Reveals a Dimeric Gtpase
  189. 2z7s: Crystal Structure of The N-terminal Kinase Domain of Human Rsk1 Bound to Purvalnol a
  190. 2z7r: Crystal Structure of The N-terminal Kinase Domain of Human Rsk1 Bound to Staurosporine
  191. 2z7q: Crystal Structure of The N-terminal Kinase Domain of Human Rsk-1 Bound to Amp-pcp
  192. 2z6d: Crystal Structure of Lov1 Domain of Phototropin2 from Arabidopsis Thaliana
  193. 2z6c: Crystal Structure of Lov1 Domain of Phototropin1 from Arabidopsis Thaliana
  194. 2yza: Crystal Structure of Kinase Domain of Human 5'-amp- Activated Protein Kinase Alpha-2 Subunit Mutant (T172D)
  195. 2yz0: Solution Structure of Rwd/gi Domain of Saccharomyces Cerevisiae Gcn2
  196. 2ywp: Crystal Structure of Chk1 with a Urea Inhibitor
  197. 2yub: Solution Structure of The Pdz Domain from Mouse Lim Domain Kinase
  198. 2xru: Aurora-a T288E Complexed with Pha-828300
  199. 2xng: Structure of Aurora-a Bound to a Selective Imidazopyrazine Inhibitor
  200. 2xne: Structure of Aurora-a Bound to an Imidazopyrazine Inhibitor
  201. 2xkf: Structure of Nek2 Bound to Aminopyrazine Compound 2
  202. 2xke: Structure of Nek2 Bound to Aminipyrazine Compound 5
  203. 2xkd: Structure of Nek2 Bound to Aminopyrazine Compound 12
  204. 2xkc: Structure of Nek2 Bound to Aminopyrazine Compound 14
  205. 2xk8: Structure of Nek2 Bound to Aminopyrazine Compound 15
  206. 2xk7: Structure of Nek2 Bound to Aminopyrazine Compound 23
  207. 2xk6: Structure of Nek2 Bound to Aminopyrazine Compound 36
  208. 2xk4: Structure of Nek2 Bound to Aminopyrazine Compound 17
  209. 2xk3: Structure of Nek2 Bound to Aminopyrazine Compound 35
  210. 2xik: Structure of Human Ysk1 (yeast Sps1-ste20-related Kinase 1)
  211. 2xh5: Structure of 4-(4-tert-butylbenzyl)-1-(7h-pyrrolo(2,3-d) Pyrimidin-4-yl)piperidin-4-amine Bound to Pkb
  212. 2xf0: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  213. 2xez: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  214. 2xey: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  215. 2xck: Crystal Structure of Pdk1 in Complex with a Pyrazoloquinazoline Inhibitor
  216. 2xch: Crystal Structure of Pdk1 in Complex with a Pyrazoloquinazoline Inhibitor
  217. 2x8i: Discovery of a Novel Class of Triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration
  218. 2x8e: Discovery of a Novel Class of Triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration
  219. 2x8d: Discovery of a Novel Class of Triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration
  220. 2x81: Structure of Aurora a in Complex with Mln8054
  221. 2x7g: Structure of Human Serine-arginine-rich Protein-specific Kinase 2 (srpk2) Bound to Purvalanol B
  222. 2x7f: Crystal Structure of The Kinase Domain of Human Traf2- and Nck-interacting Kinase with WEE1CHK1 Inhibitor
  223. 2x6e: Aurora-a Bound to an Inhibitor
  224. 2x6d: Aurora-a Bound to an Inhibitor
  225. 2x4z: Crystal Structure of The Human P21-activated Kinase 4 in Complex with Pf-03758309
  226. 2x4f: The Crystal Structure of The Human Myosin Light Chain Kinase Loc340156.
  227. 2x39: Structure of 4-amino-n-(4-chlorobenzyl)-1-(7h-pyrrolo(2,3-d) Pyrimidin-4-yl)piperidine-4-carboxamide Bound to Pkb
  228. 2x18: The Crystal Structure of The Ph Domain of Human Akt3 Protein Kinase
  229. 2x0g: X-ray Structure of a Dap-kinase Calmodulin Complex
  230. 2wzj: Catalytic and Uba Domain of Kinase Mark2/(par-1) K82R, T208E Double Mutant
  231. 2wwm: Crystal Structure of The Titin M10-obscurin like 1 Ig Complex in Space Group P1
  232. 2wwk: Crystal Structure of The Titin M10-obscurin like 1 Ig F17R Mutant Complex
  233. 2wvi: Crystal Structure of The N-terminal Domain of Bubr1
  234. 2wtw: Aurora-a Inhibitor Structure (2nd Crystal Form)
  235. 2wtv: Aurora-a Inhibitor Structure
  236. 2wtk: Structure of The Heterotrimeric LKB1-STRADALPHA-MO25ALPHA Complex
  237. 2wtj: Crystal Structure of Chk2 in Complex with an Inhibitor
  238. 2wti: Crystal Structure of Chk2 in Complex with an Inhibitor
  239. 2wtd: Crystal Structure of Chk2 in Complex with an Inhibitor
  240. 2wtc: Crystal Structure of Chk2 in Complex with an Inhibitor
  241. 2wqo: Structure of Nek2 Bound to The Aminopyridine Cct241950
  242. 2wqn: Structure of Adp-bound Human Nek7
  243. 2wqm: Structure of Apo Human Nek7
  244. 2wqe: Structure of S155R Aurora-a Somatic Mutant
  245. 2wp3: Crystal Structure of The Titin M10-obscurin like 1 Ig Complex
  246. 2wnt: Crystal Structure of The Human Ribosomal Protein S6 Kinase
  247. 2wmx: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  248. 2wmw: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  249. 2wmv: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  250. 2wmu: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  251. 2wmt: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  252. 2wms: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  253. 2wmr: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  254. 2wmq: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  255. 2wiu: Mercury-modified Bacterial Persistence Regulator Hipba
  256. 2wb8: Crystal Structure of Haspin Kinase
  257. 2w7x: Cellular Inhibition of Checkpoint Kinase 2 and Potentiation of Cytotoxic Drugs by Novel Chk2 Inhibitor Pv1019
  258. 2w7r: Structure of The Pdz Domain of Human Microtubule Associated Serine-threonine Kinase 4
  259. 2w5h: Human Nek2 Kinase Apo
  260. 2w5b: Human Nek2 Kinase Atpgammas-bound
  261. 2w5a: Human Nek2 Kinase Adp-bound
  262. 2w4k: X-ray Structure of a Dap-kinase 2-302
  263. 2w4j: X-ray Structure of a Dap-kinase 2-277
  264. 2w1g: Structure Determination of Aurora Kinase in Complex with Inhibitor
  265. 2w1f: Structure Determination of Aurora Kinase in Complex with Inhibitor
  266. 2w1e: Structure Determination of Aurora Kinase in Complex with Inhibitor
  267. 2w1d: Structure Determination of Aurora Kinase in Complex with Inhibitor
  268. 2w1c: Structure Determination of Aurora Kinase in Complex with Inhibitor
  269. 2w0j: Crystal Structure of Chk2 in Complex with Nsc 109555, a Specific Inhibitor
  270. 2vwi: Structure of The Osr1 Kinase, a Hypertension Drug Target
  271. 2vuw: Structure of Human Haspin Kinase Domain
  272. 2vu3: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  273. 2vtt: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  274. 2vts: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  275. 2vtr: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  276. 2vtq: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  277. 2vtp: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  278. 2vto: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  279. 2vtn: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  280. 2vtm: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  281. 2vtl: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  282. 2vtj: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  283. 2vti: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  284. 2vth: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
  285. 2vrx: Structure of Aurora B Kinase in Complex with Zm447439
  286. 7atu: The Limk1 Kinase Domain Bound to Lijtf500025
  287. 7b6f: Gsk3-beta in Complex with Compound (s)-5c
  288. 7b36: Mst4 in Complex with Compound G-5555
  289. 7b35: Mst3 in Complex with Compound Mria13
  290. 7b34: Mst3 in Complex with Compound Mria12
  291. 7b33: Mst3 in Complex with Mria11
  292. 7b32: Mst3 in Complex with Mria7
  293. 7b31: Mst3 in Complex with Compound Mria9
  294. 7b30: Mst3 in Complex with Compound G-5555
  295. 6zxh: Cryo-em Structure of a Late Human Pre-40s Ribosomal Subunit - State H2
  296. 6tlw: Human Ck2 Kinase Alpha Subunit in Complex with The Atp-competitive Inhibitor 4-bromobenzotriazole
  297. 6tlv: Human Ck2 Kinase Alpha Subunit in Complex with The Atp-competitive Inhibitor 5-bromobenzotriazole
  298. 6tls: Human Ck2 Kinase Alpha Subunit in Complex with The Atp-competitive Inhibitor 4,6-dibromobenzotriazole
  299. 6tlr: Human Ck2 Kinase Alpha Subunit in Complex with The Atp-competitive Inhibitor 4,7-dibromobenzotriazole
  300. 6tlp: Human Ck2 Kinase Alpha Subunit in Complex with The Atp-competitive Inhibitor 5,6-dibromobenzotriazole
  301. 6tlo: Human Ck2 Kinase Alpha Subunit in Complex with The Atp-competitive Inhibitor 4,5,6-tribromobenzotriazole
  302. 6tll: Human Ck2 Kinase Alpha Subunit in Complex with The Atp-competitive Inhibitor 4,5,6,7-tetrabromobenzotriazole (tbbt)
  303. 2vki: Structure of The Pdk1 Ph Domain K465E Mutant
  304. 2a38: Crystal Structure of The N-terminus of Titin
  305. 7jv1: Crystal Structure of Ksr1:mek1 in Complex with Amp-pnp, and Allosteric Mek Inhibitor Aps-9-95-1
  306. 7jv0: Crystal Structure of Ksr1:mek1 in Complex with Amp-pnp, and Allosteric Mek Inhibitor Pd0325901
  307. 7juz: Crystal Structure of Ksr1:mek1 in Complex with Amp-pnp, and Allosteric Mek Inhibitor Selumetinib
  308. 7juy: Crystal Structure of Ksr1:mek1 in Complex with Amp-pnp, and Allosteric Mek Inhibitor Cobimetinib
  309. 7jux: Crystal Structure of Ksr1:mek1 in Complex with Amp-pnp, and Allosteric Mek Inhibitor Trametinib
  310. 7juw: Crystal Structure of Ksr1:mek1 in Complex with Amp-pnp
  311. 7juv: Crystal Structure of Ksr2:mek1 in Complex with Amp-pnp, and Allosteric Mek Inhibitor Aps-9-95-1
  312. 7juu: Crystal Structure of Ksr2:mek1 in Complex with Amp-pnp, and Allosteric Mek Inhibitor Pd0325901
  313. 7jut: Crystal Structure of Ksr2:mek1 in Complex with Anp-pnp, and Allosteric Mek Inhibitor Selumetinib
  314. 7jus: Crystal Structure of Ksr2:mek1 in Complex with Amp-pnp, and Allosteric Mek Inhibitor Cobimetinib
  315. 7jur: Crystal Structure of Ksr2:mek1 in Complex with Amp-pnp, and Allosteric Mek Inhibitor Trametinib
  316. 7juq: Crystal Structure of Ksr2:mek1 in Complex with Adp
  317. 7jov: Crystal Structure of Rho-associated Protein Kinase 2 (rock2) in Complex with a Phenylpyrazole Amide Inhibitor
  318. 7jou: Crystal Structure of Rho-associated Protein Kinase 1 (rock1) in Complex with a Phenylpyrazole Amide Inhibitor
  319. 7jnt: Crystal Structure of Rho-associated Protein Kinase 2 (rock2) in Complex with a Potent and Selective Dual Rock Inhibitor
  320. 2vgp: Crystal Structure of Aurora B Kinase in Complex with a Aminothiazole Inhibitor
  321. 2vgo: Crystal Structure of Aurora B Kinase in Complex with Reversine Inhibitor
  322. 7jhp: Crystal Structure of Hras in Complex with The Ras-binding and Cysteine-rich Domains of Craf-kinase
  323. 2vd5: Structure of Human Myotonic Dystrophy Protein Kinase in Complex with The Bisindoylmaleide Inhibitor Bim VIII
  324. 2v9j: Crystal Structure of The Regulatory Fragment of Mammalian Ampk in Complexes with Mg.atp-amp
  325. 7c2w: Crystal Structure of Irak4 Kinase in Complex with a Small Molecule Inhibitor
  326. 7c2v: Crystal Structure of Irak4 Kinase in Complex with The Inhibitor Ca- 4948
  327. 2v92: Crystal Structure of The Regulatory Fragment of Mammalian Ampk in Complexes with Atp-amp
  328. 2v8q: Crystal Structure of The Regulatory Fragment of Mammalian Ampk in Complexes with Amp
  329. 7brc: Crystal Structure of The Tmk3 Lrr Domain
  330. 7avq: Crystal Structure of Haspin in Complex with Disubstituted Imidazo[1,2- B]pyridazine Inhibitor (compound 12)
  331. 7ats: The Limk1 Kinase Domain Bound to Lijtf500127
  332. 2v62: Structure of Vaccinia-related Kinase 2
  333. 2v55: Mechanism of Multi-site Phosphorylation from a Rock-i:rhoe Complex Structure
  334. 7akg: Crystal Structure of STK17B with Bound Dovitinib
  335. 2v3s: Structural Insights into The Recognition of Substrates and Activators by The Osr1 Kinase
  336. 7a4c: Crystal Structure of Human Protein Kinase CK2ALPHA (CSNK2A1 Gene Product) in Complex with The Atp-competitive Inhibitor 5,6,7- Tribromo-1h-triazolo[4,5-b]pyridine
  337. 7a4b: Crystal Structure of Human Protein Kinase CK2ALPHA (CSNK2A1 Gene Product) in Complex with The Atp-competitive Inhibitor 5,6-dibromo- 1h-triazolo[4,5-b]pyridine
  338. 7a49: Crystal Structure of Human Protein Kinase CK2ALPHA (CSNK2A1 Gene Product) in Complex with The Atp-competitive Inhibitor 6-bromo-5- Chloro-1h-triazolo[4,5-b]pyridine
  339. 7a2h: Crystal Structure of Human Protein Kinase CK2ALPHA' (CSNK2A2 Gene Product) in Complex with The Atp-competitive Inhibitor 5,6,7- Tribromo-1h-imidazo[4,5-b]pyridine
  340. 7a22: Crystal Structure of Human Protein Kinase CK2ALPHA' (CSNK2A2 Gene Product) in Complex with The Atp-competitive Inhibitor 5,6,7- Tribromo-1h-triazolo[4,5-b]pyridine
  341. 7a1z: Crystal Structure of Human Protein Kinase CK2ALPHA' (CSNK2A2 Gene Product) in Complex with The Atp-competitive Inhibitor 6-bromo-5- Chloro-1h-triazolo[4,5-b]pyridine
  342. 7a1b: Crystal Structure of Human Protein Kinase CK2ALPHA' (CSNK2A2 Gene Product) in Complex with The Atp-competitive Inhibitor 5,6-dibromo- 1h-triazolo[4,5-b]pyridine
  343. 6zxg: Cryo-em Structure of a Late Human Pre-40s Ribosomal Subunit - State H1
  344. 6zxf: Cryo-em Structure of a Late Human Pre-40s Ribosomal Subunit - State G
  345. 2uzs: A Transforming Mutation in The Pleckstrin Homology Domain of Akt1 in Cancer (AKT1-PH_E17K)
  346. 2uzr: A Transforming Mutation in The Pleckstrin Homology Domain of Akt1 in Cancer (AKT1-PH_E17K)
  347. 6zxe: Cryo-em Structure of a Late Human Pre-40s Ribosomal Subunit - State F2
  348. 6zxd: Cryo-em Structure of a Late Human Pre-40s Ribosomal Subunit - State F1
  349. 6zwo: Cryo-em Structure of Human Mtor Complex 2, Focused on One Half
  350. 6zwm: Cryo-em Structure of Human Mtor Complex 2, Overall Refinement
  351. 2uw9: Structure of Pkb-beta (akt2) Complexed with 4-(4-chloro- Phenyl)-4-(4-(1h-pyrazol-4-yl)-phenyl)-piperidine
  352. 2uvm: Structure of Pkbalpha Ph Domain in Complex with a Novel Inositol Headgroup Surrogate, Benzene 1,2,3,4- Tetrakisphosphate
  353. 2uv2: Crystal Structure of Human Ste20-like Kinase Bound to 4-(4-( 5-cyclopropyl-1h-pyrazol-3-ylamino)-quinazolin-2-ylamino)- Phenyl)-acetonitrile
  354. 2uue: Replace: a Strategy for Iterative Design of Cyclin Binding Groove Inhibitors
  355. 6zjf: Crystal Structure of STK17B (drak2) in Complex with Ap-229
  356. 6ziw: The Irak3 Pseudokinase Domain Bound to Atpgammas
  357. 6zhe: Cryo-em Structure of Dna-pk Dimer
  358. 6zha: Cryo-em Structure of Dna-pk Monomer
  359. 6zh8: Cryo-em Structure of Dna-pkcs:dna
  360. 6zh6: Cryo-em Structure of DNA-PKCS:KU80CT194
  361. 6zh4: Cryo-em Structure of Dna-pkcs (state 3)
  362. 6zh2: Cryo-em Structure of Dna-pkcs (state 1)
  363. 6zfp: Cryo-em Structure of Dna-pkcs (state 2)
  364. 2rq8: Solution Nmr Structure of Titin I27 Domain Mutant
  365. 2row: The C1 Domain of Rock II
  366. 2rov: The Split Ph Domain of Rock II
  367. 2bfx: Mechanism of Aurora-b Activation by Incenp and Inhibition by Hesperidin.
  368. 2bfy: Complex of Aurora-b with Incenp and Hesperidin.
  369. 2rjm: 3ig Structure of Titin Domains I67-i69 E-to-a Mutated Variant
  370. 2rio: Structure of The Dual Enzyme Ire1 Reveals The Basis for Catalysis and Regulation of Non-conventional Splicing
  371. 2rik: I-band Fragment I67-i69 from Titin
  372. 2r7i: Crystal Structure of Catalytic Subunit of Protein Kinase Ck2
  373. 2r7b: Crystal Structure of The Phosphoinositide-dependent Kinase- 1 (pdk-1)catalytic Domain Bound to a Dibenzonaphthyridine Inhibitor
  374. 2r5t: Crystal Structure of Inactive Serum and Glucocorticoid- Regulated Kinase 1 in Complex with Amp-pnp
  375. 2r0u: Crystal Structure of Chek1 in Complex with Inhibitor 54
  376. 2r0i: Crystal Structure of a Kinase Mark2/par-1 Mutant
  377. 2qre: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase in Complex with 5-aminoimidazole- 4-carboxamide 1-beta-d-ribofuranotide (zmp)
  378. 2qrd: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase in Complex with Adp and Atp
  379. 2qrc: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase in Complex with Adp and Amp
  380. 2qr8: 2.0a X-ray Structure of C-terminal Kinase Domain of P90 Ribosomal S6 Kinase 2 (rsk2)
  381. 2qr7: 2.0a X-ray Structure of C-terminal Kinase Domain of P90 Ribosomal S6 Kinase 2: Se-met Derivative
  382. 2qr1: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase in Complex with Adp
  383. 2qnj: Kinase and Ubiquitin-associated Domains of Mark3/par-1
  384. 2qme: Crystal Structure of Human Rac3 in Complex with Crib Domain of Human P21-activated Kinase 1 (pak1)
  385. 2qlv: Crystal Structure of The Heterotrimer Core of The S. Cerevisiae Ampk Homolog Snf1
  386. 2qkw: Structural Basis for Activation of Plant Immunity by Bacterial Effector Protein Avrpto
  387. 2qhn: Crystal Structure of Chek1 in Complex with Inhibitor 1a
  388. 2qhm: Crystal Structure of Chek1 in Complex with Inhibitor 2a
  389. 2cke: Human Death-associated Drp-1 Kinase in Complex with Inhibitor
  390. 2qc6: Protein Kinase Ck2 in Complex with Dbc
  391. 2cmw: Structure of Human Casein Kinase 1 Gamma-1 in Complex with 2-(2-hydroxyethylamino)-6-(3-chloroanilino)-9- Isopropylpurine (casp Target)
  392. 2cn5: Crystal Structure of Human Chk2 in Complex with Adp
  393. 2cn8: Crystal Structure of Human Chk2 in Complex with Debromohymenialdisine
  394. 2q0n: Structure of Human P21 Activating Kinase 4 (pak4) in Complex with a Consensus Peptide
  395. 2pzy: Structure of Mk2 Complexed with Compound 76
  396. 2pzi: Crystal Structure of Protein Kinase Pkng from Mycobacterium Tuberculosis in Complex with Tetrahydrobenzothiophene Ax20017
  397. 2pvr: Crystal Structure of The Catalytic Subunit of Protein Kinase Ck2 (c-terminal Deletion Mutant 1-335) in Complex with Two Sulfate Ions
  398. 2pvn: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
  399. 2pvm: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
  400. 2pvl: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
  401. 2pvk: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
  402. 2pvj: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
  403. 2pvh: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
  404. 2pe2: Crystal Structure of Human Phosphoinositide-dependent Protein Kinase 1 (pdk1) 3-{5-[2-oxo-5-ureido-1,2-dihydro- Indol-(3z)-ylidenemethyl]-1h-pyrrol-3-yl}-n-(2-piperidin-1- Yl-ethyl)-benzamide Complex
  405. 2pe1: Crystal Structure of Human Phosphoinositide-dependent Protein Kinase 1 (pdk1) {2-oxo-3-[1-(1h-pyrrol-2-yl)-eth- (z)-ylidene]-2,3-dihydro-1h-indol-5-yl}-urea {bx-517} Complex
  406. 2pe0: Crystal Structure of Human Phosphoinositide-dependent Protein Kinase 1 (pdk1) 5-hydroxy-3-[1-(1h-pyrrol-2-yl)- Eth-(z)-ylidene]-1,3-dihydro-indol-2-one Complex
  407. 2p3g: Crystal Structure of a Pyrrolopyridine Inhibitor Bound to Mapkap Kinase-2
  408. 2oza: Structure of P38ALPHA Complex
  409. 2oxy: Protein Kinase Ck2 in Complex with Tetrabromobenzoimidazole Derivatives K17, K22 and K32
  410. 2oxx: Protein Kinase Ck2 in Complex with Tetrabromobenzoimidazole Derivatives K17, K22 and K32
  411. 2oxd: Protein Kinase Ck2 in Complex with Tetrabromobenzoimidazole K17, K22 and K32 Inhibitors
  412. 2ov2: The Crystal Structure of The Human Rac3 in Complex with The Crib Domain of Human P21-activated Kinase 4 (pak4)
  413. 6z3a: Mec1-ddc2 (wild-type) in Complex with Amp-pnp
  414. 6z2x: Mec1-ddc2 (F2244L Mutant) in Complex with Mg Amp-pnp (state Ii)
  415. 6z2w: Mec1-ddc2 (F2244L Mutant) in Complex with Mg Amp-pnp
  416. 2ooy: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase Complexed with Atp
  417. 2oox: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase Complexed with Amp
  418. 2onl: Crystal Structure of The P38A-MAPKAP Kinase 2 Heterodimer
  419. 2okr: Crystal Structure of The P38A-MAPKAP Kinase 2 Heterodimer
  420. 6ypn: Crystal Structure of CK2ALPHA with 2 Molecules of Adp Bound
  421. 6ypk: Crystal Structure of CK2ALPHA with Gtp Bound
  422. 6ypj: Crystal Structure of CK2ALPHA with Compound 1 Bound
  423. 6yph: Crystal Structure of CK2ALPHA with Compound 2 Bound
  424. 6ypg: Crystal Structure of CK2ALPHA with Compound 2 Bound to Second Crystal Form
  425. 6ykd: Human Pim-1 Kinase in Complex with an Inhibitor Identified by Virtual Screening
  426. 2oid: Crystal Structure of Irak4 Kinase Domain Complexed with Amppnp
  427. 2oic: Crystal Structure of Irak4 Kinase Domain Complexed with Staurosporine
  428. 2oib: Crystal Structure of Irak4 Kinase Domain Apo Form
  429. 2oi4: Crystal Structure of Human Pim1 in Complex with Fluorinated Ruthenium Pyridocarbazole
  430. 6y9o: Crystal Structure of Whirlin Pdz3_c-ter in Complex with Cask Internal Pdz Binding Motif Peptide
  431. 6xwe: Crystal Structure of Lyk3 Ectodomain
  432. 2obj: Crystal Structure of Human Pim-1 Kinase in Complex with Inhibitor
  433. 6xrm: Crystal Structure of Human PI3K-GAMMA in Complex with Compound 4
  434. 6xrl: Crystal Structure of Human PI3K-GAMMA in Complex with Inhibitor Ipi- 549
  435. 6xr4: Integrative in Situ Structure of Parkinsons Disease-linked Human Lrrk2
  436. 2o8y: Apo Irak4 Kinase Domain
  437. 6xka: Tpx2 Residues 7-20 Fused to Aurora a Residues 116-389 Dephosphorylated, and Coalated on C290
  438. 6c83: Structure of Aurora a (122-403) Bound to Inhibitory Monobody Mb2 and Amppcp
  439. 6c4d: Structure Based Design of Rip1 Kinase Inhibitors
  440. 6c3e: Crystal Structure of Rip1 Kinase Bound to Inhibitor
  441. 6c2t: Aurora a Ligand Complex
  442. 6c2r: Aurora a Ligand Complex
  443. 6c1s: Phosphoinositide 3-kinase Gamma Bound to an Pyrrolopyridinone Inhibitor
  444. 6bxi: X-ray Crystal Structure of Ndr1 Kinase Domain
  445. 6bx6: Amp-activated Protein Kinase (ampk) Inhibition by Sbi-0206965: Alpha 2 Kinase Domain Bound to Sbi-0206965
  446. 6buu: Crystal Structure of Akt1 (aa 144-480) with a Bisubstrate
  447. 6bu6: Crystal Structure of The Human Vaccinia-related Kinase Bound to a Bis- Difluorophenol-aminopyridine Inhibitor
  448. 6btw: Crystal Structure of The Human Vaccinia-related Kinase Bound to a Phenyl-pteridinone Inhibitor
  449. 6bsk: Human Pim1 Kinase in Complex with Compound 12b
  450. 6bru: Crystal Structure of The Human Vaccinia-related Kinase Bound to a (s)- 2-phenylaminopteridinone Inhibitor
  451. 6bqd: Taf1-bd2 Bromodomain in Complex with (e)-3-(6-(but-2-en-1-yl)-7-oxo-6, 7-dihydro-1h-pyrrolo[2,3-c]pyridin-4-yl)-n,n-dimethylbenzamide
  452. 6bp0: Crystal Structure of The Human Vaccinia-related Kinase 1 Bound to (r)- 2-phenylaminopteridinone Inhibitor
  453. 6boe: Tbk1 in Complex with Amide-coupled Tetrazole Analog of Amlexanox
  454. 6bod: Tbk1 in Complex with Ethyl Ester Analog of Amlexanox
  455. 6bny: Tbk1 in Complex with Tetrazole Analog of Amlexanox
  456. 6bn1: Salvador Hippo Sarah Domain Complex
  457. 6bfn: Crystal Structure of Human Irak1
  458. 2dwb: Aurora-a Kinase Complexed with Amppnp
  459. 2o65: Crystal Structure of Pim1 with Pentahydroxyflavone
  460. 2o64: Crystal Structure of Pim1 with Quercetagetin
  461. 2o63: Crystal Structure of Pim1 with Myricetin
  462. 6bdn: Crystal Structure of Human Tao3 Kinase Binding Adp
  463. 2o3p: Crystal Structure of Pim1 with Quercetin
  464. 6b8u: Crystals Structure of B-raf Kinase Domain in Complex with an Imidazopyridinyl Benzamide Inhibitor
  465. 6b8j: Co-structure of Human Glycogen Synthase Kinase Beta with a Selective (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino) Ethyl]amine Inhibitor
  466. 6b5j: TNNI3K Complexed with a 4,6-diaminopyrimidine
  467. 2nzi: Crystal Structure of Domains A168-a170 from Titin
  468. 6b2q: Dual Inhibition of The Essential Protein Kinases a and B in Mycobacterium Tuberculosis
  469. 6b2p: Dual Inhibition of The Essential Protein Kinases a and B in Mycobacterium Tuberculosis
  470. 6b2e: Structure of Full Length Human Ampk (A2B2G1) in Complex with a Small Molecule Activator Sc4.
  471. 6b1u: Structure of Full-length Human Ampk (A2B1G1) in Complex with a Small Molecule Activator Sc4
  472. 6b16: P21-activated Kinase 1 in Complex with a 4-azaindole Inhibitor
  473. 6ayd: Pim1 Complexed with N-(6-(4-hydroxyphenyl)-1h-indazol-3-yl) Cyclopropanecarboxamide
  474. 6aud: PI3K-GAMMA K802T in Complex with Cpd 8 10-((1-(tert-butyl)piperidin-4- Yl)sulfinyl)-2-(1-isopropyl-1h-1,2,4-triazol-5-yl)-5,6- Dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
  475. 2nry: Crystal Structure of Irak-4
  476. 2nru: Crystal Structure of Irak-4
  477. 2e9n: Structure of H-chk1 Complexed with A767085
  478. 2e9o: Structure of H-chk1 Complexed with Aa582939
  479. 2e9p: Structure of H-chk1 Complexed with A771129
  480. 2e9u: Structure of H-chk1 Complexed with A780125
  481. 2e9v: Structure of H-chk1 Complexed with A859017
  482. 6ao5: Crystal Structure of Human Mst2 in Complex with Sav1 Sarah Domain
  483. 2np8: Structural Basis for The Inhibition of Aurora a Kinase by a Novel Class of High Affinity Disubstituted Pyrimidine Inhibitors
  484. 6ae3: Crystal Structure of GSK3BETA Complexed with Morin
  485. 6ac9: Crystal Structure of Human Vaccinia-related Kinase 1 (vrk1) in Complex with Amp-pnp
  486. 6ac5: Crystal Structure of Ripk1 Death Domain Glcnacylated by Epec Effector Nleb
  487. 6aar: Crystal Structure of Dapk1 in Complex with Purpurin
  488. 6a5e: Crystal Structure of Plant Peptide Ralf23 in Complex with fer and Llg2
  489. 6a5c: Crystal Structure of Plant Receptor-like Kinase Anx2
  490. 6a5b: Crystal Structure of Plant Receptor-like Kinase fer
  491. 6a5a: Crystal Structure of Plant Receptor-like Kinase Anx1
  492. 6a1c: Crystal Structure of The CK2A1-GO289 Complex
  493. 5zxb: Crystal Structure of Ack1 with Compound 10d
  494. 5zx5: 3.3 Angstrom Structure of Mouse Trpm7 with Edta
  495. 2ehb: The Structure of The C-terminal Domain of The Protein Kinase Atsos2 Bound to The Calcium Sensor Atsos3
  496. 2l05: Solution Nmr Structure of The Ras-binding Domain of Serine/threonine- Protein Kinase B-raf from Homo Sapiens, Northeast Structural Genomics Consortium Target HR4694F
  497. 5zn5: X-ray Structure of Protein Kinase Ck2 Alpha Subunit H148A Mutant
  498. 5zn4: X-ray Structure of Protein Kinase Ck2 Alpha Subunit H148N Mutant
  499. 5zn3: X-ray Structure of Protein Kinase Ck2 Alpha Subunit H148S Mutant
  500. 5zn2: X-ray Structure of Protein Kinase Ck2 Alpha Subunit H148A Mutant
  501. 5zn1: X-ray Structure of Protein Kinase Ck2 Alpha Subunit in D2O
  502. 5zn0: Joint X-ray/neutron Structure of Protein Kinase Ck2 Alpha Subunit
  503. 5zjw: Crystal Structure of Pak4 in Complex with Inhibitor Czg353
  504. 5zcs: 4.9 Angstrom Cryo-em Structure of Human Mtor Complex 2
  505. 2kui: Nmr Structure of The Pasta Domain of Mycobacterium Tuberculosis of Pknb
  506. 2kuf: Nmr Structure of The Pasta Domain 3 and 4 of Mycobacterium Tuberculosis of Pknb
  507. 2kue: Nmr Structure of The Pasta Domain 2 and 3 of Mycobacterium Tuberculosis of Pknb
  508. 2kud: Nmr Structure of The Pasta Domain 1 and 2 of Mycobacterium Tuberculosis of Pknb
  509. 5zan: Crystal Structure of Aurora-a in Complex with a New Quinazoline Inhibitor
  510. 5yzv: Biophysical and Structural Characterization of The Thermostable Wd40 Domain of a Prokaryotic Protein, Thermomonospora Curvata Pkwa
  511. 5yz8: Crystal Structure of N-terminal C1 Domain of Kaic
  512. 5yz0: Cryo-em Structure of Human Atr-atrip Complex
  513. 5yyz: Crystal Structure of The Mek1 Fha Domain in Complex with The Hop1 Pthr318 Peptide.
  514. 5yyx: Crystal Structure of The Mek1 Fha Domain
  515. 6l24: Crystal Structure of CK2A1 H115Y/V116I with Hematein
  516. 5ywm: Crystal Structure of CK2A2 Form-1
  517. 2h34: Apoenzyme Crystal Structure of The Tuberculosis Serine/threonine Kinase, Pkne
  518. 5yrn: Structure of Rip2 Card Domain
  519. 2h6d: Protein Kinase Domain of The Human 5'-amp-activated Protein Kinase Catalytic Subunit Alpha-2 (ampk Alpha-2 Chain)
  520. 2h9v: Structural Basis for Induced-fit Binding of Rho-kinase to The Inhibitor Y27632
  521. 2hak: Catalytic and Ubiqutin-associated Domains of Mark1/par-1
  522. 6g78: Rsk4 N-terminal Kinase Domain S232E in Complex with Amp-pnp
  523. 6g77: Rsk4 N-terminal Kinase Domain in Complex with Amp-pnp
  524. 6g76: Phosphorylated Rsk4 N-terminal Kinase Domain in Complex with Amp-pnp
  525. 6pxo: Human Casein Kinase 1 Delta (anion-free Crystallization Conditions)
  526. 6pxp: Human Casein Kinase 1 Delta Site 2 Mutant (K171E)
  527. 6u5l: Structure of Human Ulk4 in Complex with an Inhibitor
  528. 6tsz: The Ulk4 Pseudokinase Domain Bound to Atpgammas
  529. 6t3c: Crystal Structure of PI3KGAMMA in Complex with Dna-pk Inhibitor Azd7648
  530. 6t3b: Crystal Structure of PI3KGAMMA with a Dihydropurinone Inhibitor (compound 4)
  531. 6syt: Structure of The Smg1-smg8-smg9 Complex
  532. 2hog: Crystal Structure of Chek1 in Complex with Inhibitor 20
  533. 2hw6: Crystal Structure of Mnk1 Catalytic Domain
  534. 2hw7: Crystal Structure of MNK2-D228G in Complex with Staurosporine
  535. 2hxl: Crystal Structure of Chek1 in Complex with Inhibitor 1
  536. 2hxq: Crystal Structure of Chek1 in Complex with Inhibitor 2
  537. 2hy0: Crystal Structure of Chek1 in Complex with Inhibitor 22
  538. 2hy8: Pak1 Complex with St2001
  539. 2i3s: Bub3 Complex with Bub1 Glebs Motif
  540. 2ill: Anomalous Substructure of Titin-a168169
  541. 2iwi: Crystal Structure of The Human Pim2 in Complex with a Ruthenium Organometallic Ligand Ru1
  542. 2izr: Structure of Casein Kinase Gamma 3 in Complex with Inhibitor
  543. 2izs: Structure of Casein Kinase Gamma 3 in Complex with Inhibitor
  544. 2izt: Structure of Casein Kinase Gamma 3 in Complex with Inhibitor
  545. 2izu: Structure of Casein Kinase Gamma 3 in Complex with Inhibitor
  546. 2j0i: Crystal Structure of The Human P21-activated Kinase 4
  547. 2j2i: Crystal Structure of The Humab Pim1 in Complex with Ly333531
  548. 2j4z: Structure of Aurora-2 in Complex with Pha-680626
  549. 2j50: Structure of Aurora-2 in Complex with Pha-739358
  550. 2j51: Crystal Structure of Human Ste20-like Kinase Bound to 5- Amino-3-((4-(aminosulfonyl)phenyl)amino)-n-(2,6- Difluorophenyl)-1h-1,2,4-triazole-1-carbothioamide
  551. 2j7t: Crystal Structure of Human Serine Threonine Kinase-10 Bound to Su11274
  552. 2j8h: Structure of The Immunoglobulin Tandem Repeat A168-a169 of Titin
  553. 2j8o: Structure of The Immunoglobulin Tandem Repeat of Titin A168- A169
  554. 2j90: Crystal Structure of Human Zip Kinase in Complex with a Tetracyclic Pyridone Inhibitor (pyridone 6)
  555. 2jbo: Protein Kinase Mk2 in Complex with an Inhibitor (crystal Form-1, Soaking)
  556. 2jbp: Protein Kinase Mk2 in Complex with an Inhibitor (crystal Form-2, Co-crystallization)
  557. 2jd5: SKY1P Bound to NPL3P-DERIVED Substrate Peptide
  558. 2jdo: Structure of Pkb-beta (akt2) Complexed with Isoquinoline-5- Sulfonic Acid (2-(2-(4-chlorobenzyloxy) Ethylamino)ethyl) Amide
  559. 2jdr: Structure of Pkb-beta (akt2) Complexed with The Inhibitor A- 443654
  560. 2jfl: Crystal Structure of Human Ste20-like Kinase ( Diphosphorylated Form) Bound to 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-n-(2,6- Difluorophenyl)-1h-1,2, 4-triazole-1-carbothioamide
  561. 2jfm: Crystal Structure of Human Ste20-like Kinase (unliganded Form)
  562. 2jii: Structure of Vaccinia Related Kinase 3
  563. 6xag: Apo Braf Dimer Bound to 14-3-3
  564. 2jo8: Solution Structure of C-terminal Domain of Human Mammalian Sterile 20-like Kinase 1 (mst1)
  565. 2jqi: Nmr Structure of The Rad53 Fha1 Domain in Complex with a Phosphothreonien Peptide Derived from Rad53 Scd1
  566. 2jqj: Nmr Structure of Yeast Dun1 Fha Domain
  567. 2jql: Nmr Structure of The Yeast Dun1 Fha Domain in Complex with a Doubly Phosphorylated (pt) Peptide Derived from Rad53 Scd1
  568. 6w3k: Structure of Unphosphorylated Human Ire1 Bound to G-9807
  569. 6w3e: Structure of Phosphorylated Ire1 in Complex with G-0701
  570. 6w3c: Structure of Phosphorylated Apo Ire1
  571. 6w3b: Structure of Apo Unphosphorylated Ire1
  572. 6w3a: Structure of Unphosphorylated Ire1 in Complex with G-7658
  573. 6w39: Structure of Unphosphorylated Ire1 in Complex with G-1749
  574. 6vxr: Structure of Maternal Embryonic Leucine Zipper Kinase Bound to Ldsm276
  575. 6vrv: Discovery of Sarxxxx92, a Pan-pim Kinase Inhibitor, Efficacious in a Kg1 Tumor Model
  576. 6vru: Pim-inhibitor Complex 1
  577. 6vpm: Tpx2 Residues 7-20 Fused to Aurora a Residues 116-389 with C290 Disulfide Bonded to Compound 8-34, and in Complex with Amp-pnp
  578. 6vpl: Tpx2 Residues 7-20 Fused to Aurora a Residues 116-389 with C290 Disulfide Bonded to Compound 7-80, and in Complex with Amp-pnp
  579. 6vpj: Tpx2 Residues 7-20 Fused to Aurora a Residues 116-389 C247V + C319V Double Mutant Dephosphorylated, and in Complex with Amp-pnp
  580. 6vpi: Tpx2 Residues 7-20 Fused to Aurora a Residues 116-389 C247V + D256N + C319V Triple Mutant Disulfide Homodimer in Complex with Amp-pnp
  581. 6vph: Tpx2 Residues 7-20 Fused to Aurora a Residues 116-389 Modified with Cacodylate and in Complex with Amp-pnp
  582. 6vpg: Tpx2 Residues 7-20 Fused to Aurora a Residues 116-389 in Complex with Amp-pnp
  583. 6vp8: Cryo-em Structure of The C-terminal Half of The Parkinson's Disease- Linked Protein Leucine Rich Repeat Kinase 2 (lrrk2)
  584. 6vp7: Cryo-em Structure of The C-terminal Half of The Parkinson's Disease- Linked Protein Leucine Rich Repeat Kinase 2 (lrrk2)
  585. 6vp6: Cryo-em Structure of The C-terminal Half of The Parkinson's Disease- Linked Protein Leucine Rich Repeat Kinase 2 (lrrk2)
  586. 6vno: Cryo-em Structure of The C-terminal Half of The Parkinson's Disease- Linked Protein Leucine Rich Repeat Kinase 2 (lrrk2)
  587. 6vjj: Crystal Structure of Wild-type KRAS4B (gmppnp-bound) in Complex with Ras-binding Domain (rbd) of Raf1/craf
  588. 6v2w: Crystal Structure of The Braf:mek1 Kinases in Complex with Amppnp
  589. 6v2u: Crystal Structure of The Insect Cell-expressed Wt-braf Kinase in Complex with Dabrafenib
  590. 6tia: Irak4 in Complex with Inhibitor
  591. 6ti8: Irak4 in Complex with Inhibitor
  592. 6thz: Irak4 in Complex with Inhibitor
  593. 6thx: Irak4 in Complex with Inhibitor
  594. 6thw: Irak4 in Complex with Inhibitor
  595. 6tgu: Crystal Structure of Human Protein Kinase CK2ALPHA'(CSNK2A2 Gene Product) in Complex with The 2-aminothiazole-type Inhibitor Cl-oh-3
  596. 2kbx: Solution Structure of Ilk-pinch Complex
  597. 6tew: Crystal Structure of Human Protein Kinase CK2ALPHA' (CSNK2A2 Gene Product) in Complex with The 2-aminothiazole-type Inhibitor 27
  598. 6tei: Crystal Structure of Human Protein Kinase CK2ALPHA (CSNK2A1 Gene Product) in Complex with The 2-aminothiazole-type Inhibitor 17
  599. 6te2: Crystal Structure of Human Protein Kinase CK2ALPHA' (CSNK2A2 Gene Product) in Complex with The 2-aminothiazole-type Inhibitor 17
  600. 6tcu: Glycogen Synthase Kinase-3 Beta (GSK3B) in Complex with Ligand 1
  601. 6tca: Phosphorylated P38 and Mapkapk2 Complex with Inhibitor
  602. 6seq: Lemur Tyrosine Kinase 3 (lmtk3)
  603. 6s46: Room Temperature Structure of The Lov2 Domain of Phototropin-2 from Arabidopsis Thaliana 4158 Ms after Initiation of Illumination, Determined with a Serial Crystallography Approach
  604. 6s45: Room Temperature Structure of The Dark State of The Lov2 Domain of Phototropin-2 from Arabidopsis Thaliana Determined with a Serial Crystallography Approach
  605. 2kio: Nmr Structure of The Oxidized Yeast Tor1 Fatc Domain Bound to Dpc Micelles at 318k
  606. 2kit: The Solution Struture of The Reduced Yeast Tor1 Fatc Domain Bound to Dpc Micelles at 298k
  607. 6ruu: Pseudokinase Domain of Human Irak3
  608. 6p7g: The Co-crystal Structure of BRAF(V600E) with Phi1
  609. 6p3d: The Co-crystal Structure of BRAF(V600E) with Ponatinib
  610. 6ojf: Dimeric Structure of Lrrk2 Gtpase Domain
  611. 6oje: Dimeric Structure of Lrrk2 Gtpase Domain
  612. 6m4w: Crystal Structure of Mbp Fused Split Fkbp-frb T2098L Mutant in Complex with Rapamycin
  613. 6m4u: Crystal Structure of Fkbp-frb T2098L Mutant in Complex with Rapamycin
  614. 6m37: The Crystal Structure of B. Subtilis Rsbv/rsbw Complex in The Hexagonal Crystal Form
  615. 6m36: The Crystal Structure of B. Subtilis Rsbv/rsbw Complex in The Monoclinic Crystal Form
  616. 6lxy: Irak4 in Complex with Inhibitor
  617. 6l17: Crystal Structure of Ser/thr Kinase Pim1 in Complex with 10-debc Derivatives
  618. 6kyr: Crystal Structure of Dclk1 Mutant (P675L) Autoinhibited Kinase Domain
  619. 6kyq: Crystal Structure of Dclk1 Autoinhibited Kinase Domain
  620. 6kmh: The Crystal Structure of Cask/mint1 Complex
  621. 3ncz: X-ray Co-structure of Rho-associated Protein Kinase (rock1) with a Potent 2h-isoquinolin-1-one Inhibitor
  622. 6jpd: Mouse Receptor-interacting Protein Kinase 3 (rip3) Amyloid Structure by Solid-state Nmr
  623. 3pa3: X-ray Crystal Structure of Compound 70 Bound to Human Chk1 Kinase Domain
  624. 3pa4: X-ray Crystal Structure of Compound 2a Bound to Human Chk1 Kinase Domain
  625. 3pa5: X-ray Crystal Structure of Compound 1 Bound to Human Chk1 Kinase Domain
  626. 3pm8: Cad Domain of PFF0520W, Calcium Dependent Protein Kinase
  627. 2kr9: Kalirin Dh1 Nmr Structure
  628. 2kty: Solution Structure of Human Vaccinia Related Kinase-1
  629. 2kul: Solution Structure of Human Vaccinia Related Kinase 1(vrk1)
  630. 6z3r: Structure of Smg1-8-9 Kinase Complex Bound to Upf1-lsq
  631. 6wly: Pak4 Kinase Domain in Complex with Limk1 Thr508 Substrate Peptide
  632. 6wlx: Pak4 Kinase Domain in Complex with Beta-catenin Ser675 Substrate Peptide
  633. 6vql: Crystal Structure of Interleukin-1 Receptor-associated Kinase 4 (irak4-wt) Complex with a Nicotinamide Inhibitor
  634. 2xbj: Crystal Structure of Chk2 in Complex with an Inhibitor
  635. 2xix: Protein Kinase Pim-1 in Complex with Fragment-1 from Crystallographic Fragment Screen
  636. 2xiy: Protein Kinase Pim-1 in Complex with Fragment-2 from Crystallographic Fragment Screen
  637. 2xiz: Protein Kinase Pim-1 in Complex with Fragment-3 from Crystallographic Fragment Screen
  638. 2xj0: Protein Kinase Pim-1 in Complex with Fragment-4 from Crystallographic Fragment Screen
  639. 2xj1: Protein Kinase Pim-1 in Complex with Small Molecule Inibitor
  640. 2xj2: Protein Kinase Pim-1 in Complex with Small Molecule Inhibitor
  641. 2xm8: Co-crystal Structure of a Small Molecule Inhibitor Bound to The Kinase Domain of Chk2
  642. 2xm9: Structure of a Small Molecule Inhibitor with The Kinase Domain of Chk2
  643. 6yid: Crystal Structure of Ulk2 in Complex with Sbi-0206965
  644. 2y9r: Crystal Structure of The M10 Domain of Titin
  645. 6sk9: Nek2 Bound to Purine Compound 51
  646. 6sgk: Nek2 Kinase Bound to Inhibitor 102
  647. 6sgi: Nek2 Kinase Bound to Inhibitor 96
  648. 6sgh: Nek2 Kinase Covalently Bound to 2-arylamino-6-ethynylpurine Inhibitor 66
  649. 6sgd: Nek2 Kinase Covalently Bound to 2-arylamino-6-ethynylpurine Inhibitor 24
  650. 6s76: Crystal Structure of Human Nek7
  651. 3nga: Human Ck2 Catalytic Domain in Complex with Cx-4945
  652. 6s75: Crystal Structure of Nek7 Bound to Compound 51
  653. 6s73: Crystal Structure of Nek7 Srs Mutant Bound to Compound 51
  654. 3nsz: Human Ck2 Catalytic Domain in Complex with Amppn
  655. 6z5e: Crystal Structure of Haspin (gsg2) in Complex with Macrocycle Ods2004093
  656. 6z5d: Crystal Structure of Haspin (gsg2) in Complex with Macrocycle Ods2004082
  657. 6z5c: Crystal Structure of Haspin (gsg2) in Complex with Macrocycle Ods2004070
  658. 6z5b: Crystal Structure of Haspin (gsg2) in Complex with Macrocycle Ods2003128
  659. 6z5a: Crystal Structure of Haspin (gsg2) in Complex with Macrocycle Ods2002941
  660. 6z59: Crystal Structure of Haspin (gsg2) in Complex with Macrocycle Ods2003816
  661. 6z58: Crystal Structure of Haspin (gsg2) in Complex with Macrocycle Ods2003791
  662. 6z57: Crystal Structure of Haspin (gsg2) in Complex with Macrocycle Ods2004078
  663. 6z56: Crystal Structure of Haspin (gsg2) in Complex with Macrocycle Ods2003208
  664. 6z4y: Crystal Structure of Aurora a (stk6) in Complex with Macrocycle Ods2003208
  665. 3ofm: Structure of a Human CK2ALPHA Prime, The Paralog Isoform of The Catalytic Subunit of Protein Kinase Ck2 from Homo Sapiens
  666. 3ose: Structure of The Kinase Associated Domain 1 (ka1) from Mark1 Kinase
  667. 3osm: Structure of The Kinase Associated Domain-1 (ka1) from KCC4P
  668. 3ost: Structure of The Kinase Associated-1 (ka1) from KCC4P
  669. 6vrf: Adp Bound Ttbk2 Kinase Domain
  670. 6uuo: Crystal Structure of Braf Kinase Domain Bound to The Protac P4B
  671. 3p23: Crystal Structure of The Human Kinase and Rnase Domains in Complex with Adp
  672. 3pcs: Structure of Espg-pak2 Autoinhibitory Ialpha3 Helix Complex
  673. 3ppj: Human B-raf Kinase in Complex with a Furopyridine Inhibitor
  674. 3ppk: Human B-raf Kinase in Complex with a Non-oxime Furopyridine Inhibitor
  675. 3prf: Crystal Structure of Human B-raf Kinase Domain in Complex with a Non- Oxime Furopyridine Inhibitor
  676. 3pri: Crystal Structure of Human B-raf Kinase in Complex with a Non-oxime Furopyridine Inhibitor
  677. 3ps4: Pdz Domain from Human Microtubule-associated Serine/threonine-protein Kinase 1
  678. 3psb: Furo[2,3-c]pyridine-based Indanone Oximes as Potent and Selective B- Raf Inhibitors
  679. 6ya8: Cdc7-dbf4 Bound to Adp-bef3
  680. 6ya7: Cdc7-dbf4 Bound to an Mcm2-s40 Derived Bivalent Substrate
  681. 6ya6: Minimal Construct of Cdc7-dbf4 Bound to Xl413
  682. 3pvg: Crystal Structure of Z. Mays Ck2 Alpha Subunit in Complex with The Inhibitor 4,5,6,7-tetrabromo-1-carboxymethylbenzimidazole (k68)
  683. 3q4c: Crystal Structure of Wild Type Braf Kinase Domain in Complex with Organometallic Inhibitor Cns292
  684. 3q5z: Crystal Structure of Virulent Allele ROP5B Pseudokinase Domain
  685. 3q60: Crystal Structure of Virulent Allele ROP5B Pseudokinase Domain Bound to Atp
  686. 6p3a: Crystal Structure Analysis of Taf1 Bromodomain
  687. 6p39: Crystal Structure Analysis of Taf1 Bromodomain
  688. 6p38: Crystal Structure Analysis of Taf1 Bromodomain
  689. 6l16: Crystal Structure of Ser/thr Kinase Pim1 in Complex with 10-debc Derivatives
  690. 6l15: Crystal Structure of Ser/thr Kinase Pim1 in Complex with 10-debc Derivatives
  691. 6l14: Crystal Structure of Ser/thr Kinase Pim1 in Complex with 10-debc Derivatives
  692. 6l13: Crystal Structure of Ser/thr Kinase Pim1 in Complex with 10-debc Derivatives
  693. 6l12: Crystal Structure of Ser/thr Kinase Pim1 in Complex with 10-debc Derivatives
  694. 6l11: Crystal Structure of Ser/thr Kinase Pim1 in Complex with 10-debc Derivatives
  695. 3qf9: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Furan- Thiazolidinedione Ligand
  696. 6y9s: Crystal Structure of Gsk-3b in Complex with The Imidazo[1,5- A]pyridine-3-carboxamide Inhibitor 16
  697. 6y9r: Crystal Structure of Gsk-3b in Complex with The 1h-indazole-3- Carboxamide Inhibitor 2
  698. 2xnm: Structure of Nek2 Bound to Cct
  699. 2xnn: Structure of Nek2 Bound to Cct242430
  700. 2xno: Structure of Nek2 Bound to Cct243779
  701. 2xnp: Structure of Nek2 Bound to Cct244858
  702. 6jlr: Crystal Structure of Wild Type Mnk2 in Complex with Inhibitor
  703. 2y8l: Structure of The Regulatory Fragment of Mammalian Ampk in Complex with Two Adp
  704. 2y8q: Structure of The Regulatory Fragment of Mammalian Ampk in Complex with One Adp
  705. 2ya3: Structure of The Regulatory Fragment of Mammalian Ampk in Complex with Coumarin Adp
  706. 2ya9: Crystal Structure of The Autoinhibited Form of Mouse Dapk2
  707. 2yaa: Crystal Structure of The Autoinhibited Form of Mouse Dapk2 in Complex with Atp
  708. 2yab: Crystal Structure of The Autoinhibited Form of Mouse Dapk2 in Complex with Amp
  709. 2yak: Structure of Death-associated Protein Kinase 1 (dapk1) in Complex with a Ruthenium Octasporine Ligand (osv)
  710. 3aqv: Human Amp-activated Protein Kinase Alpha 2 Subunit Kinase Domain (T172D) Complexed with Compound C
  711. 3m11: Crystal Structure of Aurora a Kinase Complexed with Inhibitor
  712. 3m42: Crystal Structure of Mapkap Kinase 2 (mk2) Complexed with a Tetracyclic Atp Site Inhibitor
  713. 3o0z: Crystal Structure of a Coiled-coil Domain from Human Rock I
  714. 6ru8: Crystal Structure of Casein Kinase I Delta (CK1D) in Complex with Triple Phosphorylated P63 PAD3P Peptide
  715. 6ru7: Crystal Structure of Casein Kinase I Delta (CK1D) in Complex with Double Phosphorylated P63 PAD2P Peptide
  716. 6ru6: Crystal Structure of Casein Kinase I Delta (CK1D) in Complex with Monophosphorylated P63 PAD1P Peptide
  717. 3orx: Pdk1 Mutant Bound to Allosteric Disulfide Fragment Inhibitor 1f8
  718. 3orz: Pdk1 Mutant Bound to Allosteric Disulfide Fragment Activator 2a2
  719. 3otu: Pdk1 Mutant Bound to Allosteric Disulfide Fragment Activator Js30
  720. 3p9j: Aurora a Kinase Domain with Phthalazinone Pyrazole Inhibitor
  721. 3pwy: Crystal Structure of an Extender (spd28345)-modified Human Pdk1 Complex 2
  722. 3q96: B-raf Kinase Domain in Complex with a Tetrahydronaphthalene Inhibitor
  723. 3qc4: Pdk1 in Complex with Dfg-out Inhibitor XXX
  724. 3qcq: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 6-(3- Amino-1h-indazol-6-yl)-n4-ethyl-2,4-pyrimidinediamine
  725. 3qcs: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 6-[2- Amino-6-(4-morpholinyl)-4-pyrimidinyl]-1h-indazol-3-amine
  726. 3qcx: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 6-{2- Amino-6-[(3r)-3-methyl-4-morpholinyl]-4-pyrimidinyl}-1h-indazol-3- Amine
  727. 3qcy: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 4-[2- Amino-6-(3-amino-1h-indazol-6-yl)-4-pyrimidinyl]-n-phenyl-2- Morpholinecarboxamide
  728. 3qd0: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with (2r,5s)- 1-[2-amino-6-(3-amino-1h-indazol-6-yl)-4-pyrimidinyl]-6-methyl-n- Phenyl-3-piperidinecarboxamide
  729. 3qd2: Crsytal Structure of Mouse Perk Kinase Domain
  730. 3qd3: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 1,1- Dimethylethyl {(3r,6s)-1-[2-amino-6-(3-amino-1h-indazol-6-yl)-4- Pyrimidinyl]-6-methyl-3-piperidinyl}carbamate
  731. 3qd4: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 1,1- Dimethylethyl{(3r,5r)-1-[2-amino-6-(3-amino-1h-indazol-6-yl)-4- Pyrimidinyl]-5-methyl-3-piperidinyl}carbamate
  732. 3qkk: Spirochromane Akt Inhibitors
  733. 3qkl: Spirochromane Akt Inhibitors
  734. 3qkm: Spirocyclic Sulfonamides as Akt Inhibitors
  735. 6ra5: Human Tnik in Complex with Compound 9
  736. 6yat: Crystal Structure of Stk4 (mst1) in Complex with Compound 6
  737. 2lav: Nmr Solution Structure of Human Vaccinia-related Kinase 1
  738. 2lah: Solution Nmr Structure of Mitotic Checkpoint Serine/threonine-protein Kinase Bub1 N-terminal Domain from Homo Sapiens, Northeast Structural Genomics Consortium Target HR5460A (methods Development)
  739. 3r00: The Discovery of Novel Benzofuran-2-carboxylic Acids as Potent Pim-1 Inhibitors
  740. 3r01: The Discovery of Novel Benzofuran-2-carboxylic Acids as Potent Pim-1 Inhibitors
  741. 3r02: The Discovery of Novel Benzofuran-2-carboxylic Acids as Potent Pim-1 Inhibitors
  742. 3r04: The Discovery of Novel Benzofuran-2-carboxylic Acids as Potent Pim-1 Inhibitors
  743. 3lcy: Titin Ig Tandem Domains A164-a165
  744. 3nlb: Novel Kinase Profile Highlights The Temporal Basis of Context Dependent Checkpoint Pathways to Cell Death
  745. 3psd: Non-oxime Pyrazole Based Inhibitors of B-raf Kinase
  746. 6xx9: Arabidopsis Thaliana Casein Kinase 2 (ck2) Alpha-1 Crystal Form III
  747. 6xx8: Arabidopsis Thaliana Casein Kinase 2 (ck2) Alpha-1 Crystal Form II
  748. 3r1n: Mk3 Kinase Bound to Compound 5b
  749. 6xx7: Arabidopsis Thaliana Casein Kinase 2 (ck2) Alpha-1 Crystal in Complex with Anp
  750. 6xx6: Arabidopsis Thaliana Casein Kinase 2 (ck2) Alpha-1 Crystal Form I
  751. 3r2b: Mk2 Kinase Bound to Compound 5b
  752. 3r2y: Mk2 Kinase Bound to Compound 1
  753. 3r30: Mk2 Kinase Bound to Compound 2
  754. 2kyl: Solution Structure of Mast2-pdz Complexed with The C-terminus of Pten
  755. 6ol2: Crystallography of Novel Wnk1 and Wnk3 Inhibitors Discovered from High-throughput-screening
  756. 6l54: Structure of Smg189
  757. 6l53: Structure of Smg1
  758. 6rff: Human Protein Kinase Ck2 Alpha in Complex with 2-cyano-2-propenamide Compound 7
  759. 6rfe: Human Protein Kinase Ck2 Alpha in Complex with 2-cyano-2-propenamide Compound 4
  760. 6rcm: Human Protein Kinase Ck2 Alpha in Complex with 2-cyano-2-propenamide Compound 3
  761. 6rcb: Human Protein Kinase Ck2 Alpha in Complex with 2-cyano-2-propenamide Compound 14
  762. 6rb1: Human Protein Kinase Ck2 Alpha in Complex with 2-cyano-2-propenamide Compound 1
  763. 6lnm: Crystal Structure of Cask-camk in Complex with Mint1-cid
  764. 6rsu: Tbk1 in Complex with Inhibitor Compound 35
  765. 6rch: Crystal Structure of Casein Kinase I Isoform Delta (ck1 Delta) Complexed with Sr4133 Inhibitor
  766. 6rcg: Crystal Structure of Casein Kinase 1 Delta (ck1 Delta) Complexed with Sr3029 Inhibitor
  767. 6qy8: Human CSNK2A2 Bound to Erb-041
  768. 6qy7: Human CSNK2A1 Bound to Erb-041
  769. 6y7c: Early Cytoplasmic Yeast Pre-40s Particle (purified with Tsr1 as Bait)
  770. 6l1z: Crystal Structure of CK2A1 with Hematein
  771. 6p5p: Discovery of a Novel, Highly Potent, and Selective Thieno[3,2- D]pyrimidinone-based Cdc7 Inhibitor with a Quinuclidine Moiety (tak- 931) as an Orally Active Investigational Anti-tumor Agent
  772. 6y6h: Crystal Structure of STK17B (drak2) in Complex with Unc-ap-194 Probe
  773. 6y6f: Crystal Structure of STK17B (drak2) in Complex with Pkis43
  774. 6vzh: Structure of Human Vaccinia-related Kinase 1 (vrk1) Bound to Ldsm311
  775. 3rcj: Rapid Preparation of Triazolyl Substituted Nh-heterocyclic Kinase Inhibitors via One-pot Sonogashira Coupling Tms-deprotection Cuaac Sequence
  776. 3rgx: Structural Insight into Brassinosteroid Perception by Bri1
  777. 3rgz: Structural Insight into Brassinosteroid Perception by Bri1
  778. 3riz: Crystal Structure of The Plant Steroid Receptor Bri1 Ectodomain
  779. 3rj0: Plant Steroid Receptor Bri1 Ectodomain in Complex with Brassinolide
  780. 3rps: Structure of Human CK2ALPHA in Complex with The Atp-competitive Inhibitor 3-(4,5,6,7-tetrabromo-1h-benzotriazol-1-yl)propan-1-ol
  781. 6u0k: Ttbk2 Kinase Domain in Complex with Compound 1
  782. 6ntd: Crystal Structure of G12V Hras-gppnhp Bound in Complex with The Engineered Rbd Variant 12 of Craf Kinase Protein
  783. 3s95: Crystal Structure of The Human Limk1 Kinase Domain in Complex with Staurosporine
  784. 3sdj: Structure of Rnase-inactive Point Mutant of Oligomeric Kinase/rnase Ire1
  785. 3sdm: Structure of Oligomeric Kinase/rnase Ire1 in Complex with an Oligonucleotide
  786. 6shc: Crystal Structure of Human Ire1 Luminal Domain Q105C
  787. 3r21: Design, Synthesis, and Biological Evaluation of Pyrazolopyridine- Sulfonamides as Potent Multiple-mitotic Kinase (mmk) Inhibitors (part I)
  788. 3r22: Design, Synthesis, and Biological Evaluation of Pyrazolopyridine- Sulfonamides as Potent Multiple-mitotic Kinase (mmk) Inhibitors (part I)
  789. 6rst: Tbk1 in Complex with Inhibitor Compound 24
  790. 6rsr: Tbk1 in Complex with Compound 2
  791. 3skc: Human B-raf Kinase in Complex with an Amide Linked Pyrazolopyridine Inhibitor
  792. 6nid: Crystal Structure of a Human Calcium/calmodulin Dependent Serine Protein Kinase (cask) Pdz Domain in Complex with Neurexin-1 Peptide
  793. 6nh9: Crystal Structure of a Human Calcium/calmodulin Dependent Serine Protein Kinase (cask) Pdz Domain
  794. 2yiq: Structural Analysis of Checkpoint Kinase 2 in Complex with Inhibitor Pv1322
  795. 2yir: Structural Analysis of Checkpoint Kinase 2 in Complex with Inhibitor Pv1352
  796. 2yit: Structural Analysis of Checkpoint Kinase 2 in Complex with Pv1162, a Novel Inhibitor
  797. 6k9l: 4.27 Angstrom Resolution Cryo-em Structure of Human Dimeric Atm Kinase
  798. 6k9k: Monomeric Human Atm (ataxia Telangiectasia Mutated) Kinase
  799. 3pe1: Crystal Structure of Human Protein Kinase Ck2 Alpha Subunit in Complex with The Inhibitor Cx-4945
  800. 3pe2: Crystal Structure of Human Protein Kinase Ck2 in Complex with The Inhibitor Cx-5011
  801. 5qqn: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-010-382-606
  802. 5qqm: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-009-565-325
  803. 5qql: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-009-565-301
  804. 5qqk: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-009-359-835
  805. 5qqj: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-009-587-558
  806. 5qqi: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-009-178-994
  807. 5qqh: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-020-096-465
  808. 5qqg: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-009-541-216
  809. 5qqf: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-004-412-710
  810. 5qqe: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-009-531-494
  811. 5qqd: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Z56880342
  812. 6uya: Crystal Structure of Compound 19 Bound to Irak4
  813. 6urc: Crystal Structure of IRE1A in Complex with Compound 18
  814. 6ul8: Rip2 Kinase Catalytic Domain Complex with (5s,6s,8r)-2- (benzo[d]thiazol-5-yl)-6-hydroxy-4,5,6,7,8,9-hexahydro-5,8- Methanopyrazolo[1,5-a][1,3]diazocine-3-carboxamide
  815. 3s1a: Crystal Structure of The Phosphorylation-site Double Mutant S431E/T432E of The Kaic Circadian Clock Protein
  816. 6uan: B-raf:14-3-3 Complex
  817. 6u2h: Braf Dimer Bound to 14-3-3
  818. 6u2g: Braf-mek Complex with Amp-pcp Bound to Braf
  819. 3amy: Crystal Structure of Human Ck2 Alpha Complexed with Apigenin
  820. 6szj: Rip2 Kinase Catalytic Domain Complex with 5AMINO1TERTBUTYL3(3METHOXYPHENYL)1H PYRAZOLE4CARBOXAMIDE.
  821. 6sze: Rip2 Kinase Catalytic Domain Complex with 5-amino-1-phenylpyrazole-4- Carboxamide.
  822. 3t9i: Pim1 Complexed with a Novel 3,6-disubstituted Indole at 2.6 Ang Resolution
  823. 3tac: Crystal Structure of The Liprin-alpha/cask Complex
  824. 3tku: Mrck Beta in Complex with Fasudil
  825. 3tv4: Human B-raf Kinase Domain in Complex with an Bromopyridine Benzamide Inhibitor
  826. 3tv6: Human B-raf Kinase Domain in Complex with a Methoxypyrazolopyridinyl Benzamide Inhibitor
  827. 6sl1: Structure of The Open Conformation of Cttel1
  828. 6sl0: Complete Cttel1 Dimer with C2 Symmetry
  829. 6skz: Structure of The Closed Conformation of Cttel1
  830. 6sky: Fat and Kinase Domain of Cttel1
  831. 3zut: The Structure of Ost1 (D160A) Kinase
  832. 3zuu: The Structure of Ost1 (D160A, S175D) Kinase in Complex with Gold
  833. 6sdb: Chimeric Titin Z1Z2 Functionalized with a Kler Exogenous Peptide from Decorin
  834. 6sb2: Cryo-em Structure of Mtorc1 Bound to Active Raga/c Gtpases
  835. 6sb0: Cryo-em Structure of Mtorc1 Bound to Pras40-fused Active Raga/c Gtpases
  836. 6s9x: Crystal Structure of Akt1 in Complex with Covalent-allosteric Akt Inhibitor 15c
  837. 6s9w: Crystal Structure of Akt1 in Complex with Covalent-allosteric Akt Inhibitor 16a
  838. 6s8f: Structure of Nucleotide-bound Tel1/atm
  839. 3p86: Crystal Structure of Ctr1 Kinase Domain Mutant D676N in Complex with Staurosporine
  840. 3sc1: Novel Isoquinolone Pdk1 Inhibitors Discovered through Fragment-based Lead Discovery
  841. 3si5: Kinetochore-bubr1 Kinase Complex
  842. 6s1f: Structure of The Kinase Domain of Human Ripk2 in Complex with The Inhibitor Cslp3
  843. 2xuu: Crystal Structure of a Dap-kinase 1 Mutant
  844. 3at2: Crystal Structure of CK2ALPHA
  845. 3at3: Crystal Structure of CK2ALPHA with Pyradine Derivative
  846. 3at4: Crystal Structure of CK2ALPHA with Pyradine Derivertive
  847. 3pwd: Crystal Structure of Maize Ck2 in Complex with Nbc (z1)
  848. 3t4n: Structure of The Regulatory Fragment of Saccharomyces Cerevisiae Ampk in Complex with Adp
  849. 3tdh: Structure of The Regulatory Fragment of Sccharomyces Cerevisiae Ampk in Complex with Amp
  850. 3te5: Structure of The Regulatory Fragment of Sacchromyces Cerevisiae Ampk in Complex with Nadh
  851. 6rna: Rip2 Kinase Catalytic Domain Complex with 2({4[(1,3BENZOTHIAZOL5YL) AMINO]6(2METHYLPROPANE2SULFONYL)QUINAZOLIN7YL}OXY)ETHAN1OL
  852. 6rn8: Rip2 Kinase Catalytic Domain Complex with 2(4[(1,3BENZOTHIAZOL5YL) AMINO]6(2METHYLPROPANE2SULFONYL)QUINAZOLIN7YL)OXY)ETHYL Phosphate
  853. 6rln: Crystal Structure of Rip1 Kinase in Complex with Gsk3145095
  854. 2ycf: Crystal Structure of Checkpoint Kinase 2 in Complex with Inhibitor Pv1531
  855. 2ycq: Crystal Structure of Checkpoint Kinase 2 in Complex with Inhibitor Pv1115
  856. 2ycr: Crystal Structure of Checkpoint Kinase 2 in Complex with Inhibitor Pv976
  857. 2ycs: Crystal Structure of Checkpoint Kinase 2 in Complex with Pv788
  858. 3rwp: Discovery of a Novel, Potent and Selective Inhibitor of 3- Phosphoinositide Dependent Kinase (pdk1)
  859. 3rwq: Discovery of a Novel, Potent and Selective Inhibitor of 3- Phosphoinositide Dependent Kinase (pdk1)
  860. 3tax: A Neutral Diphosphate Mimic Crosslinks The Active Site of Human O- Glcnac Transferase
  861. 3udb: Crystal Structure of Snrk2.6
  862. 6rfj: Irak4 in Complex with Inhibitor
  863. 6rfi: Irak4 in Complex with Inhibitor
  864. 6rbd: State 1 of Yeast Tsr1-tap Rps20-deltaloop Pre-40s Particles
  865. 2xzs: Death Associated Protein Kinase 1 Residues 1-312
  866. 6ra7: Human Tnik in Complex with Compound 9
  867. 2y0a: Structure of Dapk1 Construct Residues 1-304
  868. 3ppz: Crystal Structure of Ctr1 Kinase Domain in Complex with Staurosporine
  869. 3puc: Atomic Resolution Structure of Titin Domain M7
  870. 3pzh: Crystal Structure of Maize Ck2 Alpha in Complex with Emodin at 1.92 a Resolution
  871. 3q04: Crystal Structure of The Apo-form of Human Ck2 Alpha at Ph 8.5
  872. 3q4z: Structure of Unphosphorylated Pak1 Kinase Domain
  873. 3q52: Structure of Phosphorylated Pak1 Kinase Domain
  874. 3q53: Structure of Phosphorylated Pak1 Kinase Domain in Complex with Atp
  875. 3r0t: Crystal Structure of Human Protein Kinase Ck2 Alpha Subunit in Complex with The Inhibitor Cx-5279
  876. 6r5f: Crystal Structure of Rip1 Kinase in Complex with Dhp77
  877. 6r4d: Aurora-a in Complex with Shape-diverse Fragment 58
  878. 6r4c: Aurora-a in Complex with Shape-diverse Fragment 57
  879. 3she: Novel Atp-competitive Mk2 Inhibitors with Potent Biochemical and Cell- Based Activity throughout The Series
  880. 6r4b: Aurora-a in Complex with Shape-diverse Fragment 56
  881. 6r4a: Aurora-a in Complex with Shape-diverse Fragment 55
  882. 6r49: Aurora-a in Complex with Shape-diverse Fragment 39
  883. 6r1h: Crystal Structure of The Lrr Ectodomain of The Receptor Kinase Sobir1 from Arabidopsis Thaliana.
  884. 6qy9: Human CSNK2A2 Bound to a Pyrrolo[2,3-d]pyrimidinyl Inhibitor
  885. 3uc3: The Crystal Structure of Snf1-related Kinase 2.3
  886. 3uc4: The Crystal Structure of Snf1-related Kinase 2.6
  887. 6qxk: Human Pim1 Bound to Ox0999
  888. 4a06: Human Pdk1 Kinase Domain in Complex with Allosteric Activator Ps114 Bound to The Pif-pocket
  889. 4a07: Human Pdk1 Kinase Domain in Complex with Allosteric Activator Ps171 Bound to The Pif-pocket
  890. 6qsa: Cryogenic Temperature Structure of Blue Light-irradiated ATPHOT2LOV2 Recorded after an Accumulated Dose of 48 Kgy
  891. 6qs5: Crystal Structure of Maize Ck2 in Complex with Tyrphostin Ag99
  892. 6qqk: Room Temperature Structure of Blue Light-irradiated ATPHOT2LOV2 Recorded after an Accumulated Dose of 34 Kgy
  893. 6qqj: Room Temperature Structure of The Ground State of ATPHOT2LOV2 Recorded after an Accumulated Dose of 354 Kgy
  894. 6qqi: Cryogenic Temperature Structure of Blue Light-irradiated ATPHOT2LOV2 Recorded after an Accumulated Dose of 24 Kgy
  895. 6qqh: Cryogenic Temperature Structure of The Ground State of ATPHOT2LOV2 Recorded after an Accumulated Dose of 2.68 Mgy
  896. 2y4v: Crystal Structure of Human Calmodulin in Complex with a Dap Kinase-1 Mutant (W305Y) Peptide
  897. 6qn4: Death-associated Protein Kinase 1 (dapk1) Catalytic and Auto- Regulatory Domains with S289E and S308E Mutations
  898. 6qmo: Death-associated Protein Kinase 1 (dapk1) Catalytic and Auto- Regulatory Domains with S289E and S308A Mutations
  899. 4a55: Crystal Structure of P110ALPHA in Complex with Ish2 of P85ALPHA and The Inhibitor Pik-108
  900. 2ym3: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  901. 2ym4: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  902. 2ym5: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  903. 2ym6: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  904. 2ym7: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  905. 2ym8: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  906. 3q9w: Crystal Structure of Human Ck2 Alpha in Complex with Emodin at Ph 8.5
  907. 3q9x: Crystal Structure of Human Ck2 Alpha in Complex with Emodin at Ph 6.5
  908. 3q9y: Crystal Structure of Human Ck2 Alpha in Complex with Quinalizarin at Ph 8.5
  909. 3q9z: Crystal Structure of Human Ck2 Alpha in Complex with Quinalizarin at Ph 6.5
  910. 3qa0: Crystal Structure of The Apo-form of Human Ck2 Alpha at Ph 6.5
  911. 6qf4: X-ray Structure of Human Serine/threonine Kinase 17b (STK17B) Aka Drak2 in Complex with Adp Obtained by On-chip Soaking
  912. 3tl8: The Avrptob-bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains in a Single Type III Effector
  913. 3uys: Crystal Structure of Apo Human CK1D
  914. 3uyt: Crystal Structure of CK1D with Pf670462 from P1 Crystal Form
  915. 3uzp: Crystal Structure of CK1D with Pf670462 from P21 Crystal Form
  916. 2y4p: Dimeric Structure of Dapk-1 Catalytic Domain
  917. 6qav: Crystal Structure of Ulk2 in Complexed with Mrt68921
  918. 6qau: Crystal Structure of Ulk2 in Complexed with Mrt67307
  919. 6qat: Crystal Structure of Ulk2 in Complexed with Hesperadin
  920. 6qas: Crystal Structure of Ulk1 in Complexed with Pf-03814735
  921. 3qbn: Structure of Human Aurora a in Complex with a Diaminopyrimidine
  922. 3uv5: Crystal Structure of The Tandem Bromodomains of Human Transcription Initiation Factor Tfiid Subunit 1 (taf1)
  923. 2ydj: Discovery of Checkpoint Kinase Inhibitor Azd7762 by Structure Based Design and Optimization of Thiophene Carboxamide Ureas
  924. 6q4q: The Crystal Structure of CK2A Bound to P2-c4
  925. 6q38: The Crystal Structure of CK2A Bound to P1-c4
  926. 6q0t: Structure of a Mapk Pathway Complex
  927. 6q0k: Structure of a Mapk Pathway Complex
  928. 6q0j: Structure of a Mapk Pathway Complex
  929. 3u9n: X-ray Crystal Structure of Compound 1 Bound to Human Chk1 Kinase Domain
  930. 3unz: Aurora a in Complex with Rpm1679
  931. 3uo4: Aurora a in Complex with Rpm1680
  932. 3uo5: Aurora a in Complex with Yl1-038-31
  933. 3uo6: Aurora a in Complex with Yl5-083
  934. 3uod: Aurora a in Complex with Rpm1693
  935. 3uoh: Aurora a in Complex with Rpm1722
  936. 3uoj: Aurora a in Complex with Rpm1715
  937. 3uok: Aurora a in Complex with Yl5-81-1
  938. 3uol: Aurora a in Complex with So2-162
  939. 3up2: Aurora a in Complex with Rpm1686
  940. 3up7: Aurora a in Complex with Yl1-038-09
  941. 6pys: Human PI3KALPHA in Complex with Compound 2-10 ((3s)-3-benzyl-3-methyl- 5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3- Dihydro-2h-indol-2-one)
  942. 2lcs: Yeast NBP2P Sh3 Domain in Complex with a Peptide from STE20P
  943. 3q5o: Crystal Structure of Human Titin Domain M10
  944. 3ztx: Aurora Kinase Selective Inhibitors Identified Using a Taxol- Induced Checkpoint Sensitivity Screen.
  945. 6pp9: Crystal Structure of Braf:mek1 Complex
  946. 3v8s: Human Rho-associated Protein Kinase 1 (rock 1) in Complex with Indazole Derivative (compound 18)
  947. 2ygv: Conserved N-terminal Domain of The Yeast Histone Chaperone Asf1 in Complex with The C-terminal Fragment of Rad53
  948. 3qp3: Crystal Structure of Titin Domain M4, Tetragonal Form
  949. 3tv7: Human Rho-associated Protein Kinase 1 (rock 1) in Complex with Rki1342
  950. 3ujg: Crystal Structure of Snrk2.6 in Complex with Hab1
  951. 4a7c: Crystal Structure of Pim1 Kinase with Etp46546
  952. 6pk6: Human PRPF4B Bound to Benzothiophene Inhibitor 329
  953. 6pjj: Human PRPF4B Bound to Benzothiophene Inhibitor 224
  954. 4dit: Crystal Structure of GSK3BETA in Complex with a Imidazolopyridine Inhibitor
  955. 6pdp: Human Pim1 Bound to Benzothiophene Inhibitor 379
  956. 6pdo: Human Pim1 Bound to Benzothiophene Inhibitor 354
  957. 6pdn: Human Pim1 Bound to Benzothiophene Inhibitor 292
  958. 6pdi: Human Pim1 Bound to Benzothiophene Inhibitor 224
  959. 6pcw: Human Pim1 Bound to Benzothiophene Inhibitor 213
  960. 2y9q: Crystal Structure of Human Erk2 Complexed with a Mapk Docking Peptide
  961. 6p5s: Hipk2 Kinase Domain Bound to Cx-4945
  962. 4a1g: The Crystal Structure of The Human Bub1 Tpr Domain in Complex with The Ki Motif of Knl1
  963. 4afj: 5-aryl-4-carboxamide-1,3-oxazoles: Potent and Selective Gsk-3 Inhibitors
  964. 2yer: Synthesis and Evaluation of Triazolones as Checkpoint Kinase 1 Inhibitors
  965. 2yex: Synthesis and Evaluation of Triazolones as Checkpoint Kinase 1 Inhibitors
  966. 3uv4: Crystal Structure of The Second Bromodomain of Human Transcription Initiation Factor Tfiid Subunit 1 (taf1)
  967. 6oko: Crystal Structure of Mripk3 Complexed with N-(3-fluoro-4-{1h- Pyrrolo[2,3-b]pyridin-4-yloxy}phenyl)-1-(4-fluorophenyl)-2-oxo-1,2- Dihydropyridine-3-carboxamide
  968. 4daw: Crystal Structure of Pak1 Kinase Domain with The Ruthenium Phthalimide Complex
  969. 4dug: Crystal Structure of Circadian Clock Protein Kaic E318A Mutant
  970. 6ocq: Crystal Structure of Rip1 Kinase in Complex with a Pyrrolidine
  971. 3vbq: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  972. 3vbt: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  973. 3vbv: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  974. 3vbw: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  975. 3vbx: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  976. 3vby: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  977. 3vc4: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  978. 6oac: Pqr530 [(s)-4-(difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino- 1,3,5-triazin-2-yl)pyridin-2-amine] Bound to The PI3KA Catalytic Subunit P110ALPHA
  979. 6o9d: Structure of The Irak4 Kinase Domain with Compound 5
  980. 6o95: Structure of The Irak4 Kinase Domain with Compound 41
  981. 6o94: Structure of The Irak4 Kinase Domain with Compound 17
  982. 6o8u: Crystal Structure of Irak4 in Complex with Compound 23
  983. 6o8c: Crystal Structure of Sting Ctt in Complex with Tbk1
  984. 6o8b: Crystal Structure of Sting Ctd in Complex with Tbk1
  985. 2ydi: Discovery of Checkpoint Kinase Inhibitor Azd7762 by Structure Based Design and Optimization of Thiophene Carboxamide Ureas
  986. 2ydk: Discovery of Checkpoint Kinase Inhibitor Azd7762 by Structure Based Design and Optimization of Thiophene Carboxamide Ureas
  987. 3axw: Crystal Structure of Human CK2ALPHA Complexed with a Potent Inhibitor
  988. 3tkh: Crystal Structure of Chk1 in Complex with Inhibitor S01
  989. 3tki: Crystal Structure of Chk1 in Complex with Inhibitor S25
  990. 3uix: Crystal Structure of Pim1 Kinase in Complex with Small Molecule Inhibitor
  991. 4af3: Human Aurora B Kinase in Complex with Incenp and Vx-680
  992. 4aot: Crystal Structure of Human Serine Threonine Kinase-10 (lok) Bound to GW830263A
  993. 4d9u: Rsk2 C-terminal Kinase Domain, (e)-tert-butyl 3-(4-amino-7-(3- Hydroxypropyl)-5-p-tolyl-7h-pyrrolo[2,3-d]pyrimidin-6-yl)-2- Cyanoacrylate
  994. 4dbn: Crystal Structure of The Kinase Domain of Human B-raf with a [1, 3]thiazolo[5,4-b]pyridine Derivative
  995. 6nyh: Structure of Human Ripk1 Kinase Domain in Complex with Gne684
  996. 6nyb: Structure of a Mapk Pathway Complex
  997. 6nw2: Structure of Human Ripk1 Kinase Domain in Complex with Compound 11
  998. 6nt9: Cryo-em Structure of The Complex between Human Tbk1 and Chicken Sting
  999. 3rny: Crystal Structure of Human Rsk1 C-terminal Kinase Domain
  1000. 6nsq: Crystal Structure of Braf Kinase Domain Bound to The Inhibitor 2l
  1001. 4a4x: Nek2-ede Bound to Cct248662
  1002. 4afe: Nek2 Bound to Hybrid Compound 21
  1003. 4apc: Crystal Structure of Human Nima-related Kinase 1 (nek1)
  1004. 4d9t: Rsk2 C-terminal Kinase Domain with Inhibitor (e)-methyl 3-(4-amino-7- (3-hydroxypropyl)-5-p-tolyl-7h-pyrrolo[2,3-d]pyrimidin-6-yl)-2- Cyanoacrylate
  1005. 6npz: Crystal Structure of Akt1 (aa 123-480) Kinase with a Bisubstrate
  1006. 6npy: Cryo-em Structure of Nlrp3 Bound to Nek7
  1007. 3re4: Crystal Structure of Archaeoglobus Fulgidus Rio1 Kinase Bound to Toyocamycin.
  1008. 6npn: Crystal Structure of The Human Vaccinia-related Kinase Bound to a N,n- Dipropynyl-dihydropteridine-3-hydroxyindazole Inhibitor
  1009. 6no9: Pim1 in Complex with Cpd16 (5-amino-n-(5-((4r,5r)-4-amino-5- Fluoroazepan-1-yl)-1-methyl-1h-pyrazol-4-yl)-2-(2,6-difluorophenyl) Thiazole-4-carboxamide)
  1010. 6no8: Pim1 in Complex with Cpd9 ((r)-5-amino-n-(3-(4-aminoazepan-1-yl)-1h- Pyrazol-4-yl)-2-(2,6-difluorophenyl)thiazole-4-carboxamide)
  1011. 3vap: Synthesis and Sar Studies of Imidazo-[1,2-a]-pyrazine Aurora Kinase Inhibitors with Improved off Target Kinase Selectivity
  1012. 4anu: Complexes of PI3KGAMMA with Isoform Selective Inhibitors.
  1013. 4anv: Complexes of PI3KGAMMA with Isoform Selective Inhibitors.
  1014. 4anw: Complexes of PI3KGAMMA with Isoform Selective Inhibitors.
  1015. 4anx: Complexes of PI3KGAMMA with Isoform Selective Inhibitors.
  1016. 4aof: Selective Small Molecule Inhibitor Discovered by Chemoproteomic Assay Platform Reveals Regulation of Th17 Cell Differentiation by PI3KGAMMA
  1017. 4dgl: Crystal Structure of The Ck2 Tetrameric Holoenzyme
  1018. 4e26: Braf in Complex with an Organic Inhibitor 7898734
  1019. 4e4x: Crystal Structure of B-raf Kinase Domain in Complex with a Dihydropyrido[2,3-d]pyrimidinone-based Inhibitor
  1020. 6ng0: Crystal Structure of Hpk1 Kinase Domain T165E,S171E Phosphomimetic Mutant in Complex with Sunitinib in The Inactive State.
  1021. 6nfz: Crystal Structure of Diphosphorylated Hpk1 Kinase Domain in Complex with Sunitinib in The Active State.
  1022. 6nfy: Crystal Structure of Nonphosphorylated, Hpk1 Kinase Domain in Complex with Sunitinib in The Inactive State.
  1023. 4acc: GSK3B in Complex with Inhibitor
  1024. 4acd: GSK3B in Complex with Inhibitor
  1025. 4acg: GSK3B in Complex with Inhibitor
  1026. 4ach: GSK3B in Complex with Inhibitor
  1027. 4dk5: Crystal Structure of Human PI3K-GAMMA in Complex with a Pyridyl- Triazine Inhibitor
  1028. 4e7w: Structure of Gsk3 from Ustilago Maydis
  1029. 4eep: Crystal Structure of Lov2 Domain of Arabidopsis Thaliana Phototropin 2
  1030. 4eer: Crystal Structure of Lov2 Domain of Arabidopsis Thaliana Phototropin 2 C426A Mutant
  1031. 4ees: Crystal Structure of Ilov
  1032. 4eet: Crystal Structure of Ilov
  1033. 4eeu: Crystal Structure of Philov2.1
  1034. 6nct: Structure of P110ALPHA/NISH2 - Vector Data Collection
  1035. 6ncg: Crystal Structure of Human Vaccinia-related Kinase 2 (vrk-2) Bound to Pyridin-benzenesulfonamide Inhibitor
  1036. 2lru: Solution Structure of The Wnk1 Autoinhibitory Domain
  1037. 3uim: Structural Basis for The Impact of Phosphorylation on Plant Receptor- like Kinase Bak1 Activation
  1038. 5qu9: Pandda Analysis Group Deposition of Ground-state Model of Kalirin/rac1 Screened against a Customized Urea Fragment Library by X-ray Crystallography at The Xchem Facility of Diamond Light Source Beamline I04-1
  1039. 4anm: Complex of Ck2 with a Cdc7 Inhibitor
  1040. 4ejn: Crystal Structure of Autoinhibited Form of Akt1 in Complex with N-(4- (5-(3-acetamidophenyl)-2-(2-aminopyridin-3-yl)-3h-imidazo[4,5- B]pyridin-3-yl)benzyl)-3-fluorobenzamide
  1041. 4ekk: Akt1 with Amp-pnp
  1042. 4ekl: Akt1 with Gdc0068
  1043. 4eut: Structure of Bx-795 Complexed with Unphosphorylated Human Tbk1 Kinase- Uld Domain
  1044. 4euu: Structure of Bx-795 Complexed with Human Tbk1 Kinase Domain Phosphorylated on Ser172
  1045. 6n8g: Irak4 Bound to Benzoxazole Compound
  1046. 2rse: Nmr Structure of Fkbp12-mtor Frb Domain-rapamycin Complex Structure Determined Based on Pcs
  1047. 3u87: Structure of a Chimeric Construct of Human CK2ALPHA and Human CK2ALPHA' in Complex with a Non-hydrolysable Atp-analogue
  1048. 3u9c: Structure of a C-terminal Deletion Mutant of Human Protein Kinase Ck2 Catalytic Subunit with The Atp-competitive Inhibitor Resorufin
  1049. 6l20: Crystal Structure of CK2A2 with Hematein
  1050. 6n45: Crystal Structure of The Cryptic Polo Box Domain of Human Activated Plk4 Variant 1
  1051. 6n3o: Identification of Novel, Potent and Selective Gcn2 Inhibitors as First-in-class Anti-tumor Agents
  1052. 6n3n: Identification of Novel, Potent and Selective Gcn2 Inhibitors as First-in-class Anti-tumor Agents
  1053. 6n3l: Identification of Novel, Potent and Selective Gcn2 Inhibitors as First-in-class Anti-tumor Agents
  1054. 6n0q: Braf in Complex with N-(4-methyl-3-(1-methyl-2-oxo-2,3-dihydro-1h- Benzo[d]imidazol-5-yl)phenyl)-3-(trifluoromethyl)benzamide.
  1055. 6n0p: Braf in Complex with N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4- Yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide (lxh254)
  1056. 6mzl: Human Tfiid Canonical State
  1057. 6mzd: Human Tfiid Lobe a Canonical
  1058. 4eai: Co-crystal Structure of an Ampk Core with Amp
  1059. 4eaj: Co-crystal of Ampk Core with Amp Soaked with Atp
  1060. 4eak: Co-crystal Structure of an Ampk Core with Atp
  1061. 4eal: Co-crystal of Ampk Core with Atp Soaked with Amp
  1062. 4aw2: Crystal Structure of Cdc42 Binding Protein Kinase Alpha (mrck Alpha)
  1063. 6mt0: Crystal Structure of Human Pim-1 Kinase in Complex with a Quinazolinone-pyrrolodihydropyrrolone Inhibitor
  1064. 6mom: Crystal Structure of Human Interleukin-1 Receptor Associated Kinase 4 (irak 4, Cid 100300) in Complex with Compound Ncc00371481 (bsi 107591)
  1065. 6mnh: Ulk1 Unc-51 like Autophagy Activating Kinase in Complex with Inhibitor Btc
  1066. 4efo: Crystal Structure of The Ubiquitin-like Domain of Human Tbk1
  1067. 4f0f: Crystal Structure of The Roco4 Kinase Domain Bound to Appcp from D. Discoideum
  1068. 4f0g: Crystal Structure of The Roco4 Kinase Domain from D. Discoideum
  1069. 4f1m: Crystal Structure of The G1179S Roco4 Kinase Domain Bound to Appcp from D. Discoideum.
  1070. 4f1t: Crystal Structure of The Roco4 Kinase Domain from D. Discoideum Bound to The Rock Inhibitor H1152
  1071. 6mib: Crystal Structure of The Ilk Atp-binding Deficient Mutant (L207W) /alpha-parvin Core Complex
  1072. 6mg9: Human Obscurin Ig57 Domain
  1073. 4dhf: Structure of Aurora a Mutant Bound to Biogenidec Cpd 15
  1074. 4dtk: Novel and Selective Pan-pim Kinase Inhibitor
  1075. 4fhj: Crystal Structure of PI3K-GAMMA in Complex with Imidazopyridine 2
  1076. 4fr4: Crystal Structure of Human Serine/threonine-protein Kinase 32a (yank1)
  1077. 6mcq: L. Pneumophila Effector Kinase Legk7 in Complex with Human MOB1A
  1078. 6mcp: L. Pneumophila Effector Kinase Legk7 (amp-pnp Bound) in Complex with Human MOB1A
  1079. 3zxt: Dimeric Structure of Dapk-1 Catalytic Domain in Complex with Amppcp-mg
  1080. 6qdr: Crystal Structure of 14-3-3sigma in Complex with a Pak6 Pt99 Phosphopeptide
  1081. 6qds: Crystal Structure of 14-3-3sigma in Complex with a Pak6 Pt99 Phosphopeptide Stabilized by Semi-synthetic Fusicoccane Fc-ncpc
  1082. 4dgm: Crystal Structure of Maize Ck2 in Complex with The Inhibitor Apigenin
  1083. 4dgn: Crystal Structure of Maize Ck2 in Complex with The Inhibitor Luteolin
  1084. 3umx: Crystal Structure of Pim1 Kinase in Complex with Inhibitor (z)-2-[(1h- Indol-3-yl)methylene]-7-(azepan-1-ylmethyl)-6-hydroxybenzofuran- 3(2h)-one
  1085. 3uto: Twitchin Kinase Region from C.elegans (fn31-nl-kin-crd-ig26)
  1086. 4enx: Crystal Structure of Pim-1 Kinase in Complex with Inhibitor (2e,5z)-2- (2-chlorophenylimino)-5-(4-hydroxy-3-nitrobenzylidene)thiazolidin-4- One
  1087. 4eny: Crystal Structure of Pim-1 Kinase in Complex with (2e,5z)-2-(2- Chlorophenylimino)-5-(4-hydroxy-3-methoxybenzylidene)thiazolidin-4- One
  1088. 4f1s: Crystal Structure of Human PI3K-GAMMA in Complex with a Pyridyl- Triazine-sulfonamide Inhibitor
  1089. 4fk3: B-raf Kinase V600E Oncogenic Mutant in Complex with Plx3203
  1090. 4g31: Crystal Structure of Gsk6414 Bound to Perk (r587-r1092, Delete A660- T867) at 2.28 a Resolution
  1091. 4g34: Crystal Structure of Gsk6924 Bound to Perk (r587-r1092, Delete A660- T867) at 2.70 a Resolution
  1092. 3tei: Crystal Structure of Human Erk2 Complexed with a Mapk Docking Peptide
  1093. 3twj: Rho-associated Protein Kinase 1 (rock 1) in Complex with Rki1447
  1094. 3u4u: Casein Kinase 2 in Complex with Az-inhibitor
  1095. 4dea: Aurora a in Complex with Yl1-038-18
  1096. 4deb: Aurora a in Complex with Rk2-17-01
  1097. 4ded: Aurora a in Complex with Yl1-038-21
  1098. 4dee: Aurora a in Complex with Adp
  1099. 6jxc: Tel1 Kinase Butterfly Symmetric Dimer
  1100. 6jxa: Tel1 Kinase Compact Monomer
  1101. 6jwa: Crystal Structure of CK2A1 with 5-iodotubercidin
  1102. 4fsm: Crystal Structure of The Chk1
  1103. 4fsn: Crystal Structure of The Chk1
  1104. 4fsq: Crystal Structure of The Chk1
  1105. 4fsr: Crystal Structure of The Chk1
  1106. 4fst: Crystal Structure of The Chk1
  1107. 4fsu: Crystal Structure of The Chk1
  1108. 4fsw: Crystal Structure of The Chk1
  1109. 4fsy: Crystal Structure of The Chk1
  1110. 4fsz: Crystal Structure of The Chk1
  1111. 4ft0: Crystal Structure of The Chk1
  1112. 4ft3: Crystal Structure of The Chk1
  1113. 4ft5: Crystal Structure of The Chk1
  1114. 4ft7: Crystal Structure of The Chk1
  1115. 4ft9: Crystal Structure of The Chk1
  1116. 4fta: Crystal Structure of The Chk1
  1117. 4ftc: Crystal Structure of The Chk1
  1118. 4fti: Crystal Structure of The Chk1
  1119. 4ftj: Crystal Structure of The Chk1
  1120. 4ftk: Crystal Structure of The Chk1
  1121. 4ftl: Crystal Structure of The Chk1
  1122. 4ftm: Crystal Structure of The Chk1
  1123. 4ftn: Crystal Structure of The Chk1
  1124. 4fto: Crystal Structure of The Chk1
  1125. 4ftq: Crystal Structure of The Chk1
  1126. 4ftr: Crystal Structure of The Chk1
  1127. 4ftt: Crystal Structure of The Chk1
  1128. 4ftu: Crystal Structure of The Chk1
  1129. 4gb9: Potent and Highly Selective Benzimidazole Inhibitors of PI3K-DELTA
  1130. 6jle: Crystal Structure of MORN4/MYO3A Complex
  1131. 3ubd: Structure of N-terminal Domain of Rsk2 Kinase in Complex with Flavonoid Glycoside Sl0101
  1132. 3uib: Map Kinase Lmampk10 from Leishmania Major in Complex with Sb203580
  1133. 4aze: Human DYRK1A in Complex with Leucettine L41
  1134. 4azf: Human Dyrk2 in Complex with Leucettine L41
  1135. 4b9d: Crystal Structure of Human Nima-related Kinase 1 (nek1) with Inhibitor.
  1136. 4el9: Structure of N-terminal Kinase Domain of Rsk2 with Afzelin
  1137. 6j6i: Reconstitution and Structure of a Plant Nlr Resistosome Conferring Immunity
  1138. 4ewh: Co-crystal Structure of Ack1 with Inhibitor
  1139. 6j68: Structure of Kibra and Lats1 Complex
  1140. 6j5v: Ligand-triggered Allosteric Adp Release Primes a Plant Nlr Complex
  1141. 6j5u: Ligand-triggered Allosteric Adp Release Primes a Plant Nlr Complex
  1142. 6j5t: Reconstitution and Structure of a Plant Nlr Resistosome Conferring Immunity
  1143. 4fie: Full-length Human Pak4
  1144. 4fif: Catalytic Domain of Human Pak4 with Rpkplvdp Peptide
  1145. 4fig: Catalytic Domain of Human Pak4
  1146. 4fih: Catalytic Domain of Human Pak4 with Qkftglprqw Peptide
  1147. 4fii: Catalytic Domain of Human Pak4 with Rpkplvdp Peptide
  1148. 4fij: Catalytic Domain of Human Pak4
  1149. 4fj3: 14-3-3 Isoform Zeta in Complex with a Diphoyphorylated C-raf Peptide
  1150. 4flh: Crystal Structure of Human PI3K-GAMMA in Complex with Amg511
  1151. 3tpb: Structure of HIPA(S150A)
  1152. 3tpd: Structure of Phipa, Monoclinic Form
  1153. 3tpe: The Phipa P3121 Structure
  1154. 3tpt: Structure of HIPA(D309Q) Bound to Adp
  1155. 3tpv: Structure of Phipa Bound to Adp
  1156. 3umw: Crystal Structure of Pim1 Kinase in Complex with Inhibitor (z)-2-[(1h- Indazol-3-yl)methylene]-6-methoxy-7-(piperazin-1-ylmethyl)benzofuran- 3(2h)-one
  1157. 4a9r: Crystal Structure of Human Chk2 in Complex with Benzimidazole Carboxamide Inhibitor
  1158. 4a9s: Crystal Structure of Human Chk2 in Complex with Benzimidazole Carboxamide Inhibitor
  1159. 4a9t: Crystal Structure of Human Chk2 in Complex with Benzimidazole Carboxamide Inhibitor
  1160. 4a9u: Crystal Structure of Human Chk2 in Complex with Benzimidazole Carboxamide Inhibitor
  1161. 4as0: Cyclometalated Phthalimides as Protein Kinase Inhibitors
  1162. 4aw0: Human Pdk1 Kinase Domain in Complex with Allosteric Compound Ps182 Bound to The Pif-pocket
  1163. 4aw1: Human Pdk1 Kinase Domain in Complex with Allosteric Compound Ps210 Bound to The Pif-pocket
  1164. 4bc6: Crystal Structure of Human Serine Threonine Kinase-10 Bound to Novel Bosutinib Isoform 1, Previously Thought to Be Bosutinib
  1165. 6in4: Crystal Structure of Apo Dapk1 in The Presence of 18-crown-6
  1166. 4fbx: Complex Structure of Human Protein Kinase Ck2 Catalytic Subunit Crystallized in The Presence of a Bisubstrate Inhibitor
  1167. 4ful: Pi3 Kinase Gamma Bound to a Pyrmidine Inhibitor
  1168. 4gh2: Crystal Structure of The Chk1
  1169. 6t8x: Crystal Structure of Mapkapk2 (mk2) Complexed with Pf-3644022 and 5- (4-bromophenyl)-n-[4-(1-piperazinyl)phenyl]-n-(2-pyridinylmethyl)-2- Furancarboxamide
  1170. 4gw8: Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and Leucettine L41
  1171. 4f99: Human Cdc7 Kinase in Complex with Dbf4 and Nucleotide
  1172. 4f9a: Human Cdc7 Kinase in Complex with Dbf4 and Nucleotide
  1173. 4f9b: Human Cdc7 Kinase in Complex with Dbf4 and Pha767491
  1174. 4f9c: Human Cdc7 Kinase in Complex with Dbf4 and Xl413
  1175. 4fjy: Crystal Structure of PI3K-GAMMA in Complex with Quinoline-indoline Inhibitor 24f
  1176. 4fjz: Crystal Structure of PI3K-GAMMA in Complex with Pyrrolo-pyridine Inhibitor 63
  1177. 4gyw: Crystal Structure of Human O-glcnac Transferase in Complex with Udp and a Glycopeptide
  1178. 4gyy: Crystal Structure of Human O-glcnac Transferase with Udp-5sglcnac and a Peptide Substrate
  1179. 4gz3: Crystal Structure of Human O-glcnac Transferase with Udp and a Thioglycopeptide
  1180. 6i2y: Human Stk10 Bound to Foretinib
  1181. 6i2u: Aurora-a Kinase Domain in Complex with Coenzyme a
  1182. 6i2p: Crystal Structure of The Mycobacterium Tuberculosis Pknb Kinase Domain (L33E Mutant) in Complex with Its Substrate Gara
  1183. 6i0y: Tnac-stalled Ribosome Complex with The Titin I27 Domain Folding close to The Ribosomal Exit Tunnel
  1184. 6hyo: Structure of Ulk1 Lir Motif Bound to Gabarap
  1185. 3uiu: Crystal Structure of Apo-pkr Kinase Domain
  1186. 3ulz: Crystal Structure of Apo Bak1
  1187. 6hxf: Human Stk10 Bound to a Maleimide Inhibitor
  1188. 6hx1: Ire1 Alpha in Complex with Imidazo[1,2-b]pyridazin-8-amine Compound 2
  1189. 4equ: Human Stk-10 (lok) Kinase Domain in Dfg-out Conformation with Inhibitor Dsa-7
  1190. 4g11: X-ray Structure of PI3K-GAMMA Bound to a 4-(morpholin-4-yl)- (6-oxo-1, 6-dihydropyrimidin-2-yl)amide Inhibitor
  1191. 4g9c: Human B-raf Kinase Domain Bound to a Type II Pyrazolopyridine Inhibitor
  1192. 4g9r: B-raf V600E Kinase Domain Bound to a Type II Dihydroquinazoline Inhibitor
  1193. 4ggd: Structural Analysis of Human Cdc20 Supports Multisite Degron Recognition by Apc/c.
  1194. 4hgl: Crystal Structure of CK1G3 with Compound 1
  1195. 4hgs: Crystal Structure of CK1GS with Compound 13
  1196. 4hgt: Crystal Structure of CK1D with Compound 13
  1197. 4hnf: Crystal Structure of CK1D in Complex with Pf4800567
  1198. 4hni: Crystal Structure of CK1E in Complex with Pf4800567
  1199. 4hok: Crystal Structure of Apo CK1E
  1200. 3zdi: Glycogen Synthase Kinase 3 Beta Complexed with Axin Peptide and Inhibitor 7d
  1201. 3zhp: Human Mst3 (stk24) in Complex with MO25BETA
  1202. 3zim: Discovery of a Potent and Isoform-selective Targeted Covalent Inhibitor of The Lipid Kinase PI3KALPHA
  1203. 4alu: Benzofuropyrimidinone Inhibitors of Pim-1
  1204. 4alv: Benzofuropyrimidinone Inhibitors of Pim-1
  1205. 4b7t: Glycogen Synthase Kinase 3 Beta Complexed with Axin Peptide and Leucettine L4
  1206. 4drh: Co-crystal Structure of The Ppiase Domain of Fkbp51, Rapamycin and The Frb Fragment of Mtor at Low Ph
  1207. 4dri: Co-crystal Structure of The Ppiase Domain of Fkbp51, Rapamycin and The Frb Fragment of Mtor
  1208. 4drj: O-crystal Structure of The Ppiase Domain of Fkbp52, Rapamycin and The Frb Fragment of Mtor
  1209. 4gue: Structure of N-terminal Kinase Domain of Rsk2 with Flavonoid Glycoside Quercitrin
  1210. 4gv1: Pkb Alpha in Complex with Azd5363
  1211. 4h3p: Crystal Structure of Human Erk2 Complexed with a Mapk Docking Peptide
  1212. 4h58: Braf in Complex with Compound 3
  1213. 4hle: Compound 21 (1-alkyl-substituted 1,2,4-triazoles)
  1214. 6hvd: Human Slk Bound to a Maleimide Inhibitor
  1215. 6hv0: Ire1 Kinase/rnase in Complex with Imidazo[1,2-b]pyridazin-8-amine Compound 33
  1216. 6hou: Human Protein Kinase Ck2 Alpha in Complex with Vanillin
  1217. 6hot: Human Protein Kinase Ck2 Alpha in Complex with Ferulic Aldehyde
  1218. 6hor: Human Protein Kinase Ck2 Alpha in Complex with Feruloylmethane
  1219. 6hoq: Human Protein Kinase Ck2 Alpha in Complex with Ferulic Acid
  1220. 6hop: Human Protein Kinase Ck2 Alpha in Complex with Curcumin Degradation Products
  1221. 6hny: Human Protein Kinase Ck2 Alpha in Complex with Boldine
  1222. 6hnw: Human Protein Kinase Ck2 Alpha in Complex with Coumestrol
  1223. 6hmx: Rip2 Kinase Catalytic Domain Complex with N(4,5DIMETHYL1HPYRAZOL3YL) 7METHOXY6(2METHYLPROPANE2SULFONYL)QUINOLIN4AMINE
  1224. 6hmr: Crystal Structure of Human Casein Kinase I Delta in Complex with a Photoswitchable 2-azothiazole-based Inhibitor (compound 2)
  1225. 6hmp: Crystal Structure of Human Casein Kinase I Delta in Complex with a Photoswitchable 2-azoimidazole-based Inhibitor (compound 3)
  1226. 4hzr: Crystal Structure of Ack1 Kinase Domain
  1227. 6hme: Low-salt Structure of Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA; CSNK2A1 Gene Product) in Complex with The Indenoindole-type Inhibitor Thn27
  1228. 4hzs: Crystal Structure of Ack1 Kinase Domain with C-terminal Sh3 Domain
  1229. 6hmd: Structure of Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA'; CSNK2A2 Gene Product) in Complex with The Indenoindole-type Inhibitor Ar18
  1230. 6hmc: Structure of Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA'; CSNK2A2 Gene Product) in Complex with The Indenoindole-type Inhibitor Thn27
  1231. 6hmb: Structure of Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA'; CSNK2A2 Gene Product) in Complex with The Inhibitor Cx-4945 (silmitasertib)
  1232. 6hka: The Solution Structure of The Micelle-associated Fatc Domain of The Human Protein Kinase Ataxia Telangiectasia Mutated (atm)
  1233. 6hk7: Crystal Structure of Gsk-3b in Complex with Pyrazine Inhibitor C50
  1234. 6hk6: Human Riok2 Bound to Inhibitor
  1235. 4id7: Ack1 Kinase in Complex with The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
  1236. 6hk4: Crystal Structure of Gsk-3b in Complex with Pyrazine Inhibitor C22
  1237. 6hk3: Crystal Structure of Gsk-3b in Complex with Pyrazine Inhibitor C44
  1238. 6pxn: Human Casein Kinase 1 Delta Tau Mutant (R178C)
  1239. 6hjk: Crystal Structure of Aurora-a L210C Catalytic Domain in Complex with Asdo2
  1240. 6hjj: Crystal Structure of Aurora-a L210C Catalytic Domain in Complex with Asdo6 Ligand
  1241. 4ijm: Crystal Structure of Circadian Clock Protein Kaic A422V Mutant
  1242. 6hho: Crystal Structure of Rip1 Kinase in Complex with Gsk547
  1243. 6hhj: Crystal Structure of Akt1 in Complex with Covalent-allosteric Akt Inhibitor 24b
  1244. 6hhg: Crystal Structure of Akt1 in Complex with Covalent-allosteric Akt Inhibitor 27
  1245. 6hhf: Crystal Structure of Akt1 in Complex with Covalent-allosteric Akt Inhibitor Borussertib
  1246. 6hci: Crystal Structure of Titin M3 Domain
  1247. 6hbn: High-salt Structure of Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA/CSKN2A1 Gene Product) in Complex with The Indenoindole-type Inhibitor Thn27
  1248. 3zon: Human Tyk2 Pseudokinase Domain Bound to a Kinase Inhibitor
  1249. 6h4l: Structure of Titin M4 Trigonal Form
  1250. 4b0g: Complex of Aurora-a Bound to an Imidazopyridine-based Inhibitor
  1251. 6h0u: Glycogen Synthase Kinase-3 Beta (gsk3) Complex with a Covalent [1,2, 4]triazolo[1,5-a][1,3,5]triazine Inhibitor
  1252. 6paw: Crystal Structure of Dapk2 S308A Calcium/calmodulin Complex
  1253. 6gzm: Crystal Structure of Human Ckidelta with A86
  1254. 6gzd: Crystal Structure of Human CSNK1A1 with A86
  1255. 4ezj: Potent and Selective Inhibitors of PI3K-DELTA: Obtaining Isoform Selectivity from The Affinity Pocket and Tryptophan Shelf
  1256. 4ezk: Potent and Selective Inhibitors of PI3K-DELTA: Obtaining Isoform Selectivity from The Affinity Pocket and Tryptophan Shelf
  1257. 4ezl: Potent and Selective Inhibitors of PI3K-DELTA: Obtaining Isoform Selectivity from The Affinity Pocket and Tryptophan Shelf
  1258. 4fa6: Design and Synthesis of a Novel Pyrrolidinyl Pyrido Pyrimidinone Derivative as a Potent Inhibitor of PI3KA and Mtor
  1259. 4fad: Design and Synthesis of a Novel Pyrrolidinyl Pyrido Pyrimidinone Derivative as a Potent Inhibitor of PI3KA and Mtor
  1260. 4fhk: Crystal Structure of PI3K-GAMMA in Complex with Imidazopyridazine 19e
  1261. 4fza: Crystal Structure of Mst4-mo25 Complex
  1262. 4fzd: Crystal Structure of Mst4-mo25 Complex with Wsf Motif
  1263. 4fzf: Crystal Structure of Mst4-mo25 Complex with Dki
  1264. 4geh: Crystal Structure of Mst4 Dimerization Domain Complex with Pdcd10
  1265. 6gwm: Solution Structure of Rat Rip2 Caspase Recruitment Domain
  1266. 6gvx: Crystal Structure of Maternal Embryonic Leucine Zipper Kinase (melk) in Complex with Dorsomorphin (compound C)
  1267. 6gvi: Crystal Structure of PI3K Alpha in Complex with 3-(2-amino- Benzooxazol-5-yl)-1-isopropyl-1h-pyrazolo[3,4-d]pyrimidine-4,6- Diamine
  1268. 6gvh: Crystal Structure of PI3K Alpha in Complex with 3-(2-amino- Benzooxazol-5-yl)-4-chloro-1-isopropyl-1h-pyrazolo[3,4-d]pyrimidin-6- Ylamine
  1269. 6gvg: Crystal Structure of PI3K Alpha in Complex with 3-(2-amino- Benzooxazol-5-yl)-1-isopropyl-4-methyl-1h-pyrazolo[3,4-d]pyrimidin-6- Ylamine
  1270. 6gvf: Crystal Structure of PI3K Alpha in Complex with 3-(2-amino- Benzooxazol-5-yl)-1-isopropyl-1h-pyrazolo[3,4-d]pyrimidin-4-ylamine
  1271. 4hyh: X-ray Crystal Structure of Compound 39 Bound to Human Chk1 Kinase Domain
  1272. 4hyi: X-ray Crystal Structure of Compound 40 Bound to Human Chk1 Kinase Domain
  1273. 6gtt: Human Stk10 Bound to Birb-796
  1274. 4ib5: Structure of Human Protein Kinase Ck2 Catalytic Subunit in Complex with a CK2BETA-COMPETITIVE Cyclic Peptide
  1275. 4im0: Structure of Tank-binding Kinase 1
  1276. 4im2: Structure of Tank-binding Kinase 1
  1277. 4im3: Structure of Tank-binding Kinase 1
  1278. 6gro: Human CSNK1G3 Bound to Sb-223133
  1279. 6gra: Human Aurka Bound to Brd-7880
  1280. 6gr9: Human Aurkc Incenp Complex Bound to Vx-680
  1281. 6gr8: Human Aurkc Incenp Complex Bound to Brd-7880
  1282. 6gq7: PI3KG in Complex with Inh
  1283. 4ith: Crystal Structure of Rip1 Kinase in Complex with Necrostatin-1 Analog
  1284. 4iti: Crystal Structure of Rip1 Kinase in Complex with Necrostatin-3 Analog
  1285. 4itj: Crystal Structure of Rip1 Kinase in Complex with Necrostatin-4
  1286. 4iw0: Crystal Structure and Mechanism of Activation of Tbk1
  1287. 4iwo: Crystal Structure and Mechanism of Activation of Tbk1
  1288. 4iwp: Crystal Structure and Mechanism of Activation of Tbk1
  1289. 4iwq: Crystal Structure and Mechanism of Activation of Tbk1
  1290. 6gpv: Crystal Structure of Blue-light Irradiated Minisog
  1291. 6gpu: Crystal Structure of Minisog at 1.17a Resolution
  1292. 4j1r: Crystal Structure of GSK3B in Complex with Inhibitor 15r
  1293. 4j71: Crystal Structure of GSK3B in Complex with Inhibitor 1r
  1294. 6gn1: Crystal Structure of Glycogen Synthase Kinase-3 Beta (GSK3B) in Complex with Pik-75
  1295. 4jg6: Rsk2 Ctd Bound to 2-cyano-3-(1h-indazol-5-yl)acrylamide
  1296. 4jg7: Structure of Rsk2 Ctd Bound to 3-(3-(1h-pyrrolo[2,3-b]pyridine-3- Carbonyl)phenyl)-2-cyanoacrylamide
  1297. 4jg8: Structure of Rsk2 T493M Ctd Mutant Bound to 2-cyano-n-(1-hydroxy-2- Methylpropan-2-yl)-3-(3-(3,4,5-trimethoxyphenyl)-1h-indazol-5-yl) Acrylamide
  1298. 4jik: X-ray Crystal Structure of Compound 22a (r)-2-(4-chlorophenyl)-8- (piperidin-3-ylamino)imidazo[1,2-c]pyrimidine-5-carboxamide Bound to Human Chk1 Kinase Domain
  1299. 6gmd: The Crystal Structure of CK2ALPHA in Complex with Compound 3
  1300. 6gjo: Crystal Structure of Glycogen Synthase Kinase-3 Beta in Complex with Bi-91bs
  1301. 4ehe: B-raf Kinase Domain in Complex with an Aminothienopyrimidine-based Inhibitor
  1302. 4ehg: B-raf Kinase Domain in Complex with an Aminopyridimine-based Inhibitor
  1303. 4iq6: Gsk-3beta with Inhibitor 6-chloro-n-cyclohexyl-4-(1h-pyrrolo[2,3- B]pyridin-3-yl)pyridin-2-amine
  1304. 4jin: X-ray Crystal Structure of Archaeoglobus Fulgidus Rio1 Bound to (2e)- N-benzyl-2-cyano-3-(pyridine-4-yl)acrylamide (wp1086)
  1305. 4bl1: Crystal Structure of Unphosphorylated Maternal Embryonic Leucine Zipper Kinase (melk) in Complex with Amp-pnp
  1306. 6gih: Crystal Structure of CK2ALPHA with Cam187 Bound
  1307. 6ggs: Structure of Rip2 Card Filament
  1308. 6gfj: Structure of Rip2 Card Domain Fused to Crystallisable Mbp Tag
  1309. 4jsn: Structure of Mtordeltan-mlst8 Complex
  1310. 4jsp: Structure of Mtordeltan-mlst8-atpgammas-mg Complex
  1311. 4jsv: Structure of Mtordeltan-mlst8-adp-mgf3-mg2 Complex
  1312. 4jsx: Structure of Mtordeltan-mlst8-torin2 Complex
  1313. 4jt5: Mtordeltan-mlst8-pp242 Complex
  1314. 6spw: Structure of Protein Kinase Ck2 Catalytic Subunit with The CK2BETA- Competitive Bisubstrate Inhibitor Arc3140
  1315. 6spx: Structure of Protein Kinase Ck2 Catalytic Subunit in Complex with The CK2BETA-COMPETITIVE Bisubstrate Inhibitor Arc1502
  1316. 6g5i: Cryo-em Structure of a Late Human Pre-40s Ribosomal Subunit - State R
  1317. 6g51: Cryo-em Structure of a Late Human Pre-40s Ribosomal Subunit - State D
  1318. 6g4j: Structure of The Protein Kinase Yabt from Bacillus Subtilis in Complex with an Alpharep Crystallization Helper
  1319. 6g3w: Crystal Structure of The Bir3 - Serk2 Complex from Arabidopsis Thaliana.
  1320. 6g3a: Crystal Structure of Haspin F605T Mutant in Complex with 5- Iodotubercidin
  1321. 6g39: Crystal Structure of Haspin F605Y Mutant in Complex with 5- Iodotubercidin
  1322. 6g38: Crystal Structure of Haspin in Complex with Tubercidin
  1323. 6g37: Crystal Structure of Haspin in Complex with 5-fluorotubercidin
  1324. 6g36: Crystal Structure of Haspin in Complex with 5-chlorotubercidin
  1325. 6g35: Crystal Structure of Haspin in Complex with 5-bromotubercidin
  1326. 6g34: Crystal Structure of Haspin in Complex with 5-iodotubercidin
  1327. 6g18: Cryo-em Structure of a Late Human Pre-40s Ribosomal Subunit - State C
  1328. 6fwx: Chimeric Titin Z1Z2-Z1Z2 Tandem (z1212) Functionalized with a Grgds Exogenous Peptide from Fibronectin
  1329. 4g16: Crystal Structure of CK1G3 with 2-[(4-{[3-(trifluoromethyl)pyridin2- Yl]oxy}phenyl)amino]-1h-benzimidazole-6-carbonitrile
  1330. 4g17: Crystal Structure of CK1G3 with 2-[(4-tert-butylphenyl)amino]-1h- Benzimidazole-6-carbonitrile
  1331. 6fvg: The Structure of CK2ALPHA with Cch507 Bound
  1332. 6fvf: The Structure of CK2ALPHA with Cch503 Bound
  1333. 6fu5: Structure of The Kinase Domain of Human Ripk2 in Complex with The Inhibitor Cslp18
  1334. 4hq1: Crystal Structure of an Lrr Protein with Two Solenoids
  1335. 4jai: Crystal Structure of Aurora Kinase a in Complex with N-{4-[(6-oxo-5,6- Dihydrobenzo[c][1,8]naphthyridin-1-yl)amino]phenyl}benzamide
  1336. 4jaj: Crystal Structure of Aurora Kinase a in Complex with Benzo[c][1, 8]naphthyridin-6(5h)-one
  1337. 4jbo: Novel Aurora Kinase Inhibitors Reveal Mechanisms of Hurp in Nucleation of Centrosomal and Kinetochore Microtubules
  1338. 4jbp: Novel Aurora Kinase Inhibitors Reveal Mechanisms of Hurp in Nucleation of Centrosomal and Kinetochore Microtubules
  1339. 4jbq: Novel Aurora Kinase Inhibitors Reveal Mechanisms of Hurp in Nucleation of Centrosomal and Kinetochore Microtubules
  1340. 4jjr: A P21 Crystal Form of Mammalian Casein Kinase 1d with a Novel Dimer Interface.
  1341. 4jvg: B-raf Kinase in Complex with Birb796
  1342. 4k0y: Structure of Pim-1 Kinase Bound to N-(4-fluorophenyl)-7-hydroxy-5- (piperidin-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
  1343. 4k18: Structure of Pim-1 Kinase Bound to 5-(4-cyanobenzyl)-n-(4- Fluorophenyl)-7-hydroxypyrazolo[1,5-a]pyrimidine-3-carboxamide
  1344. 4k1b: Structure of Pim-1 Kinase Bound to N-(5-(2-fluorophenyl)-1h-pyrrolo[2, 3-b]pyridin-3-yl)-5-((((3r,4r)-3-fluoropiperidin-4-yl)methyl)amino) Pyrazolo[1,5-a]pyrimidine-3-carboxamide
  1345. 6fih: Crystal Structure of The Anx2 Ectodomain from Arabidopsis Thaliana
  1346. 6fig: Crystal Structure of The Anx1 Ectodomain from Arabidopsis Thaliana
  1347. 6fif: Crystal Structure of The Bri1 Gly644-asp (bri1-6) Mutant from Arabidopsis Thaliana.
  1348. 6fic: Bivalent Inhibitor Unc4512 Bound to The Taf1 Bromodomain Tandem
  1349. 6fhb: Death-associated Protein Kinase 1 (dapk1) Catalytic and Auto- Regulatory Domains with S289A and S308E Mutations
  1350. 6fha: Death-associated Protein Kinase 1 (dapk1) Catalytic and Auto- Regulatory Domains with S289A and S308A Mutations
  1351. 6fh5: PI3KG in Complex with Compound 7
  1352. 6fg8: Crystal Structure of The Bir3 - Serk1 Complex from Arabidopsis Thaliana.
  1353. 4fi1: Crystal Structure of Scck2 Alpha in Complex with Atp
  1354. 6fdz: Unc-51-like Kinase 3 (ulk3) in Complex with Momelotinib
  1355. 6fdy: Unc-51-like Kinase 3 (ulk3) in Complex with Bosutinib
  1356. 6fdo: Rio2 Structure
  1357. 6fdn: Rio2 Structure
  1358. 6fdm: Human Rio2 Kinase Structure
  1359. 4jl9: Crystal Structure of Mouse Tbk1 Bound to Bx795
  1360. 4jlc: Crystal Structure of Mouse Tbk1 Bound to Su6668
  1361. 6fd3: Thiophosphorylated Pak3 Kinase Domain
  1362. 6fck: Chk1 Kinase in Complex with Compound 13
  1363. 6fcf: Chk1 Kinase in Complex with Compound 44
  1364. 6fc8: Chk1 Kinase in Complex with Compound 13
  1365. 4l0n: Crystal Structure of Stk3 (mst2) Sarah Domain
  1366. 6fbk: Crystal Structure of The Human Wnk2 Cct-like 1 Domain in Complex with a Wnk1 Rfxv Peptide
  1367. 6fai: Structure of a Eukaryotic Cytoplasmic Pre-40s Ribosomal Subunit
  1368. 4bda: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1369. 4bdb: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1370. 4bdc: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1371. 4bdd: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1372. 4bde: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1373. 4bdf: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1374. 6fad: Sr Protein Kinase 1 (srpk1) in Complex with The Rgg-box of Hsv1 Icp27
  1375. 4bdg: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1376. 4bdh: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1377. 4bdi: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1378. 4bdj: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1379. 4bdk: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1380. 4f2l: Structure of a Regulatory Domain of Ampk
  1381. 6f7b: Crystal Structure of The Human Bub1 Kinase Domain in Complex with Bay 1816032
  1382. 2m9x: Solution Nmr Structure of Microtubule-associated Serine/threonine- Protein Kinase 1 from Homo Sapiens, Northeast Structural Genomics Consortium (nesg) Target HR9151A
  1383. 3w8h: Crystal Structure of Ccm3 in Complex with The C-terminal Regulatory Domain of Stk25
  1384. 3w8i: Crystal Structure of Ccm3 in Complex with The C-terminal Regulatory Domain of Mst4
  1385. 4b8l: Aurora B Kinase P353G Mutant
  1386. 4b8m: Aurora B Kinase in Complex with Vx-680
  1387. 6f3i: Irak4 in Complex with Inhibitor
  1388. 6f3g: Irak4 in Complex with Inhibitor
  1389. 6f3e: Irak4 in Complex with Inhibitor
  1390. 6f3d: Irak4 in Complex with Inhibitor
  1391. 6f26: Crystal Structure of Human Casein Kinase I Delta in Complex with Compound 31b
  1392. 6f1w: Crystal Structure of Human Casein Kinase I Delta in Complex with Compound 31a
  1393. 4g0n: Crystal Structure of Wt H-ras-gppnhp Bound to The Rbd of Raf Kinase
  1394. 4g3x: Crystal Structure of Q61L H-ras-gppnhp Bound to The Rbd of Raf Kinase
  1395. 6tlj: Cryo-em Structure of The Anaphase-promoting Complex/cyclosome, in Complex with The Mitotic Checkpoint Complex (apc/c-mcc) at 3.8 Angstrom Resolution
  1396. 6tm5: Cryo-em Structure of The Anaphase-promoting Complex/cyclosome, in Complex with The NEK2A Substrate at 3.9 Angstrom Resolution
  1397. 6s6q: Crystal Structure of The Lrr Ectodomain of The Plant Membrane Receptor Kinase Gassho1/schengen3 from Arabidopsis Thaliana in Complex with Casparian Strip Integrity Factor 2.
  1398. 4kz0: Structure of PI3K Gamma with Imidazopyridine Inhibitors
  1399. 4kzc: Structure of PI3K Gamma with Imidazopyridine Inhibitors
  1400. 6es0: Crystal Structure of The Kinase Domain of Human Ripk2 in Complex with The Activation Loop Targeting Inhibitor Cs-r35
  1401. 6eqi: Structure of Pink1 Bound to Ubiquitin
  1402. 6eml: Cryo-em Structure of a Late Pre-40s Ribosomal Subunit from Saccharomyces Cerevisiae
  1403. 6emk: Cryo-em Structure of Saccharomyces Cerevisiae Target of Rapamycin Complex 2
  1404. 4j0m: Crystal Structure of Brl1 (lrr) in Complex with Brassinolide
  1405. 6elm: Crystal Structure of The Human Wnk2 Cct1 Domain
  1406. 4ksp: Crystal Structure of Human B-raf Bound to a Dfg-out Inhibitor Tak-632
  1407. 4ksq: Crystal Structure of Human B-raf Bound to a Dfg-out Inhibitor 5b
  1408. 6eim: Human Stk10 Bound to GW683134A
  1409. 6eii: The Crystal Structure of CK2ALPHA in Complex with Compound 18
  1410. 6ehu: The Crystal Structure of CK2ALPHA in Complex with Compound 32
  1411. 6ehk: The Crystal Structure of CK2ALPHA in Complex with Cam4712 and Compound 37
  1412. 6egf: Crystal Structure of The Inactive Unphosphorylated Irak4 Kinase Domain Bound to Amp-pnp
  1413. 6ege: Crystal Structure of The Unphosphorylated Irak4 Kinase Domain Bound to a Type I Inhibitor
  1414. 6egd: Crystal Structure of The Unphosphorylated Irak4 Kinase Domain Bound to a Type I Inhibitor
  1415. 6ega: Irak4 in Complex with a Type II Inhibitor
  1416. 6eg9: Irak4 in Complex with Ponatinib
  1417. 6edx: Crystal Structure of Sgk3 Px Domain
  1418. 6ed6: Crystal Structure of Rock2 with a Pyridinylbenzamide Based Inhibitor
  1419. 6e9w: Crystal Structure of Rock1 with a Pyridinylbenzamide Based Inhibitor
  1420. 6e4w: Structure of Ampk Bound to Activator
  1421. 6e4u: Structure of Ampk Bound to Activator
  1422. 6e4t: Structure of Ampk Bound to Activator
  1423. 6dlp: Crystal Structure of Lrrk2 Wd40 Domain Dimer
  1424. 6dlo: Crystal Structure of Lrrk2 Wd40 Domain Dimer
  1425. 6dl4: Human Titin Zig10
  1426. 6dd4: Crystal Structure of The Human Vaccinia-related Kinase Bound to a N,n- Dipropyl-dihydropteridine Inhibitor
  1427. 6d8z: Crystal Structure of The C-terminal Guanine Exchange Factor Module of Human Trio
  1428. 2rsv: Solution Structure of Human Full-length Vaccinia Related Kinase 1 (vrk1)
  1429. 6p5m: Discovery of a Novel, Highly Potent, and Selective Thieno[3,2- D]pyrimidinone-based Cdc7 Inhibitor with a Quinuclidine Moiety (tak- 931) as an Orally Active Investigational Anti-tumor Agent
  1430. 6d3l: Crystal Structure of Unphosphorylated Human Pkr
  1431. 6d3k: Crystal Structure of Unphosphorylated Human Pkr Kinase Domain in Complex with Adp
  1432. 3w10: Aurora Kinase a Complexed to Pyrazole Aminoquinoline I
  1433. 3w16: Structure of Aurora Kinase a Complexed to Pyrazole-aminoquinoline Inhibitor III
  1434. 3w18: Structure of Aurora Kinase a Complexed to Benzoimidazole-indazole Inhibitor XIII
  1435. 3w2c: Structure of Aurora Kinase a Complexed to Benzoimidazole-indazole Inhibitor Xv
  1436. 3w8l: Crystal Structure of Human Ck2 in Complex with Inositol Hexakisphosphate
  1437. 3war: Crystal Structure of Human CK2A
  1438. 6csw: Crystal Structure of The Human Vaccinia-related Kinase Bound to a N- Methyl-n-propyl-dihydropteridine Inhibitor
  1439. 3we4: Crystal Structure of S6K1 Kinase Domain in Complex with a Pyrimidine Derivative Pf-4708671 2-{[4-(5-ethylpyrimidin-4-yl)piperazin-1- Yl]methyl}-5-(trifluoromethyl)-1h-benzimidazole
  1440. 3we8: Pim-1 Kinase in Complex with Ruthenium-based Inhibitor
  1441. 3wf5: Crystal Structure of S6K1 Kinase Domain in Complex with a Pyrazolopyrimidine Derivative 4-[4-(1h-benzimidazol-2-yl)piperidin-1- Yl]-1h-pyrazolo[3,4-d]pyrimidine
  1442. 3wf6: Crystal Structure of S6K1 Kinase Domain in Complex with a Pyrazolopyrimidine Derivative 4-[4-(1h-indol-3-yl)-3,6- Dihydropyridin-1(2h)-yl]-1h-pyrazolo[3,4-d]pyrimidine
  1443. 3wf7: Crystal Structure of S6K1 Kinase Domain in Complex with a Purine Derivative 1-(9h-purin-6-yl)-n-[3-(trifluoromethyl)phenyl]piperidine- 4-carboxamide
  1444. 3wf8: Crystal Structure of S6K1 Kinase Domain in Complex with a Quinoline Derivative 2-oxo-2-[(4-sulfamoylphenyl)amino]ethyl 7,8,9,10- Tetrahydro-6h-cyclohepta[b]quinoline-11-carboxylate
  1445. 3wf9: Crystal Structure of S6K1 Kinase Domain in Complex with a Quinoline Derivative 1-oxo-1-[(4-sulfamoylphenyl)amino]propan-2-yl-2-methyl-1, 2,3,4-tetrahydroacridine-9-carboxylate
  1446. 6cqh: Crystal Structure of The Human Vaccinia-related Kinase Bound to a N- Propynyl-n-ethyl-dihydropteridine Inhibitor
  1447. 6cqf: Crystal Structure of Hpk1 in Complex an Inhibitor G1858
  1448. 6cqe: Crystal Structure of Hpk1 Kinase Domain S171A Mutant
  1449. 6cqd: Crystal Structure of Hpk1 in Complex with Atp Analogue (amppnp)
  1450. 6cq5: Tbk1 in Complex with Sulfone Analog of Amlexanox
  1451. 6cq4: Tbk1 in Complex with Cyclohexyl Analog of Amlexanox
  1452. 6cq0: Tbk1 in Complex with Dimethyl Amino Analog of Amlexanox
  1453. 6cpg: Structure of Dephosphorylated Aurora a (122-403) in Complex with Inhibiting Monobody and At9283 in an Inactive Conformation
  1454. 6cpf: Structure of Dephosphorylated Aurora a (122-403) Bound to Amppcp in an Active Conformation
  1455. 6cpe: Structure of Apo, Dephosphorylated Aurora a (122-403) in an Active Conformation
  1456. 3wi6: Crystal Structure of Mapkap Kinase-2 (mk2) in Complex with Non- Selective Inhibitor
  1457. 3wik: Crystal Structure of The CK2ALPHA/COMPOUND10 Complex
  1458. 3wil: Crystal Structure of The CK2ALPHA/COMPOUND3 Complex
  1459. 6cnx: Crystal Structure of The Human Vaccinia-related Kinase 1 (vrk1) Bound to an N-propynyl-n-isopentyl-dihydropteridin Inhibitor
  1460. 6cnh: Human PRPF4B in Complex with Rebastinib
  1461. 6cn9: Crystal Structure of The Kinase Domain of Wnk1
  1462. 6cmm: Crystal Structure of The Human Vaccinia-related Kinase Bound to a N,n- Dipropynyl-dihydropteridine Inhibitor
  1463. 6cki: Co-crystal Structure of Mnk2 in Complex with Inhibitor
  1464. 6ck6: Crystal Structure of MNK2-D228G in Complex with Inhibitor
  1465. 6ck3: Co-crytsal Structure of Mnk2 in Complex with an Inhibitor
  1466. 6cjy: Crystal Structure of MNK2-D228G in Complex with Inhibitor
  1467. 6cjw: Crystal Structure of MNK2-D228G in Complex with Inhibitor
  1468. 6cjh: Co-crystal Structure of Mnk2 in Complex with an Inhibitor
  1469. 6cje: Crystal Structure of MNK2-D228G in Complex with Inhibitor
  1470. 6cj5: Crystal Structure of MNK2-D228G in Complex with Inhibitor
  1471. 6cfm: Crystal Structure of The Human Vaccinia-related Kinase Bound to a Propynyl-pteridinone Inhibitor
  1472. 4b4l: Crystal Structure of an Ard Dap-kinase 1 Mutant
  1473. 4bfm: The Crystal Structure of Mouse Pk38
  1474. 4bky: Crystal Structure of Unphosphorylated Maternal Embryonic Leucine Zipper Kinase (melk) in Complex with Pyrrolopyrazole Inhibitor
  1475. 4bkz: Crystal Structure of Unphosphorylated Maternal Embryonic Leucine Zipper Kinase (melk) in Complex with a Benzodipyrazole Inhibitor
  1476. 4bl0: Crystal Structure of Yeast Bub3-bub1 Bound to Phospho-spc105
  1477. 6ccy: Crystal Structure of Akt1 in Complex with a Selective Inhibitor
  1478. 4bn1: Crystal Structure of V174M Mutant of Aurora-a Kinase
  1479. 4btj: Ttbk1 in Complex with Atp
  1480. 4btk: Ttbk1 in Complex with Inhibitor
  1481. 4btm: Ttbk1 in Complex with Inhibitor
  1482. 6cad: Crystal Structure of Raf Kinase Domain Bound to The Inhibitor 2a
  1483. 6c9j: Amp-activated Protein Kinase Bound to Pharmacological Activator R734
  1484. 6c9h: Non-phosphorylated Amp-activated Protein Kinase Bound to Pharmacological Activator R734
  1485. 6c9g: Amp-activated Protein Kinase Bound to Pharmacological Activator R739
  1486. 6c9f: Amp-activated Protein Kinase Bound to Pharmacological Activator R734
  1487. 6c9d: Crystal Structure of Ka1-autoinhibited Mark1 Kinase
  1488. 4byi: Aurora a Kinase Bound to a Highly Selective Imidazopyridine Inhibitor
  1489. 4byj: Aurora a Kinase Bound to a Highly Selective Imidazopyridine Inhibitor
  1490. 4bzn: Crystal Structure of Pim1 in Complex with a Pyrrolo(1,2-a) Pyrazinone Inhibitor
  1491. 4bzo: Crystal Structure of Pim1 in Complex with a Pyrrolo- Pyrazinone Inhibitor
  1492. 4c0t: Candida Albicans Pkh Kinase Domain
  1493. 4c2v: Aurora B Kinase in Complex with The Specific Inhibitor Barasertib
  1494. 4c2w: Crystal Structure of Aurora B in Complex with Amp-pnp
  1495. 4c3p: Structure of Dephosphorylated Aurora a (122-403) Bound to Tpx2 and Amppcp
  1496. 4c3r: Structure of Dephosphorylated Aurora a (122-403) Bound to Amppcp
  1497. 4c4k: Crystal Structure of The Titin M10-obscurin Ig Domain 1 Complex
  1498. 4c57: Structure of Gak Kinase in Complex with a Nanobody
  1499. 4c58: Structure of Gak Kinase in Complex with Nanobody (nbgak_4)
  1500. 4c59: Structure of Gak Kinase in Complex with Nanobody (nbgak_4)
  1501. 4c8b: Structure of The Kinase Domain of Human Ripk2 in Complex with Ponatinib
  1502. 4cfe: Structure of Full Length Human Ampk in Complex with a Small Molecule Activator, a Benzimidazole Derivative (991)
  1503. 4cff: Structure of Full Length Human Ampk in Complex with a Small Molecule Activator, a Thienopyridone Derivative (a-769662)
  1504. 4cfh: Structure of an Active Form of Mammalian Ampk
  1505. 4ch9: Crystal Structure of The Human Klhl3 Kelch Domain in Complex with a Wnk4 Peptide
  1506. 4chb: Crystal Structure of The Human Klhl2 Kelch Domain in Complex with a Wnk4 Peptide
  1507. 4cqg: The Crystal Structure of Mpk38 in Complex with Otssp167, an Orally-administrative Melk Selective Inhibitor
  1508. 4ct1: Human Pdk1-pkczeta Kinase Chimera in Complex with Allosteric Compound Ps315 Bound to The Pif-pocket
  1509. 4ct2: Human Pdk1-pkczeta Kinase Chimera
  1510. 4czt: Crystal Structure of The Kinase Domain of Snrk3.23 AT1G30270
  1511. 4czu: Crystal Structure of The Kinase Domain of Snrk3.23 AT1G30270 T190D Mutant
  1512. 4d28: Crystal Structure of The Kinase Domain of Snrk3.11 AT5G35410
  1513. 4d2p: Structure of Melk in Complex with Inhibitors
  1514. 4d2t: Structure of Melk in Complex with Inhibitors
  1515. 4d2v: Structure of Melk in Complex with Inhibitors
  1516. 4d2w: Structure of Melk in Complex with Inhibitors
  1517. 4eqc: Crystal Structure of Pak1 Kinase Domain in Complex with Frax597 Inhibitor
  1518. 4fc0: Crystal Structure of Human Kinase Domain of B-raf with a Dfg-out Inhibitor
  1519. 4grb: Casein Kinase 2 (ck2) Bound to Inhibitor
  1520. 4gub: Casein Kinase II Bound to Inhibitor
  1521. 4hhd: 2.75 Angstrom Resolution Crystal Structure of The A. Thaliana Lov2 Domain with an Extended N-terminal A' Helix (cryo Dark Structure)
  1522. 4hi8: Structure of Integrin-linked Kinase Ankyrin Repeat Domain in Complex with Pinch1 Lim1 Domain Collected at High Energy, Wavelength 0.32800
  1523. 4hi9: 1.2 Structure of Integrin-linked Kinase Ankyrin Repeat Domain in Complex with Pinch1 Lim1 Domain Collected at Wavelength 0.91974
  1524. 4hkd: Crystal Structure of Human Mst2 Sarah Domain
  1525. 4hvb: Catalytic Unit of PI3KG in Complex with PI3K/MTOR Dual Inhibitor Pf- 04979064
  1526. 4i41: Crystal Structure of Human Ser/thr Kinase Pim1 in Complex with Mitoxantrone
  1527. 4i92: Structure of The Bsk8 Kinase Domain
  1528. 4i93: Structure of The Bsk8 Kinase Domain (semet Labeled)
  1529. 4i94: Structure of Bsk8 in Complex with Amp-pnp
  1530. 4iaa: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Thioridazine
  1531. 4ian: Crystal Structure of Apo Human PRPF4B Kinase Domain
  1532. 4iea: 14-3-3 Isoform Sigma in Complex with a Phosphorylated C-raf Peptide
  1533. 4ifc: Crystal Structure of Adp-bound Human PRPF4B Kinase Domain
  1534. 4ihl: Human 14-3-3 Isoform Zeta in Complex with a Diphoyphorylated C-raf Peptide and Cotylenin a
  1535. 4iir: Crystal Structure of Amppnp-bound Human PRPF4B Kinase Domain
  1536. 4ijp: Crystal Structure of Human PRPF4B Kinase Domain in Complex with 4-{5- [(2-chloro-pyridin-4-ylmethyl)-carbamoyl]-thiophen-2-yl}- Benzo[b]thiophene-2-carboxylic Acid Amine
  1537. 4ixp: Crystal Structure of Maternal Embryonic Leucine Zipper Kinase (melk)
  1538. 4j6i: Discovery of Thiazolobenzoxepin Pi3-kinase Inhibitors That Spare The Pi3-kinase Beta Isoform
  1539. 4j8m: Aurora a in Complex with Cd532
  1540. 4j8n: Aurora a Kinase Apo
  1541. 4jdh: Crystal Structure of Serine/threonine-protein Kinase Pak 4 in Complex with Paktide T Peptide Substrate
  1542. 4jdi: Crystal Structure of Serine/threonine-protein Kinase Pak 4 in Complex with Paktide S Peptide Substrate
  1543. 4jdj: Crystal Structure of Serine/threonine-protein Kinase Pak 4 F461V Mutant in Complex with Paktide T Peptide Substrate
  1544. 4jdk: Crystal Structure of Serine/threonine-protein Kinase Pak 4 F461V Mutant in Complex with Paktide S Peptide Substrate
  1545. 4jnw: Bacterially Expressed Titin Kinase
  1546. 4jps: Co-crystal Structures of The Lipid Kinase PI3K Alpha with Pan and Isoform Selective Inhibitors
  1547. 4jqe: Crystal Structure of Scck2 Alpha in Complex with Amppn
  1548. 4jr7: Crystal Structure of Scck2 Alpha in Complex with Gmppnp
  1549. 4jx3: Crystal Structure of Pim1 Kinase
  1550. 4jx7: Crystal Structure of Pim1 Kinase in Complex with Inhibitor 2-[(trans- 4-aminocyclohexyl)amino]-4-{[3-(trifluoromethyl) Phenyl]amino}pyrido[4,3-d]pyrimidin-5(6h)-one
  1551. 6l21: Crystal Structure of CK2A1 H160A with Hematein
  1552. 6l22: Crystal Structure of CK2A1 H115Y with Hematein
  1553. 4kb8: CK1D in Complex with 1-{4-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4- Yl]pyridin-2-yl}-n-methylmethanamine Ligand
  1554. 4kba: CK1D in Complex with 9-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]- 2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine Inhibitor
  1555. 4kbc: CK1D in Complex with {4-[3-(4-fluorophenyl)-1h-pyrazol-4-yl]pyridin-2- Yl}methanol Inhibitor
  1556. 4kbk: CK1D in Complex with (3s)-3-{4-[3-(4-fluorophenyl)-1-methyl-1h- Pyrazol-4-yl]pyridin-2-yl}morpholine Inhibitor
  1557. 4ks7: Pak6 Kinase Domain in Complex with Pf-3758309
  1558. 4ks8: Pak6 Kinase Domain in Complex with Sunitinib
  1559. 4kwp: Crystal Structure of Human Ck2-alpha in Complex with a Benzimidazole Inhibitor (k164) at 1.25 a Resolution
  1560. 4l1b: Crystal Structure of P110ALPHA Complexed with Nish2 of P85ALPHA
  1561. 4l23: Crystal Structure of P110ALPHA Complexed with Nish2 of P85ALPHA and Pi-103
  1562. 4l2y: Crystal Structure of P110ALPHA Complexed with Nish2 of P85ALPHA and Compound 9d
  1563. 4l67: Crystal Structure of Catalytic Domain of Pak4
  1564. 4l6q: Rock2 in Complex with Benzoxaborole
  1565. 4lb5: Crystal Structure of Pkz Zalpha in Complex with Ds(cg)6 (hexagonal Form)
  1566. 4lb6: Crystal Structure of Pkz Zalpha in Complex with Ds(cg)6 (tetragonal Form)
  1567. 4lfi: Crystal Structure of Scck2 Alpha in Complex with Gmppnp
  1568. 4lg4: Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by Rassf5
  1569. 4lgd: Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by Rassf5
  1570. 6v6l: Co-structure of Human Glycogen Synthase Kinase Beta with 1-(6-((2-((6- Amino-5-nitropyridin-2-yl)amino)ethyl)amino)-2-(2,4-dichlorophenyl) Pyridin-3-yl)-4-methylpiperazin-2-one
  1571. 4ll5: Crystal Structure of Pim-1 in Complex with The Fluorescent Compound Skf86002
  1572. 4lm5: Crystal Structure of Pim1 in Complex with 2-{4-[(3-aminopropyl) Amino]quinazolin-2-yl}phenol (resulting from Displacement of Skf86002)
  1573. 4lmu: Crystal Structure of Pim1 in Complex with The Inhibitor Quercetin (resulting from Displacement of Skf86002)
  1574. 4lqp: Crystal Structure of The CBK1(T743E)-MOB2 Kinase-coactivator Complex, in Crystal Form a
  1575. 4lqq: Crystal Structure of The CBK1(T743E)-MOB2 Kinase-coactivator Complex in Crystal Form B
  1576. 4lqs: Crystal Structure of The Cbk1-mob2 Kinase-coactivator Complex
  1577. 4lrj: Bacterial Effector Nleh1 Kinase Domain with Amppnp and Mg2+
  1578. 4lrk: Bacterial Effector Nleh2 Kinase Domain
  1579. 4m66: Crystal Structure of The Mouse Rip3 Kinase Domain
  1580. 4m69: Crystal Structure of The Mouse Rip3-mlkl Complex
  1581. 4m7e: Structural Insight into Bl-induced Activation of The Bri1-bak1 Complex
  1582. 4m7i: Crystal Structure of Gsk6157 Bound to Perk (r587-r1092, Delete A660- T867) at 2.34a Resolution
  1583. 4m8t: Rsk2 T493M C-terminal Kinase Domain in Complex with 3-(3-(1h-pyrazol- 4-yl)phenyl)-2-cyanoacrylamide
  1584. 4mao: Rsk2 T493M C-terminal Kinase Domain in Complex with Rmm58
  1585. 4mbi: Discovery of Pyrazolo[1,5a]pyrimidine-based Pim1 Inhibitors
  1586. 4mbj: Human B-raf Kinase Domain in Complex with an Imidazopyridine-based Inhibitor
  1587. 4mbl: Discovery of Pyrazolo[1,5a]pyrimidine-based Pim1 Inhibitors
  1588. 4md7: Crystal Structure of Full-length Symmetric Ck2 Holoenzyme
  1589. 4md8: Crystal Structure of Full-length Symmetric Ck2 Holoenzyme with Mutated Alpha Subunit (F121E)
  1590. 4md9: Crystal Structure of Symmetric Ck2 Holoenzyme with Mutated Alpha Subunit (F121E Truncated at Aa 336)
  1591. 4mn8: Crystal Structure of Flg22 in Complex with The Fls2 and Bak1 Ectodomains
  1592. 4mna: Crystal Structure of The Free Fls2 Ectodomains
  1593. 4mne: Crystal Structure of The Braf:mek1 Complex
  1594. 4mnf: Crystal Structure of BRAF-V600E Bound to Gdc0879
  1595. 4mvf: Crystal Structure of Plasmodium Falciparum Cdpk2 Complexed with Inhibitor Staurosporine
  1596. 4mwh: Crystal Structure of Scck2 Alpha in Complex with Atp
  1597. 4n6y: Pim1 Complexed with a Phenylcarboxamide
  1598. 4n6z: Pim1 Complexed with a Pyridylcarboxamide
  1599. 4n70: Pim1 Complexed with a Pyridylcarboxamide
  1600. 4neu: X-ray Structure of Receptor Interacting Protein 1 (rip1)kinase Domain with a 1-aminoisoquinoline Inhibitor
  1601. 4nfm: Human Tau Tubulin Kinase 1 (ttbk1)
  1602. 4nfn: Human Tau Tubulin Kinase 1 (ttbk1) Complexed with 3-({5-[(4-amino-4- Methylpiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)- 5-bromophenol
  1603. 4nh1: Crystal Structure of a Heterotetrameric Ck2 Holoenzyme Complex Carrying The Andante-mutation in CK2BETA and Consistent with Proposed Models of Autoinhibition and Trans-autophosphorylation
  1604. 4nif: Heterodimeric Structure of Erk2 and Rsk1
  1605. 4njd: Structure of P21-activated Kinase 4 with a Novel Inhibitor Ky-04031
  1606. 4nkb: Crystal Structure of The Cryptic Polo Box (cpb)of Zyg-1
  1607. 4nm0: Crystal Structure of Peptide Inhibitor-free Gsk-3/axin Complex
  1608. 4nm3: Crystal Structure of Gsk-3/axin Complex Bound to Phosphorylated N- Terminal Auto-inhibitory Ps9 Peptide
  1609. 4nr2: Crystal Structure of Stk4 (mst1) Sarah Domain
  1610. 4nu1: Crystal Structure of a Transition State Mimic of The Gsk-3/axin Complex Bound to Phosphorylated N-terminal Auto-inhibitory Ps9 Peptide
  1611. 4nus: Rsk2 N-terminal Kinase in Complex with Ljh685
  1612. 4nw5: Rsk2 N-terminal Kinase in Complex with 2-amino-7-substituted Benzoxazole Compound 8
  1613. 4nw6: Rsk2 N-terminal Kinase in Complex with 2-amino-7-substituted Benzoxazole Compound 27
  1614. 4nxb: Crystal Structure of Ilov-i486(2lt) at Ph 7.0
  1615. 4nxe: Crystal Structure of Ilov-i486(2lt) at Ph 6.5
  1616. 4nxf: Crystal Structure of Ilov-i486(2lt) at Ph 8.0
  1617. 4nxg: Crystal Structure of ILOV-I486Z(2LT) at Ph 9.0
  1618. 4o0m: Crystal Structure of T. Elongatus Bp-1 Clock Protein Kaic
  1619. 4o0r: Back Pocket Flexibility Provides Group-ii Pak Selectivity for Type 1 Kinase Inhibitors
  1620. 4o0t: Back Pocket Flexibility Provides Group-ii Pak Selectivity for Type 1 Kinase Inhibitors
  1621. 4o0v: Back Pocket Flexibility Provides Group-ii Pak Selectivity for Type 1 Kinase Inhibitors
  1622. 4o0x: Back Pocket Flexibility Provides Group-ii Pak Selectivity for Type 1 Kinase Inhibitors
  1623. 4o0y: Back Pocket Flexibility Provides Group-ii Pak Selectivity for Type 1 Kinase Inhibitors
  1624. 4o38: Crystal Structure of The Human Cyclin G Associated Kinase (gak)
  1625. 4obo: MAP4K4 in Complex with Inhibitor (compound 22), 6-(3-chlorophenyl) Quinazolin-4-amine
  1626. 4obp: MAP4K4 in Complex with Inhibitor (compound 29), 6-(2-fluoropyridin-4- Yl)pyrido[3,2-d]pyrimidin-4-amine
  1627. 4obq: MAP4K4 in Complex with Inhibitor (compound 31), N-[3-(4- Aminoquinazolin-6-yl)-5-fluorophenyl]-2-(pyrrolidin-1-yl)acetamide
  1628. 4oh4: Crystal Structure of Bri1 in Complex with Bki1
  1629. 4oh8: Crystal Structure of The Human Mst1-rassf5 Sarah Heterodimer
  1630. 4oh9: Crystal Structure of The Human Mst2 Sarah Homodimer
  1631. 4otm: Crystal Structure of The C-terminal Domain from Yeast Gcn2
  1632. 4otn: Crystal Structure of The C-terminal Regulatory Domain of Murine Gcn2
  1633. 4otp: Crystal Structure of The Catalytic Domain of The Human Riok1 Atypical Protein Kinase in Complex with Adp/mg2+
  1634. 4ouc: Structure of Human Haspin in Complex with Histone H3 Substrate
  1635. 5yks: Crystal Structure of Sucrose Nonfermenting-related Kinase (snrk)
  1636. 5yh3: The Structure of HFAM20C and HFAM20A Complex
  1637. 5yf9: Crystal Structure of CK2A2 Form-2
  1638. 5yf4: A Kinase Complex Mst4-mob4
  1639. 5y9m: Crystal Structure of CK2A2 Form 3
  1640. 5y96: Crystal Structure of Anxur1 Extracellular Domain from Arabidopsis Thaliana
  1641. 5y92: Crystal Structure of Anxur2 Extracellular Domain from Arabidopsis Thaliana
  1642. 4p7i: Crystal Structure of The Merlin Ferm/dcaf1 Complex
  1643. 4p90: Crystal Structure of The Kinase Domain of Human Pak1 in Complex with Compound 15
  1644. 5y80: Complex Structure of Cyclin G-associated Kinase with Gefitinib
  1645. 5y7z: Complex Structure of Cyclin G-associated Kinase with Gefitinib
  1646. 4pf4: 1.1a X-ray Structure of The Apo Catalytic Domain of Death-associated Protein Kinase 1, Aa 1-277
  1647. 5y3r: Cryo-em Structure of Human Dna-pk Holoenzyme
  1648. 4pl3: Crystal Structure of Murine Ire1 in Complex with Mkc9989 Inhibitor
  1649. 4pl4: Crystal Structure of Murine Ire1 in Complex with Oicr464 Inhibitor
  1650. 4pl5: Crystal Structure of Murine Ire1 in Complex with Oicr573 Inhibitor
  1651. 5xy9: Structure of The Mst4 and 14-3-3 Complex
  1652. 4pp7: Highly Potent and Selective 3-n-methylquinazoline-4(3h)-one Based Inhibitors of B-RAFV600E Kinase
  1653. 4prj: Aurora a Kinase Domain with Compound 2 (n-[1-(3-cyanobenzyl)-1h- Pyrazol-4-yl]-6-(1h-pyrazol-4-yl)-1h-indazole-3-carboxamide)
  1654. 4ps3: Structure of PI3K Gamma in Complex with 1-[6-(5-methoxypyridin-3-yl)- 1,3-benzothiazol-2-yl]-3-[2-(1-propyl-1h-imidazol-4-yl)ethyl]urea
  1655. 4ps7: Structure of PI3K Gamma in Complex with N-[6-(pyridin-3-yl)-1,3- Benzothiazol-2-yl]acetamide
  1656. 5xvu: Crystal Structure of The Protein Kinase Ck2 Catalytic Domain from Plasmodium Falciparum Bound to Atp
  1657. 4ps8: Structure of PI3K Gamma in Complex with N-[6-(5,6-dimethoxypyridin-3- Yl)-1,3-benzothiazol-2-yl]acetamide
  1658. 5xvg: Crystal Structure of Pak4 in Complex with Inhibitor Czh226
  1659. 5xvf: Crystal Structure of Pak4 in Complex with Inhibitor Czh062
  1660. 5xva: Crystal Structure of Pak4 in Complex with Inhibitor Czh216
  1661. 5xqz: Structure of The Mob1-ndr2 Complex
  1662. 4pwn: Crystal Structure of Active Wnk1 Kinase
  1663. 4pxw: Crystal Structure of Human Dcaf1 Wd40 Repeats (Q1250L)
  1664. 4q2a: Wnk1: a Chloride Sensor via Autophosphorylation
  1665. 5xlm: Monomer Form of M.tuberculosis Pkni Sensor Domain
  1666. 5xll: Dimer Form of M. Tuberculosis Pkni Sensor Domain
  1667. 4q5j: Crystal Structure of Semet Derivative Bri1 in Complex with Bki1
  1668. 5xkn: Crystal Structure of Plant Receptor Erl2 in Complexe with Epfl4
  1669. 5xkj: Crystal Structure of Plant Receptor Erl1-tmm in Complexe with Epf2
  1670. 5xka: Crystal Structure of M.tuberculosis Pkni Kinase Domain
  1671. 5xjx: Pre-formed Plant Receptor Erl1-tmm Complex
  1672. 5xjo: Plant Receptor Erl1-tmm in Complex with Peptide Epf1
  1673. 5xgj: Crystal Structure of PI3K Complex with an Inhibitor
  1674. 5xgi: Crystal Structure of PI3K Complex with an Inhibitor
  1675. 5xgh: Crystal Structure of PI3K Complex with an Inhibitor
  1676. 4qfg: Structure of Ampk in Complex with Staurosporine Inhibitor and in The Absence of a Synthetic Activator
  1677. 4qfr: Structure of Ampk in Complex with Cl-a769662 Activator and Staurosporine Inhibitor
  1678. 4qfs: Structure of Ampk in Complex with BR2-A769662CORE Activator and Staurosporine Inhibitor
  1679. 5x6o: Intact Atr/mec1-atrip/ddc2 Complex
  1680. 5x18: Crystal Structure of Casein Kinase I Homolog 1
  1681. 5x17: Crystal Structure of Murine CK1D in Complex with Adp
  1682. 5wnm: Crystal Structure of Murine Receptor-interacting Protein 4 (ripk4) D143N Bound to Tozasertib (vx-680)
  1683. 5wnl: Crystal Structure of Murine Receptor-interacting Protein 4 (ripk4) D143N Bound to Staurosporine
  1684. 5wnk: Crystal Structure of Murine Receptor-interacting Protein 4 (ripk4) D143N Bound to Tg100-115
  1685. 5wnj: Crystal Structure of Murine Receptor-interacting Protein Kinase 4 (ripk4) D143N in Complex with Lestaurtinib
  1686. 5wni: Crystal Structure of Murine Receptor-interacting Protein Kinase 4 (ripk4) D143N in Complex with Atp
  1687. 5wnh: X-ray Co-structure of Rho-associated Protein Kinase (rock1) with a Highly Selective Inhibitor
  1688. 5wng: X-ray Co-structure of Rho-associated Protein Kinase (rock1) with a Highly Selective Inhibitor
  1689. 5wnf: X-ray Co-structure of Rho-associated Protein Kinase (rock1) with a Highly Selective Inhibitor
  1690. 5wne: X-ray Co-structure of Rho-associated Protein Kinase (rock1) with a Highly Selective Inhibitor
  1691. 5wls: Crystal Structure of a Pollen Receptor Kinase 3
  1692. 5we8: Crystal Structure of Wnk1 in Complex with N-{(3r)-1-[(4-chlorophenyl) Methyl]pyrrolidin-3-yl}-2-(3-methoxyphenyl)-n-methylquinoline-4- Carboxamide (compound 8)
  1693. 5wdy: Crystal Structure of Wnk1 in Complex with 1-cyclohexyl-n-({6-fluoro-1- [2-(3-methoxyphenyl)pyridin-4-yl]-1h-indol-3-yl}methyl)methanamine (compound 6)
  1694. 5wby: Crystal Structure of Mtor(deltan)-mlst8-pras40(beta-strand) Complex
  1695. 5wbu: Crystal Structure of Mtor(deltan)-mlst8-pras40(alpha-helix & Beta- Strand) Complex
  1696. 5wbk: Crystal Structure of The Arabidopsis Thaliana Raptor in Complex with The Tos Peptide of Human S6K1
  1697. 5wbh: Structure of The Frb Domain of Mtor Bound to a Substrate Recruitment Peptide of S6K1
  1698. 5w85: Crystal Structure of Irak-4 with a 4,6-diaminonicotinamide Inhibitor (compound Number 9)
  1699. 5w84: Crystal Structure of Irak-4 with a 4,6-diaminonicotinamide Inhibitor (compound Number 4)
  1700. 5w7t: Structure of Phosphorylated Wnk1
  1701. 5w5v: Tbk1 Co-crystal Structure with Amlexanox
  1702. 5w5q: MAP4K4 in Complex with Inhibitor Compound 12 (n3-methyl-10-(3-methyl- 3-(5-methyloxazol-2-yl)but-1-yn-1-yl)-6,7-dihydro-5h-5,7- Methanobenzo[c]imidazo[1,2-a]azepine-2,3-dicarboxamide)
  1703. 5w5o: Identification of Potent and Selective Ripk2 Inhibitors for The Treatment of Inflammatory Diseases.
  1704. 5w4w: Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (ck1) Inhibitors
  1705. 5w1r: Cryo-em Structure of Dnapkcs
  1706. 4qox: Crystal Structure of Cdpk4 from Plasmodium Falciparum, PF3D7_0717500
  1707. 4qpm: Structure of Bub1 Kinase Domain
  1708. 5vyk: Crystal Structure of The Brs Domain of Braf in Complex with The Cc-sam Domain of Ksr1
  1709. 4qtc: Structure of Human Haspin (gsg2) in Complex with Sch772984 Revealing The First Type-i Binding Mode
  1710. 4r8q: Structure and Substrate Recruitment of The Human Spindle Checkpoint Kinase Bub1
  1711. 5vuc: Pim1 Kinase in Complex with a Benzofuranone Inhibitor
  1712. 5vub: Pim1 Kinase in Complex with a Benzofuranone Inhibitor
  1713. 5vua: Pim1 Kinase in Complex with a Benzofuranone Inhibitor
  1714. 6kzi: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Thioridazine Derivatives
  1715. 4rgj: Apo Crystal Structure of Cdpk4 from Plasmodium Falciparum, PF3D7_0717500
  1716. 5vr3: Crystal Structure of The Brs Domain of Braf
  1717. 4tpt: Crystal Structure of The Human Limk2 Kinase Domain in Complex with a Non-atp Competitive Inhibitor
  1718. 4tuu: Isolated P110A Subunit of PI3KA Provides a Platform for Structure- Based Drug Design
  1719. 4tv3: Isolated P110A Subunit of PI3KA Provides a Platform for Structure- Based Drug Design
  1720. 4tw9: Difluoro-dioxolo-benzoimidazol-benzamides as Potent Inhibitors of CK1DELTA and Epsilon with Nanomolar Inhibitory Activity on Cancer Cell Proliferation
  1721. 4twc: 2-benzamido-n-(1h-benzo[d]imidazol-2-yl)thiazole-4- Carboxamide Derivatives as Potent Inhibitors of CK1D/E
  1722. 4txc: Crystal Structure of Dapk1 Kinase Domain in Complex with a Small Molecule Inhibitor
  1723. 5vja: Crystal Structure of Human Zipper-interacting Protein Kinase (zipk, Alias Dapk3) in Complex with a Pyrazolo[3,4-d]pyrimidinone Ligand (hs38)
  1724. 4u43: MAP4K4 in Complex with Inhibitor (compound 6)
  1725. 4u44: MAP4K4 in Complex with Inhibitor (compound 16)
  1726. 4u45: MAP4K4 in Complex with Inhibitor (compound 25)
  1727. 4u6r: Crystal Structure of Human Ire1 Cytoplasmic Domains in Complex with a Sulfonamide Inhibitor.
  1728. 4u97: Crystal Structure of Asymmetric Irak4 Dimer
  1729. 4u9a: Sulphur Anomalous Crystal Structure of Asymmetric Irak4 Dimer
  1730. 4uak: Mrck Beta in Complex with Adp
  1731. 4ual: Mrck Beta in Complex with Bdp00005290
  1732. 5vef: Pak4 Kinase Domain in Complex with Fasudil
  1733. 5vee: Pak4 Kinase Domain in Complex with Frax486
  1734. 5ved: Pak4 Kinase Domain in Complex with Staurosporine
  1735. 4ump: Structure of Melk in Complex with Inhibitors
  1736. 4umq: Structure of Melk in Complex with Inhibitors
  1737. 4umr: Structure of Melk in Complex with Inhibitors
  1738. 4umt: Structure of Melk in Complex with Inhibitors
  1739. 4umu: Structure of Melk in Complex with Inhibitors
  1740. 5vd3: Crystal Structure of Human Myt1 Kinase Domain (de-phosphorylated) in Complex with Saracatinib
  1741. 5vd1: Crystal Structure of Human Myt1 Kinase Domain in Complex with Pha- 848125
  1742. 5vd0: Crystal Structure of Human Myt1 Kinase Domain in Complex with Mk1775
  1743. 5vcz: Crystal Structure of Human Myt1 Kinase Domain in Complex with Bosutinib Isomer
  1744. 5vcy: Crystal Structure of Human Myt1 Kinase Domain in Complex with Bosutinib
  1745. 5vcx: Crystal Structure of Human Myt1 Kinase Domain (untreated) in Complex with Saracatinib
  1746. 5vcw: Crystal Structure of Human Myt1 Kinase Domain in Complex with Pelitinib
  1747. 5vcv: Crystal Structure of Human Myt1 Kinase Domain in Complex with Dasatinib
  1748. 5vam: Braf in Complex with Raf709
  1749. 5val: Braf in Complex with N-(3-(tert-butyl)phenyl)-4-methyl-3-(6- Morpholinopyrimidin-4-yl)benzamide
  1750. 4urk: PI3KG in Complex with Azd6482
  1751. 5v82: Pim1 Kinase in Complex with Cpd17 (1-(6-(4,4-difluoropiperidin-3-yl) Pyridin-2-yl)-6-(6-methylpyrazin-2-yl)-1h-pyrazolo[4,3-c]pyridine)
  1752. 5v80: Pim1 Kinase in Complex with Cpd1 (1-methyl-4-(3-(6-(piperazin-1-yl) Pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridin-5-yl)piperazin-2-one)
  1753. 4uyn: Sar156497 an Exquisitely Selective Inhibitor of Aurora Kinases
  1754. 4uzd: Sar156497 an Exquisitely Selective Inhibitor of Aurora Kinases
  1755. 4uzh: Sar156497 an Exquisitely Selective Inhibitor of Aurora Kinases
  1756. 5v62: Phospho-erk2 Bound to Bivalent Inhibitor Sbp3
  1757. 5v61: Phospho-erk2 Bound to Bivalent Inhibitor Sbp2
  1758. 4w7p: Crystal Structure of Rock 1 Bound to Yb-15-qd37
  1759. 4w9w: Crystal Structure of Bmp-2-inducible Kinase in Complex with Small Molecule Azd-7762
  1760. 4w9x: Crystal Structure of Bmp-2-inducible Kinase in Complex with Baricitinib
  1761. 5uzj: Crystal Structure of Rock1 Bound to an Aminopyridine Inhibitor
  1762. 4wsq: Crystal Structure of Adaptor Protein 2 Associated Kinase (aak1) in Complex with Small Molecule Inhibitor
  1763. 5uvf: Crystal Structure of The Human Vaccinia-related Kinase Bound to Bi- D1870
  1764. 5uu1: Crystal Structure of Human Vaccinia-related Kinase 2 (vrk-2) Bound to Bi-d1870
  1765. 4nzw: Crystal Structure of Stk25-mo25 Complex
  1766. 4o27: Crystal Structure of Mst3-mo25 Complex with wif Motif
  1767. 4rgw: Crystal Structure of a Taf1-taf7 Complex in Human Transcription Factor Iid
  1768. 5upl: Cdc42 Binds Pak4 via an Extended Gtpase-effector Inteface - 2 Peptide: PAK4FL, Cdc42 - Unrefined
  1769. 5upk: Cdc42 Binds Pak4 via an Extended Gtpase-effector Interface - 3 Peptide: PAK4CAT, Pak4-n45, Cdc42
  1770. 4wo5: Crystal Structure of a Braf Kinase Domain Monomer
  1771. 5ul1: The Co-structure of 3-amino-6-(4-((1-(dimethylamino)propan-2-yl) Sulfonyl)phenyl)-n-phenylpyrazine-2-carboxamide and a Rationally Designed PI3K-ALPHA Mutant That Mimics Atr
  1772. 5ukj: The Co-structure of N,n-dimethyl-4-[(6r)-6-methyl-5-(1h-pyrrolo[2,3- B]pyridin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5- A]pyrazin-3- Yl]benzenesulfonamide and a Rationally Designed PI3K-ALPHA Mutant That Mimics Atr
  1773. 5ukf: Crystal Structure of The Human Vaccinia-related Kinase 1 Bound to an Oxindole Inhibitor
  1774. 5uke: Nmr Structure of Monomeric Human Irak-m Death Domain R56D, Y61E Mutant
  1775. 4o0s: Crystal Structures of Human Kinase Aurora a
  1776. 4o0u: Crystal Structures of Human Kinase Aurora a
  1777. 4o0w: Crystal Structures of Human Kinase Aurora a
  1778. 5uk8: The Co-structure of (r)-4-(6-(1-(cyclopropylsulfonyl)cyclopropyl)-2- (1h-indol-4-yl)pyrimidin-4-yl)-3-methylmorpholine and a Rationally Designed PI3K-ALPHA Mutant That Mimics Atr
  1779. 4qye: Chk1 Kinase Domain in Complex with Diarylpyrazine Compound 1
  1780. 4qyf: Chk1 Kinase Domain in Complex with Aminopyrazine Compound 13
  1781. 4qyg: Chk1 Kinase Domain in Complex with Diazacarbazole Compound 14
  1782. 4qyh: Chk1 Kinase Domain in Complex with Diazacarbazole Gne-783
  1783. 5uiu: Crystal Structure of Irak4 in Complex with Compound 30
  1784. 5uit: Crystal Structure of Irak4 in Complex with Compound 14
  1785. 5uis: Crystal Structure of Irak4 in Complex with Compound 12
  1786. 5uir: Crystal Structure of Irak4 in Complex with Compound 11
  1787. 5uiq: Crystal Structure of Irak4 in Complex with Compound 9
  1788. 5ufu: Structure of Ampk Bound to Activator
  1789. 5u94: Crystal Structure of The Mycobacterium Tuberculosis Pasta Kinase Pknb in Complex with The Potential Theraputic Kinase Inhibitor Gsk690693.
  1790. 5u7r: Identification of a New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-dihydrothieno[3,2-d]pyrimidin-4(1h)-ones
  1791. 5u7q: Identification of a New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-dihydrothieno[3,2-d]pyrimidin-4(1h)-ones
  1792. 5tzm: 59th Ig Domain of Human Obscurin (obscn Ig59)
  1793. 5tx5: Rip1 Kinase ( Flag 1-294, C34A, C127A, C233A, C240A) with Gsk772
  1794. 5tx3: Structure of Maternal Embryonic Leucine Zipper Kinase
  1795. 5twz: Structure of Maternal Embryonic Leucine Zipper Kinase
  1796. 5twy: Structure of Maternal Embryonic Leucine Zipper Kinase
  1797. 5twu: Structure of Maternal Embryonic Leucine Zipper Kinase
  1798. 5twl: Structure of Maternal Embryonic Leucine Zipper Kinase
  1799. 5tvt: Structure of Maternal Embryonic Leucine Zipper Kinase
  1800. 5tur: Pim-1 Kinase in Complex with a 7-azaindole
  1801. 5tos: Botrytis-induced Kinase 1 (bik1) from Arabidopsis Thaliana
  1802. 5toe: Pim-1 Kinase in Complex with a 7-azaindole
  1803. 5tf9: Crystal Structure of Wnk1 in Complex with Mn2+amppnp and Wnk476
  1804. 5tex: Pim-1 Kinase in Complex with a 7-azaindole
  1805. 5tel: Pim-1 Kinase in Complex with a 7-azaindole
  1806. 5te0: Crystal Structure of Adaptor Protein 2 Associated Kinase (aak1) in Complex with Bibf 1120
  1807. 5t5t: Ampk Bound to Allosteric Activator
  1808. 5t31: Exploiting an Asp-glu Switch in Glycogen Synthase Kinase 3 to Design Paralog Selective Inhibitors for Use in Acute Myeloid Leukemia
  1809. 5t23: PI3KG in Complex with 5d
  1810. 5t1t: Irak4 Kinase - Compound 1 Co-structure
  1811. 5t1s: Irak4 Kinase - Compound 1 Co-structure
  1812. 5t1h: Crystal Structure of Ck2
  1813. 5sxk: Crystal Structure of PI3KALPHA in Complex with Fragment 18
  1814. 5sxj: Crystal Structure of PI3KALPHA in Complex with Fragment 29
  1815. 5sxi: Crystal Structure of PI3KALPHA in Complex with Fragment 13
  1816. 5sxf: Crystal Structure of PI3KALPHA in Complex with Fragment 9
  1817. 5sxe: Crystal Structure of PI3KALPHA in Complex with Fragments 19 and 28
  1818. 5sxd: Crystal Structure of PI3KALPHA in Complex with Fragment 22
  1819. 5sxc: Crystal Structure of PI3KALPHA in Complex with Fragment 8
  1820. 5sxb: Crystal Structure of PI3KALPHA in Complex with Fragment 23
  1821. 5sxa: Crystal Structure of PI3KALPHA in Complex with Fragment 10
  1822. 5sx9: Crystal Structure of PI3KALPHA in Complex with Fragment 14
  1823. 5sx8: Crystal Structure of PI3KALPHA in Complex with Fragments 12 and 15
  1824. 5swt: Crystal Structure of PI3KALPHA in Complex with Fragments 17 and 27
  1825. 5swr: Crystal Structure of PI3KALPHA in Complex with Fragments 20 and 26
  1826. 5swp: Crystal Structure of PI3KALPHA in Complex with Fragments 6 and 24
  1827. 5swo: Crystal Structure of PI3KALPHA in Complex with Fragments 4 and 19
  1828. 5swg: Crystal Structure of PI3KALPHA in Complex with Fragments 5 and 21
  1829. 5sw8: Crystal Structure of PI3KALPHA in Complex with Fragments 7 and 11
  1830. 5sv7: The Crystal Structure of a Chaperone
  1831. 5oyf: The Crystal Structure of CK2ALPHA in Complex with Compound 31
  1832. 5oy4: GSK3BETA Complex with N-(6-(3,4-dihydroxyphenyl)-1h-pyrazolo[3,4- B]pyridin-3-yl)acetamide
  1833. 5owr: Human Stk10 Bound to Dasatinib
  1834. 5owq: Human Stk10 Bound to Dovitinib
  1835. 5owl: Low Salt Structure of Human Protein Kinase CK2ALPHA in Complex with 3- Aminopropyl-4,5,6,7-tetrabromobenzimidazol
  1836. 5owh: High Salt Structure of Human Protein Kinase CK2ALPHA in Complex with 3-aminopropyl-4,5,6,7-tetrabromobenzimidazol
  1837. 5ouu: The Crystal Structure of CK2ALPHA in Complex with Compound 22
  1838. 5oum: The Crystal Structure of CK2ALPHA in Complex with Compound 21
  1839. 5oul: The Crystal Structure of CK2ALPHA in Complex with Compound 9
  1840. 5oue: The Crystal Structure of CK2ALPHA in Complex with Compound 20
  1841. 5otz: The Crystal Structure of CK2ALPHA in Complex with Compound 1
  1842. 5oty: The Crystal Structure of CK2ALPHA in Complex with Cam4712
  1843. 5ots: The Crystal Structure of CK2ALPHA in Complex with an Analogue of Compound 22
  1844. 5otr: The Crystal Structure of CK2ALPHA in Complex with Compound 14
  1845. 5otq: The Crystal Structure of CK2ALPHA in Complex with Compound 33
  1846. 5otp: The Crystal Structure of CK2ALPHA in Complex with an Analogue of Compound 22
  1847. 5oto: The Crystal Structure of CK2ALPHA in Complex with Compound 30
  1848. 5otl: The Crystal Structure of CK2ALPHA in Complex with Compound 29
  1849. 5oti: The Crystal Structure of CK2ALPHA in Complex with Compound 27
  1850. 5oth: The Crystal Structure of CK2ALPHA in Complex with Compound 26
  1851. 5otf: Mrck Beta in Complex with Bdp-00009066
  1852. 5ote: Mrck Beta in Complex with Bdp-00008900
  1853. 5otd: The Crystal Structure of CK2ALPHA in Complex with Compound 25
  1854. 5ot6: The Crystal Structure of CK2ALPHA in Complex with Compound 19
  1855. 5ot5: The Crystal Structure of CK2ALPHA in Complex with Compound 24
  1856. 5osz: The Crystal Structure of CK2ALPHA in Complex with Compound 23
  1857. 5osu: The Crystal Structure of CK2ALPHA in Complex with Analogues of Compound 1
  1858. 5osr: The Crystal Structure of CK2ALPHA in Complex with an Analogue of Compound 1
  1859. 5osp: The Crystal Structure of CK2ALPHA in Complex with an Analogue of Compound 1
  1860. 5osl: The Crystal Structure of CK2ALPHA in Complex with Compound 7
  1861. 5osf: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1862. 5ose: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1863. 5osd: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1864. 5os8: The Crystal Structure of CK2ALPHA in Complex with Compound 11
  1865. 5os7: The Crystal Structure of CK2ALPHA in Complex with Compound 4
  1866. 5os6: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1867. 5os5: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1868. 5os4: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1869. 5os3: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1870. 5os2: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1871. 5os1: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1872. 5os0: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1873. 5orz: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1874. 5ory: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1875. 5orx: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1876. 5orw: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1877. 5orv: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1878. 5ort: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1879. 5ors: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1880. 5orr: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1881. 5orp: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1882. 5oro: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1883. 5orn: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1884. 5orl: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1885. 5ork: The Crystal Structure of CK2ALPHA in Complex with Compound 6
  1886. 5orj: The Crystal Structure of CK2ALPHA in Complex with Compound 3
  1887. 5orh: The Crystal Structure of CK2ALPHA in Complex with Compound 2
  1888. 5oqu: The Crystal Structure of CK2ALPHA in Complex with Compound 5
  1889. 5oq8: Structure of Chk1 12-pt. Mutant Complex with Arylbenzamide Lrrk2 Inhibitor
  1890. 5oq7: Structure of Chk1 8-pt. Mutant Complex with Arylbenzamide Lrrk2 Inhibitor
  1891. 5oq6: Structure of Chk1 12-pt. Mutant Complex with Aminopyrimido- Benzodiazepinone Lrrk2 Inhibitor
  1892. 5oq5: Structure of Chk1 8-pt. Mutant Complex with Aminopyrimido- Benzodiazepinone Lrrk2 Inhibitor
  1893. 5oq4: Pqr309 - a Potent, Brain-penetrant, Orally Bioavailable, Pan-class I PI3K/MTOR Inhibitor as Clinical Candidate in Oncology
  1894. 5opv: Structure of Chk1 10-pt. Mutant Complex with Pyrrolopyridine Lrrk2 Inhibitor
  1895. 5opu: Structure of Chk1 10-pt. Mutant Complex with Pyrrolopyridine Lrrk2 Inhibitor
  1896. 5ops: Structure of Chk1 10-pt. Mutant Complex with Pyrrolopyridine Lrrk2 Inhibitor
  1897. 5opr: Structure of Chk1 10-pt. Mutant Complex with Aminopyridine Lrrk2 Inhibitor
  1898. 5opb: Structure of Chk1 10-pt. Mutant Complex with Indazole Lrrk2 Inhibitor
  1899. 5op7: Structure of Chk1 10-pt. Mutant Complex with Pyrrolopyrimidine Lrrk2 Inhibitor
  1900. 5op5: Structure of Chk1 10-pt. Mutant Complex with Pyrrolopyrimidine Lrrk2 Inhibitor
  1901. 5op4: Structure of Chk1 10-pt. Mutant Complex with Aminopyrimidine Lrrk2 Inhibitor
  1902. 5op2: Structure of Chk1 10-pt. Mutant Complex with Arylbenzamide Lrrk2 Inhibitor
  1903. 5oot: Structure of Chk1 10-pt. Mutant Complex with Aminopyrimido- Benzodiazepinone Lrrk2 Inhibitor
  1904. 5oor: Structure of Chk1 10-pt. Mutant Complex with Staurosporine
  1905. 5oop: Structure of Chk1 10-pt. Mutant Complex with Amp-pnp
  1906. 5ooi: Structure of Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA') in Complex with The Indenoindole-type Inhibitor 4p
  1907. 5oni: Low-salt Structure of Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA) in Complex with The Indenoindole-type Inhibitor 4p
  1908. 5one: Crystal Structure of Aurora-a in Complex with Fmf-03-145-1 (compound 2)
  1909. 5omy: High-salt Structure of Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA) in Complex with The Indenoindole-type Inhibitor 4p
  1910. 5okt: Crystal Structure of Human Casein Kinase I Delta in Complex with Iwp-2
  1911. 5odt: Aurora-a in Complex with Tacc3
  1912. 5oc7: Crystal Structure of The Pleckstrin-homology Domain of Bcr-abl in Complex with Monobody Mb(bcr-ph_4).
  1913. 5obr: Aurora a Kinase in Complex with 2-(3-chloro-5-fluorophenyl)quinoline- 4-carboxylic Acid and Jnj-7706621
  1914. 5obj: Aurora a Kinase in Complex with 2-(3-fluorophenyl)quinoline-4- Carboxylic Acid and Atp
  1915. 5o33: A Structure of The Gef Kalirin Dh1 Domain in Complex with The Small Gtpase Rac1
  1916. 5o2c: Crystal Structure of Wnk3 Kinase and Cct1 Didomain in a Unphosphorylated State
  1917. 5o2b: Crystal Structure of Wnk3 Kinase Domain in a Diphosphorylated State and in a Complex with The Inhibitor Pp-121
  1918. 5o26: Crystal Structure of Wnk3 Kinase Domain in a Diphosphorylated State and in Complex with Amp-pnp/mg2+
  1919. 5o23: Crystal Structure of Wnk3 Kinase Domain in a Monophosphorylated Apo State
  1920. 5o21: Crystal Structure of Wnk3 Kinase Domain in a Monophosphorylated State with Chloride Bound in The Active Site
  1921. 5o1v: Crystal Structure of Wnk3 Kinase Domain in a Monophosphorylated Apo State (a-loop Swapped)
  1922. 5o1s: Dimethyl Fumarate Is an Allosteric Covalent Inhibitor of The P90 Ribosomal S6 Kinases
  1923. 5o13: Crystal Structure of Pim1 Kinase in Complex with Small-molecule Inhibitor
  1924. 5o12: Crystal Structure of Pim1 Kinase in Complex with Small-molecule Inhibitor
  1925. 5o11: Crystal Structure of Pim1 Kinase in Complex with Small-molecule Inhibitor
  1926. 5o0y: Tlk2 Kinase Domain from Human
  1927. 5nyy: Formylglycine Generating Enzyme from T. Curvata in Complex with Cd(ii)
  1928. 5nxl: Formylglycine Generating Enzyme from T. Curvata in Complex with Ag(i)
  1929. 5nxd: Lim Domain Kinase 2 (limk2) in Complex with Th-300
  1930. 5nxc: Lim Domain Kinase 1 (limk1) in Complex with Pf-00477736
  1931. 5nqc: CK2ALPHA in Complex with Nmr154
  1932. 5np1: Open Protomer of Human Atm (ataxia Telangiectasia Mutated)
  1933. 5np0: Closed Dimer of Human Atm (ataxia Telangiectasia Mutated)
  1934. 5nod: Pasta Subunit 4 of Streptococcus Pneumoniae Stkp Crystallized with Peg and Succinate
  1935. 5nkp: Crystal Structure of The Human Klhl3 Kelch Domain in Complex with a Wnk3 Peptide
  1936. 5ng3: Structure of Inactive Kinase RIP2K(K47R)
  1937. 5ng2: Structure of RIP2K(D146N) with Bound Staurosporine
  1938. 5ng0: Structure of RIP2K(L294F) with Bound Amppcp
  1939. 5ndt: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensus Peptide and Fragment like Molecule (e)-3-(2-(thiophen-2-yl)vinyl)-3, 4-dihydroquinoxalin-2(1h)-one
  1940. 5ncn: Crystal Structure Dbf2(ntr)-mob1 Complex
  1941. 5ncm: Crystal Structure Cbk1(ntr)-mob2 Complex
  1942. 5ncl: Crystal Structure of The Cbk1-mob2 Kinase-coactivator Complex with an Ssd1 Peptide
  1943. 5n9n: Crystal Structure of Human Protein Kinase Ck2 Catalytic Subunit in Complex with The Atp-competitive, Tight-binding Dibenzofuran Inhibitor Tf85 (4a)
  1944. 5n9l: Crystal Structure of Human Protein Kinase Ck2 Catalytic Subunit in Complex with The Atp-competitive Dibenzofuran Inhibitor Tf (4b)
  1945. 5n9k: Crystal Structure of Human Protein Kinase Ck2 Catalytic Subunit in Complex with The Atp-competitive, Tight-binding Dibenzofuran Inhibitor Tf107 (5)
  1946. 5n8y: Kaicba Circadian Clock Backbone Model Based on a Cryo-em Density
  1947. 5n7g: Magi-1 Complexed with a Synthetic Prsk1 Peptide
  1948. 5n7f: Magi-1 Complexed with a Prsk1 Peptide
  1949. 5n7e: Crystal Structure of The Dbl-homology Domain of Bcr-abl in Complex with Monobody Mb(bcr-dh_4).
  1950. 5n7d: Magi-1 Complexed with a Rsk1 Peptide
  1951. 5n6r: Solution Structure of The Dbl-homology Domain of Bcr-abl
  1952. 5n5m: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensuspeptide and (r)-3-(2-((isoquinolin-5-ylmethyl)(methyl) Carbamoyl)phenyl)pyrrolidin-1-ium
  1953. 5n5l: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensuspeptide and [2-oxo-2-(1h-pyrrol-2-yl)ethyl] 5-bromo-1h- Indole-3-carboxylate
  1954. 5n52: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensus Peptide and Fragment like Molecule (e)-3-(2,3-dimethoxyphenyl)acrylic Acid
  1955. 5n51: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensus Peptide and Fragment like Molecule 3,4-dibromothiophene-2-carboxylic Acid
  1956. 5n50: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensus Peptide and Fragment like Molecule 2-(4-chlorophenyl) Sulfanylacetohydrazide
  1957. 5n4z: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensus Peptide and Fragment like Molecule (e)-4-(4-hydroxyphenyl)but-3-en-2- One
  1958. 5n4y: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensus Peptide and Fragment like Molecule 2,5-dihydro-1h-isothiochromeno[3, 4-d]pyrazol-3-one
  1959. 5n4x: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensuspeptide and Fragment like Molekule 4,5-dibromothiophene-2- Carbohydrazide
  1960. 5n4v: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensuspeptide and Fragment like Molekule 2-cyclopropyl-4,5- Dimethylthieno[5,4-d]pyrimidine-6-carboxylic Acid
  1961. 5n4u: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensuspeptide and Fragment like Molekule 5-(2-amino-1,3-thiazol-4- Yl)-1,3-dihydrobenzimidazol-2-one
  1962. 5n4r: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensus Peptide and Fragment like Molecule 2-(azepan-1-yl)-1-(1h-indol-3-yl) Propan-1-one
  1963. 5n4o: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensuspeptide and Fragment like Molekule (e)-3-(p-tolyl)acrylic Acid
  1964. 5n4n: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensus Peptide and Fragment like Molecule 3,4-dimethyl-5-(1h-1,2,4-triazol- 3-yl)thiophene-2-carbonitrile
  1965. 5n1v: Crystal Structure of The Protein Kinase Ck2 Catalytic Subunit in Complex with Pyrazolo-pyrimidine Macrocyclic Ligand
  1966. 5mzl: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensuspeptide and Fragment like Molekule N-quinolin-5-ylpyridine- 3-carboxamide
  1967. 5myv: Crystal Structure of Srpk2 in Complex with Compound 1
  1968. 5myc: Crystal Structure of Human 14-3-3 Sigma in Complex with Lrrk2 Peptide Ps910
  1969. 5my9: Crystal Structure of Human 14-3-3 Sigma in Complex with Lrrk2 Peptide Ps935
  1970. 5my8: Crystal Structure of Srpk1 in Complex with Sphinx31
  1971. 5mrd: Human Pdk1-pkciota Kinase Chimera in Complex with Allosteric Compound Ps267 Bound to The Pif-pocket
  1972. 5mqv: Crystal Structure of Human Casein Kinase I Delta in Complex with 4-(2, 5-dimethoxyphenyl)-n-(4-(5-(4-fluorphenyl)-2-(methylthio)-1h- Imidazol-4-yl)-pyridin-2-yl)-1-methyl-1h-pyrrole-2-carboxamide
  1973. 5mpj: 1-(2-chloro-[1,1'-biphenyl]-4-yl)-n-methylethanamine
  1974. 5mp8: Crystal Structure of CK2ALPHA with Zt0432 Bound
  1975. 5mow: Crystal Structure of CK2ALPHA with Zt0432 Bound
  1976. 5mov: Crystal Structure of CK2ALPHA with Zt0633 Bound
  1977. 5mot: Crystal Structure of CK2ALPHA with Zt0627 Bound
  1978. 5moh: Crystal Structure of CK2ALPHA with Zt0583 Bound.
  1979. 5moe: Crystal Structure of CK2ALPHA with N-(3-(((2-chloro-[1,1'-biphenyl]-4- Yl)methyl)amino)propyl)methanesulfonamide Bound
  1980. 5mod: Crystal Structure of CK2ALPHA with N-(3-(((2-chloro-[1,1'-biphenyl]-4- Yl)methyl)amino)propyl)methanesulfonamide Bound
  1981. 5mo8: Crystal Structure of CK2ALPHA with N-(3-(((2-chloro-[1,1'-biphenyl]-4- Yl)methyl)amino)propyl)methanesulfonamide Bound
  1982. 5mo7: Crystal Structure of CK2ALPHA with N-(3-(((2-chloro-[1,1'-biphenyl]-4- Yl)methyl)amino)propyl)methanesulfonamide Bound
  1983. 5mo6: Crystal Structure of CK2ALPHA with N-(3-(((2-chloro-[1,1'-biphenyl]-4- Yl)methyl)amino)propyl)methanesulfonamide Bound
  1984. 5mo5: Crystal Structure of CK2ALPHA with N-(3-(((2-chloro-[1,1'-biphenyl]-4- Yl)methyl)amino)propyl)methanesulfonamide Bound
  1985. 5mmr: Crystal Structure of CK2ALPHA with N-((2-chloro-[1,1'-biphenyl]-4-yl) Methyl)butane-1,4-diamine Bound
  1986. 5mmf: Crystal Structure of CK2ALPHA with Compound 7 Bound
  1987. 5mg2: Crystal Structure of The Second Bromodomain of Human Taf1 in Complex with Bay-299 Chemical Probe
  1988. 5mai: Crystal Structure of Melk in Complex with an Inhibitor
  1989. 5mah: Crystal Structure of Melk in Complex with an Inhibitor
  1990. 5mag: Crystal Structure of Melk in Complex with an Inhibitor
  1991. 5maf: Crystal Structure of Melk in Complex with an Inhibitor
  1992. 5m5a: Crystal Structure of Melk in Complex with an Inhibitor
  1993. 5m57: Nek2 Bound to Arylaminopurine 6
  1994. 5m56: Monoclinic Complex Structure of Human Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA') with The Inhibitor 4'-carboxy-6,8-chloro- Flavonol (flc21)
  1995. 5m55: Nek2 Bound to Arylaminopurine 71
  1996. 5m53: Nek2 Bound to Arylaminopurine Inhibitor 11
  1997. 5m51: Nek2 Bound to Arylaminopurine Compound 8
  1998. 5m4u: Orthorhombic Complex Structure of Human Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA') with The Inhibitor 4'-carboxy-6,8-chloro- Flavonol (flc21)
  1999. 5m4i: Complex Structure of Human Protein Kinase Ck2 Catalytic Subunit with The Inhibitor 4'-carboxy-6,8-chloro-flavonol (flc21) Crystallized under High-salt Conditions
  2000. 5m4f: Complex Structure of Human Protein Kinase Ck2 Catalytic Subunit with The Inhibitor 4'-carboxy-6,8-chloro-flavonol (flc21) Crystallized under Low-salt Conditions
  2001. 5m4c: Complex Structure of Human Protein Kinase Ck2 Catalytic Subunit with a Thieno[2,3-d]pyrimidin Inhibitor Crystallized under Low-salt Conditions
  2002. 5m44: Complex Structure of Human Protein Kinase Ck2 Catalytic Subunit with a Thieno[2,3-d]pyrimidin Inhibitor Crystallized under High-salt Conditions
  2003. 5m09: Crystal Structure of Mycobacterium Tuberculosis Pkni Kinase Domain, C20A_R136N Double Mutant
  2004. 5m08: Crystal Structure of Mycobacterium Tuberculosis Pkni Kinase Domain, C20A_R136A Double Mutant
  2005. 5m07: Crystal Structure of Mycobacterium Tuberculosis Pkni Kinase Domain, C20A Mutant
  2006. 5m06: Crystal Structure of Mycobacterium Tuberculosis Pkni Kinase Domain
  2007. 5lxm: Crystal Structure of Aurora-a Bound to a Hydrocarbon-stapled Proteomimetic of Tpx2
  2008. 5lvp: Human Pdk1 Kinase Domain in Complex with an Hm-peptide Bound to The Pif-pocket
  2009. 5lvo: Human Pdk1 Kinase Domain in Complex with Allosteric Compound Pse10 Bound to The Pif-pocket
  2010. 5lvn: Human Pdk1 Kinase Domain in Complex with Adenosine Bound to The Atp- Binding Site
  2011. 5lvm: Human Pdk1 Kinase Domain in Complex with Adenine Bound to The Atp- Binding Site
  2012. 5lvl: Human Pdk1 Kinase Domain in Complex with Compound Ps653 Bound to The Atp-binding Site
  2013. 5luq: Crystal Structure of Human Dna-dependent Protein Kinase Catalytic Subunit (dna-pkcs)
  2014. 5lpz: Crystal Structure of The Bri1 Kinase Domain (865-1196) in Complex with Adp from Arabidopsis Thaliana
  2015. 5lpy: Crystal Structure of The Bri1 Kinase Domain (865-1160) in Complex with Atp from Arabidopsis Thaliana
  2016. 5lpw: Crystal Structure of The Apo-bri1 Kinase Domain (865-1160)
  2017. 5lpv: Crystal Structure of The Bri1 Kinase Domain (865-1160) in Complex with Amppnp and Mn from Arabidopsis Thaliana
  2018. 5lpb: Crystal Structure of The Bri1 Kinase Domain (865-1160) in Complex with Adp from Arabidopsis Thaliana
  2019. 5loh: Kinase Domain of Human Greatwall
  2020. 5lcw: Cryo-em Structure of The Anaphase-promoting Complex/cyclosome, in Complex with The Mitotic Checkpoint Complex (apc/c-mcc) at 4.2 Angstrom Resolution
  2021. 5l9u: Model of Human Anaphase-promoting Complex/cyclosome (apc/c-cdh1) with a cross Linked Ubiquitin VARIANT-SUBSTRATE-UBE2C (ubch10) Complex Representing Key Features of Multiubiquitination
  2022. 5l9t: Model of Human Anaphase-promoting Complex/cyclosome (apc/c-cdh1) with E2 UBE2S Poised for Polyubiquitination Where UBE2S, Apc2, and Apc11 Are Modeled into Low Resolution Density
  2023. 5l8l: Aurora-a Kinase Domain in Complex with Vnar-d01 (crystal Form 1)
  2024. 5l8k: Aurora-a Kinase Domain in Complex with Vnar-d01 (crystal Form 2)
  2025. 5l8j: Aurora-a Kinase Domain in Complex with Vnar-d01 S93R
  2026. 5l6w: Structure of The Limk1-atpgammas-cfl1 Complex
  2027. 5l4q: Crystal Structure of Adaptor Protein 2 Associated Kinase 1 (aak1) in Complex with Lkb1 (aak1 Dual Inhibitor)
  2028. 5l2q: Serine/threonine-protein Kinase 40 (stk40) Kinase Homology Domain
  2029. 5kzi: Crystal Structure of Human Pim-1 Kinase in Complex with an Imidazopyridazine Inhibitor.
  2030. 5kz8: Mark2 Complex with 7-[(1s)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3- Pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one
  2031. 5kz7: Mark2 Complex with 7-[(1s)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3- Pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one
  2032. 5kx8: Irak4-inhibitor Co-structure
  2033. 5kx7: Irak4-inhibitor Co-structure
  2034. 5kwh: Crystal Structure of Ck2
  2035. 5ku8: Crystal Structure of Ck2
  2036. 5kq5: Ampk Bound to Allosteric Activator
  2037. 5kpm: Glycogen Synthase Kinase 3 Beta Complexed with Brd3731
  2038. 5kpl: Glycogen Synthase Kinase 3 Beta Complexed with Brd0705
  2039. 5kpk: Glycogen Synthase Kinase 3 Beta Complexed with Brd0209
  2040. 5kkt: Rock 1 Bound to Azaindole Thiazole Piperazine Inhibitor
  2041. 5kks: Rock 1 Bound to Azaindole Thiazole Inhibitor
  2042. 5kkr: Ksr2:mek1 Complex Bound to The Small Molecule Aps-2-79
  2043. 5khu: Model of Human Anaphase-promoting Complex/cyclosome (apc15 Deletion Mutant), in Complex with The Mitotic Checkpoint Complex (apc/c-cdc20- Mcc) Based on Cryo Em Data at 4.8 Angstrom Resolution
  2044. 5kgk: Crystal Structure of Pim1 with Inhibitor: 3-(4-methoxyphenyl)-1~{h}- Pyrazol-5-amine
  2045. 5kgi: Crystal Structure of Pim1 with Inhibitor 2-[3,4-bis(chloranyl) Phenoxy]ethanamine
  2046. 5kgg: Crystal Structure of Pim1 with Inhibitor: 2-(5-chloranyl-1~{h}-indol- 3-yl)ethanamine
  2047. 5kge: Crystal Structure of Pim1 with Inhibitor: 5-(3,4-dichlorophenyl)- 1~{h}-pyrazol-3-amine
  2048. 5kgd: Crystal Structure of Pim1 with Inhibitor: 2-pyridin-3-yl-1~{h}- Benzimidazole
  2049. 5kcx: Pim-1 Kinase in Complex with a Selective N-substituted 7-azaindole Inhibitor
  2050. 5kcv: Crystal Structure of Allosteric Inhibitor, Arq 092, in Complex with Autoinhibited Form of Akt1
  2051. 5kc2: Negative Stain Structure of Vps15/vps34 Complex
  2052. 5kbr: Pak1 in Complex with 7-azaindole Inhibitor
  2053. 5kbq: Pak1 in Complex with Bis-anilino Pyrimidine Inhibitor
  2054. 5kae: Crystal Structure of Human PI3K-GAMMA in Complex with Quinoline- Containing Inhibitor 5g
  2055. 5k98: Structure of Hipa-hipb-o2-o3 Complex
  2056. 5k7i: Irak4 in Complex with Az3864
  2057. 5k7g: Irak4 in Complex with Az3862
  2058. 5k76: Irak4 in Complex with Compound 28
  2059. 5k75: Irak4 in Complex with Compound 1
  2060. 5k72: Irak4 in Complex with Compound 21
  2061. 5k5n: Crystal Structure of Gsk-3beta Complexed with Pf-04802367, a Highly Selective Brain-penetrant Kinase Inhibitor
  2062. 5k3y: Crystal Structure of Aurorab/incenp in Complex with Bi 811283
  2063. 5k00: Melk in Complex with Nvs-melk5
  2064. 5jzn: Crystal Structure of Dclk1-kd in Complex with Nvp-tae684
  2065. 5jzj: Crystal Structure of Dclk1-kd in Complex with Amppn
  2066. 5jwr: Crystal Structure of Foldswitch-stabilized Kaib in Complex with The N- Terminal Ci Domain of Kaic and a Dimer of Kaia C-terminal Domains from Thermosynechococcus Elongatus
  2067. 5jwq: Crystal Structure of Kaic S431E in Complex with Foldswitch-stabilized Kaib from Thermosynechococcus Elongatus
  2068. 5jwo: Crystal Structure of Foldswitch-stabilized Kaib in Complex with The N- Terminal Ci Domain of Kaic from Thermosynechococcus Elongatus
  2069. 5jt2: BRAFV600E Kinase Domain in Complex with Chemically Linked Vemurafenib Inhibitor Vem-bisamide
  2070. 5jsm: BRAFV600E Kinase Domain in Complex with Chemically Linked Vemurafenib Inhibitor Vem-3-vem
  2071. 5jrq: BRAFV600E Kinase Domain in Complex with Chemically Linked Vemurafenib Inhibitor Vem-6-vem
  2072. 5joe: Crystal Structure of I81 from Titin
  2073. 5jmv: Crystal Structure of Mjkae1-pfupcc1 Complex
  2074. 5jk7: The X-ray Structure of The Ddb1-dcaf1-vpr-ung2 Complex
  2075. 5jja: Crystal Structure of a PP2A B56GAMMA/BUBR1 Complex
  2076. 5jhb: Structure of Phosphoinositide 3-kinase Gamma (PI3K) Bound to The Potent Inhibitor Pikin3
  2077. 5jha: Structure of Phosphoinositide 3-kinase Gamma (PI3K) Bound to The Potent Inhibitor Pikin2
  2078. 5jfk: Crystal Structure of a Tdr Receptor
  2079. 5jfi: Crystal Structure of a Tdif-tdr Complex
  2080. 5jdj: Crystal Structure of Domain I10 from Titin in Space Group P212121
  2081. 5jde: Crystal Structure of I9-i11 Tandem from Titin (p1)
  2082. 5jdd: Crystal Structure of I9-i11 Tandem from Titin (p212121)
  2083. 5jda: Bacillus Cereus Coth Kinase plus Mg2+/amp
  2084. 5j95: MAP4K4 in Complex with Inhibitor
  2085. 5j7b: The Identification and Pharmacological Characterization of 6-(tert- Butylsulfonyl)-n-(5-fluoro-1h-indazol-3-yl)quinolin-4-amine (gsk583), a Highly Potent and Selective Inhibitor of Rip2 Kinase, Gsk583 Complex
  2086. 5j79: The Identification and Pharmacological Characterization of 6-(tert- Butylsulfonyl)-n-(5-fluoro-1h-indazol-3-yl)quinolin-4-amine (gsk583), a Highly Potent and Selective Inhibitor of Rip2 Kinase, Compound 3 Complex
  2087. 5j5t: Glk Co-crystal Structure with Aminopyrrolopyrimidine Inhibitor
  2088. 5j2r: Solution Structure of Ras Binding Domain (rbd) of B-raf
  2089. 5j18: Solution Structure of Ras Binding Domain (rbd) of B-raf Complexed with Rigosertib (complex I)
  2090. 5j17: Solution Structure of Ras Binding Domain (rbd) of B-raf
  2091. 5iyx: Crystal Structure of The Arabidopsis Receptor Kinase Haesa in Complex with The Peptide Hormone Ida and The Co-receptor Serk1
  2092. 5iyv: Crystal Structure of The Arabidopsis Receptor Kinase Haesa Lrr Ectdomain in Complex with The Peptide Hormone Idl1.
  2093. 5ixt: The Crystal Structure of The Arabidopsis Receptor Kinase Haesa Lrr Ectdomain in Complex with a N-terminal Extended Ida Peptide Hormone Ligand.
  2094. 5ixq: Crystal Structure of The Arabidopsis Receptor Kinase Haesa Lrr Ectdomain in Complex with The Peptide Hormone Ida.
  2095. 5ixo: Crystal Structure of The Arabidopsis Receptor Kinase Haesa Lrr Ectdomain (apo Form).
  2096. 5itd: Crystal Structure of PI3K Alpha with PI3K Delta Inhibitor
  2097. 5ita: Crystal Structure of Braf Kinase Domain Bound to Az-vem
  2098. 5iso: Structure of Full Length Human Ampk (non-phosphorylated at T-loop) in Complex with a Small Molecule Activator, a Benzimidazole Derivative (991)
  2099. 5ipj: Crystal Structure of Human Pim-1 Kinase in Complex with a Quinazolinone-pyrrolopyrrolone Inhibitor.
  2100. 5ime: Crystal Structure of P21-activated Kinase 1 (pak1) in Complex with Compound 9
  2101. 5ikw: Crystal Structure of Bmp-2-inducible Kinase in Complex with an Indazole Inhibitor
  2102. 5iis: Design, Synthesis and Structure Activity Relationship of Potent Pan- Pim Kinase Inhibitors Derived from The Pyridyl-amide Scaffold
  2103. 5ihc: Melk in Complex with NVS-MELK12B
  2104. 5iha: Melk in Complex with NVS-MELK8F
  2105. 5ih9: Melk in Complex with NVS-MELK8A
  2106. 5ih8: Melk in Complex with Nvs-melk1
  2107. 5ih6: Human Casein Kinase 1 Isoform Delta (kinase Domain) in Complex with Epiblastin a Derivative
  2108. 5ih5: Human Casein Kinase 1 Isoform Delta (kinase Domain) in Complex with Epiblastin a
  2109. 5ih4: Human Casein Kinase 1 Isoform Delta Apo (kinase Domain)
  2110. 5i3r: Crystal Structure of Bmp-2-inducible Kinase in Complex with an Indazole Inhibitor
  2111. 5i3o: Crystal Structure of Bmp-2-inducible Kinase in Complex with an Indazole Inhibitor
  2112. 5i0b: Structure of Pak4
  2113. 5hz3: Plant Peptide Hormone Receptor Rgfr1 in Complex with Rgfr5
  2114. 5hz1: Plant Peptide Hormone Receptor Rgfr1 in Complex with Rgf3
  2115. 5hz0: Plant Peptide Hormone Receptor Rgfr1 in Complex with Rgf2
  2116. 5hyx: Plant Peptide Hormone Receptor Rgfr1 in Complex with Rgf1
  2117. 5hx6: Crystal Structure of Rip1 Kinase with a Benzo[b][1,4]oxazepin-4-one
  2118. 5hvu: Rho-associated Protein Kinase 1 (rock 1) in Complex with a Pyridine Thiazole Piperidine Inhibitor
  2119. 5hvk: Crystal Structure of Limk1 Mutant D460N in Complex with Full-length Cofilin-1
  2120. 5hvj: Crystal Structure of Limk1 D460N Mutant in Complex with Amp-pnp
  2121. 5htc: Crystal Structure of Haspin (gsg2) in Complex with Bisubstrate Inhibitor Arc-3372
  2122. 5htb: Crystal Structure of Haspin (gsg2) in Complex with Bisubstrate Inhibitor Arc-3353
  2123. 5ho8: Discovery of Novel 7-azaindoles as Pdk1 Inhibitors
  2124. 5ho7: Discovery of Novel 7-azaindoles as Pdk1 Inhibitors
  2125. 5hng: Discovery of Novel 7-azaindoles as Pdk1 Inhibitors
  2126. 5hlp: X-ray Crystal Structure of GSK3B in Complex with Brd3937
  2127. 5hln: X-ray Crystal Structure of GSK3B in Complex with Chir99021
  2128. 5hkm: Discovery of Novel 7-azaindoles as Pdk1 Inhibitors
  2129. 5hie: Braf Kinase Domain B3AC Loop Deletion Mutant in Complex with Dabrafenib
  2130. 5hid: Braf Kinase Domain B3AC Loop Deletion Mutant in Complex with Az628
  2131. 5hi2: Braf Kinase Domain B3AC Loop Deletion Mutant in Complex with Sorafenib
  2132. 5hgi: Crystal Structure of Apo Human Ire1 Alpha
  2133. 5h8g: Crystal Structure of Ck2 with Compound 7b
  2134. 5h8e: Crystal Structure of Ck2 with Compound 7h
  2135. 5h8b: Crystal Structure of Ck2 with Compound 2
  2136. 5h64: Cryo-em Structure of Mtorc1
  2137. 5gr9: Crystal Structure of Pxy-tdif/cle41
  2138. 5gr8: Crystal Structure of Pepr1-atpep1
  2139. 5gqr: Crystal Structure of Pxy-cle41-serk2
  2140. 5gpg: Co-crystal Structure of The Fk506 Binding Domain of Human Fkbp25, Rapamycin and The Frb Domain of Human Mtor
  2141. 5gij: Crystal Structure of Tdr-tdif Complex
  2142. 5g1x: Crystal Structure of Aurora-a Kinase in Complex with N-myc
  2143. 5g15: Structure Aurora a (122-403) Bound to Activating Monobody Mb1 and Amppcp
  2144. 5g04: Structure of The Human Apc-cdc20-hsl1 Complex
  2145. 5fur: Structure of Human Tfiid-iia Bound to Core Promoter Dna
  2146. 5flc: Architecture of Human Mtor Complex 1 - 5.9 Angstrom Reconstruction
  2147. 5fi4: Discovery of Imidazo[1,2-a]-pyridine Inhibitors of Pan-pi3 Kinases That Are Efficacious in a Mouse Xenograft Model
  2148. 5fd2: B-raf Wild-type Kinase Domain in Complex with a Purinylpyridinylamino- Based Inhibitor
  2149. 5f95: Crystal Structure of GSK3B in Complex with Compound 18: 2- [(cyclopropylcarbonyl)amino]-n-(4-phenylpyridin-3-yl)pyridine-4- Carboxamide
  2150. 5f94: Crystal Structure of GSK3B in Complex with Compound 15: 2- [(cyclopropylcarbonyl)amino]-n-(4-methoxypyridin-3-yl)pyridine-4- Carboxamide
  2151. 5f5p: Molecular Basis for Shroom2 Recognition by Rock1
  2152. 5f4n: Multi-parameter Lead Optimization to Give an Oral Chk1 Inhibitor Clinical Candidate: (r)-5-((4-((morpholin-2-ylmethyl)amino)-5- (trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile (cct245737)
  2153. 5ezv: X-ray Crystal Structure of Amp-activated Protein Kinase Alpha-2/alpha- 1 Rim Chimaera (alpha-2(1-347)/alpha-1(349-401)/alpha-2(397-end) Beta-1 Gamma-1) Co-crystallized with C2 (5-(5-hydroxyl-isoxazol-3- Yl)-furan-2-phosphonic Acid)
  2154. 5eyk: Crystal Structure of Aurora B in Complex with Bi 847325
  2155. 5ew9: Crystal Structure of Aurora a Kinase Domain Bound to Mk-5108
  2156. 5es1: Crystal Structure of Microtubule Affinity-regulating Kinase 4 Catalytic Domain in Complex with a Pyrazolopyrimidine Inhibitor
  2157. 5ep6: The Crystal Structure of Nap1 in Complex with Tbk1
  2158. 5eol: Crystal Structure of Human Pim-1 Kinase in Complex with a Macrocyclic Quinoxaline-pyrrolodihydropiperidinone Inhibitor
  2159. 5eof: Crystal Structure of Optn Ntd and Tbk1 Ctd Complex
  2160. 5eoa: Crystal Structure of Optn E50K Mutant and Tbk1 Complex
  2161. 5eds: Crystal Structure of Human PI3K-GAMMA in Complex with Benzimidazole Inhibitor 5
  2162. 5eak: Optimization of Microtubule Affinity Regulating Kinase (mark) Inhibitors with Improved Physical Properties
  2163. 5e12: Crystal Structure of Pasta Domains 2, 3 and 4 of Mycobacterium Tuberculosis Protein Kinase B
  2164. 5e10: Crystal Structure of Pasta Domains 1 and 2 of Mycobacterium Tuberculosis Protein Kinase B
  2165. 5e0z: Crystal Structure of Pasta Domains 3 and 4 of Mycobacterium Tuberculosis Protein Kinase B
  2166. 5e0y: Crystal Structure of Pasta Domain 4 of Mycobacterium Tuberculosis Protein Kinase B
  2167. 5dxt: P110ALPHA with Gdc-0326
  2168. 5dxh: P110ALPHA/P85ALPHA with Compound 5
  2169. 5dwr: Identification of N-(4-((1r,3s,5s)-3-amino-5-methylcyclohexyl)pyridin- 3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (pim447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (pim) 1,2 and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies
  2170. 5dt4: Aurora a Kinase in Complex with Aa35 and Atp in Space Group P6122
  2171. 5dt3: Aurora a Kinase in Complex with Atp in Space Group P6122
  2172. 5dt0: Aurora a Kinase in Complex with Jnj-7706621 in Space Group P6122
  2173. 5drd: Aurora a Kinase in Complex with Atp in Space Group P6122
  2174. 5drb: Crystal Structure of Wnk1 in Complex with Wnk463
  2175. 5dr9: Aurora a Kinase in Complex with Aa29 and Jnj-7706621 in Space Group P6122
  2176. 5dr6: Aurora a Kinase in Complex with Aa30 and Jnj-7706621 in Space Group P6122
  2177. 5dr2: Aurora a Kinase in Complex with Aa30 and Atp in Space Group P6122
  2178. 5dpv: Aurora a Kinase in Complex with Aa35 and Jnj-7706621 in Space Group P6122
  2179. 5dos: Aurora a Kinase in Complex with Aa35 and Atp in Space Group P6122
  2180. 5dnr: Aurora a Kinase in Complex with Atp in Space Group P41212
  2181. 5dn3: Aurora a in Complex with Atp and Aa35.
  2182. 5dmz: Structure of Human Bub1 Kinase Domain Phosphorylated at Ser969
  2183. 5dls: Identification of Novel, in Vivo Active Chk1 Inhibitors Utilizing Structure Guided Drug Design
  2184. 5dia: Pim1 in Complex with Cpd36 ((1s,3s)-n1-(6-(5-(pyridin-3-yl)-1h- Pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl)cyclohexane-1,3-diamine)
  2185. 5di1: MAP4K4 in Complex with an Inhibitor
  2186. 5dhj: Pim1 in Complex with Cpd4 (3-methyl-5-(pyridin-3-yl)-1h-pyrazolo[3,4- C]pyridine)
  2187. 5dh3: Crystal Structure of Mst2 in Complex with Xmu-mp-1
  2188. 5dgz: Discovery of 3,5-substituted 6-azaindazoles as Potent Pan-pim Inhibitors
  2189. 5dfz: Structure of Vps34 Complex II from S. Cerevisiae.
  2190. 5dfp: Crystal Structure of Pak1 in Complex with an Inhibitor Compound Frax1036
  2191. 5dey: Crystal Structure of Pak1 in Complex with an Inhibitor Compound G-5555
  2192. 5dew: Crystal Structure of Pak1 in Complex with an Inhibitor Compound 5
  2193. 5de2: Structural Mechanism of Nek7 Activation by Nek9-induced Dimerisation
  2194. 5dbx: Crystal Structure of Murine SPAK(T243D) in Complex with Amppnp
  2195. 5d9l: Rsk2 N-terminal Kinase in Complex with Bis-phenol Pyrazole
  2196. 5d9k: Rsk2 N-terminal Kinase in Complex with Bi-d1870
  2197. 5d9h: Crystal Structure of Spak (stk39) Dimer in The Basal Activity State
  2198. 5d7a: Crystal Structure of The Kinase Domain of Traf2 and Nck-interacting Protein Kinase with Ncb-0846
  2199. 5czo: Structure of S. Cerevisiae Hrr25:mam1 Complex, Form 2
  2200. 5cyz: Structure of S. Cerevisiae Hrr25:mam1 Complex, Form 1
  2201. 5cx9: Crystal Structure of CK2ALPHA with (methyl 4-((3-(3-chloro-4-(phenyl) Benzylamino)propyl)amino)-4-oxobutanoate Bound
  2202. 5cwz: Crystal Structure of The Kinase Domain of Human Traf2 and Nck- Interacting Protein Kinase
  2203. 5cvh: Crystal Structure of CK2ALPHA
  2204. 5cvg: Crystal Structure of CK2ALPHA with a Novel Closed Conformation of The ad Loop
  2205. 5cvf: Crystal Structure of CK2ALPHA with Compound 5 Bound
  2206. 5cu6: Crystal Structure of CK2ALPHA
  2207. 5cu4: Crystal Structure of CK2ALPHA with Compound 10 Bound
  2208. 5cu3: Crystal Structure of CK2ALPHA with Compound 10 Bound
  2209. 5cu2: Crystal Structure of CK2ALPHA with 2-hydroxy-5-methylbenzoic Acid and (methyl 4-((3-(3-chloro-4-(phenyl)benzylamino)propyl)amino)-4- Oxobutanoat Bound
  2210. 5cu0: Crystal Structure of CK2ALPHA with 2-hydroxy-5-methylbenzoic Acid and N-(3-(3-chloro-4-(phenyl)benzylamino)propyl)acetamide Bound
  2211. 5ctp: Crystal Structure of CK2ALPHA with N-(3-(3-chloro-4-(phenyl) Benzylamino)propyl)acetamide Bound
  2212. 5ct7: Braf in Complex with Raf265
  2213. 5ct0: Crystal Structure of CK2ALPHA with 3-(3-chloro-4-(phenyl)benzylamino) Propan-1-ol Bound
  2214. 5csx: Crystal Structure of B-raf in Complex with Bi 882370
  2215. 5csw: B-raf in Complex with Dabrafenib
  2216. 5csv: Crystal Structure of CK2ALPHA with Compound 6 Bound
  2217. 5csp: Crystal Structure of CK2ALPHA with Compound 5 Bound
  2218. 5csn: S100B-RSK1 Crystal Structure C
  2219. 5csj: S100B-RSK1 Crystal Structure B
  2220. 5csi: S100B-RSK1 Crystal Structure A'
  2221. 5csh: Crystal Structure of CK2ALPHA with Compound 4 Bound
  2222. 5csf: S100B-RSK1 Crystal Structure a
  2223. 5cs6: Crystal Structure of CK2ALPHA with Compound 3 Bound
  2224. 5cqw: Tetragonal Complex Structure of Protein Kinase Ck2 Catalytic Subunit with a Benzotriazole-based Inhibitor Generated by Click-chemistry
  2225. 5cqu: Monoclinic Complex Structure of Protein Kinase Ck2 Catalytic Subunit with a Benzotriazole-based Inhibitor Generated by Click-chemistry
  2226. 5clp: Crystal Structure of CK2ALPHA with 3,4-dichlorophenethylamine Bound
  2227. 5ci7: Structure of Ulk1 Bound to a Selective Inhibitor
  2228. 5c9c: Crystal Structure of BRAF(V600E) in Complex with Ly3009120 Compnd
  2229. 5c1q: Serine/threonine-protein Kinase Pim-1
  2230. 4red: Crystal Structure of Human Ampk Alpha1 Kd-aid with K43A Mutation
  2231. 4rer: Crystal Structure of The Phosphorylated Human Alpha1 Beta2 Gamma1 Holo-ampk Complex Bound to Amp and Cyclodextrin
  2232. 4rew: Crystal Structure of The Non-phosphorylated Human Alpha1 Beta2 Gamma1 Holo-ampk Complex
  2233. 4rlk: Crystal Structure of Z. Mays CK2ALPHA in Complex with The Atp- Competitive Inhibitor 4-[(e)-(fluoren-9-ylidenehydrazinylidene)- Methyl] Benzoate
  2234. 4rll: Crystal Structure of Human CK2ALPHA in Complex with The Atp- Competitive Inhibitor 4-[(e)-(fluoren-9-ylidenehydrazinylidene)- Methyl] Benzoate
  2235. 4rqk: Crystal Structure of Pdk1 in Complex with Atp and The Pif-pocket Ligand Rs1
  2236. 4rqv: Crystal Structure of Pdk1 in Complex with Atp and The Pif-pocket Ligand Rs2
  2237. 4rrv: Crystal Structure of Pdk1 in Complex with Atp and Piftide
  2238. 4uow: Crystal Structure of The Titin M10-obscurin Ig Domain 1 Complex
  2239. 4wwn: Crystal Structure of Human PI3K-GAMMA in Complex with (s)-n-(1-(7- Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine Amg319 Inhibitor
  2240. 4wwo: Crystal Structure of Human PI3K-GAMMA in Complex with Phenylquinoline Inhibitor N-{(1s)-1-[8-chloro-2-(3-fluorophenyl)quinolin-3-yl]ethyl}- 9h-purin-6-amine
  2241. 4wwp: Crystal Structure of Human PI3K-GAMMA in Complex with Pyridinylquinoline Inhibitor N-{(1s)-1-[8-chloro-2-(2-methylpyridin- 3-yl)quinolin-3-yl]ethyl}-9h-purin-6-amine
  2242. 4o00: Crystal Structure of The Titin A-band Domain A3
  2243. 6ntc: Crystal Structure of G12V Hras-gppnhp Bound in Complex with The Engineered Rbd Variant 1 of Craf Kinase Protein
  2244. 3wow: Crystal Structure of Human CK2A with Amppnp
  2245. 4mta: Crystal Structure of Pim-1 Kinase Domain in Complex with 2-methyl-5- Phenylfuran-3-carboxylic Acid
  2246. 4ow8: Crystal Structure of Kinase Domain of Pkna from Mtb
  2247. 5bs0: Mage-a3 Reactive Tcr in Complex with Titin Epitope in Hla-a1
  2248. 5brm: Structural Basis for Mob1-dependent Activation of The Core Mst-lats Kinase Cascade in Hippo Signaling
  2249. 5brk: Pmob1-lats1 Complex
  2250. 5bms: Crystal Structure of P21-activated Kinase 4 in Complex with an Inhibitor Compound 29
  2251. 5bml: Rock 1 Bound to a Pyridine Thiazole Inhibitor
  2252. 5b6b: Complex of Lats1 and Phosphomimetic MOB1B
  2253. 5b5w: Crystal Structure of Mob1-lats1 Ntr Domain Complex
  2254. 5b0x: Crystal Structure of The CK2A/BENZOIC Acid Derivative Complex
  2255. 5ax9: Crystal Structure of The Kinase Domain of Human Traf2 and Nck- Interacting Protein Kinase in Complex with Compund 9
  2256. 5av4: Crystal Structure of Dapk1-genistein Complex in The Presence of Bromide Ions.
  2257. 5av3: Crystal Structure of Dapk1-kaempferol Complex in The Presence of Iodide Ions.
  2258. 5av2: Crystal Structure of Dapk1-kaempferol Complex in The Presence of Bromide Ions.
  2259. 5av1: Crystal Structure of Dapk1 in The Presence of Bromide Ions.
  2260. 5av0: Crystal Structure of Dapk1 in Complex with 7,3',4'- Trihydroxyisoflavone.
  2261. 5auz: Crystal Structure of Dapk1 in Complex with Genistein.
  2262. 5auy: Crystal Structure of Dapk1 in Complex with Morin.
  2263. 5aux: Crystal Structure of Dapk1 in Complex with Kaempferol.
  2264. 5auw: Crystal Structure of Dapk1 in Complex with Quercetin.
  2265. 5auv: Crystal Structure of Dapk1 in Complex with Apigenin.
  2266. 5auu: Crystal Structure of Dapk1 in Complex with Luteolin.
  2267. 5aut: Crystal Structure of Dapk1 in Complex with Ans.
  2268. 5ar8: Rip2 Kinase Catalytic Domain (1 - 310) Complex with Biphenylsulfonamide
  2269. 5ar7: Rip2 Kinase Catalytic Domain (1 - 310) Complex with Biaryl Urea
  2270. 5ar5: Rip2 Kinase Catalytic Domain (1 - 310) Complex with Benzimidazole
  2271. 5ar4: Rip2 Kinase Catalytic Domain (1 - 310) Complex with Sb-203580
  2272. 5ar3: Rip2 Kinase Catalytic Domain (1 - 310) Complex with Amp-pcp
  2273. 5ar2: Rip2 Kinase Catalytic Domain (1 - 310)
  2274. 5ack: Human Pdk1 Kinase Domain in Complex with Allosteric Compound 7 Bound to The Pif-pocket
  2275. 4rlo: Human P70S6K1 with Ruthenium-based Inhibitor Em5
  2276. 5aag: Aurora a Kinase Bound to an Imidazopyridine Inhibitor (14b)
  2277. 5aaf: Aurora a Kinase Bound to an Imidazopyridine Inhibitor (14a)
  2278. 5aae: Aurora a Kinase Bound to an Imidazopyridine Inhibitor (14d)
  2279. 4rlp: Human P70S6K1 with Ruthenium-based Inhibitor Fl772
  2280. 5aad: Aurora a Kinase Bound to an Imidazopyridine Inhibitor (7a)
  2281. 4rpv: Co-crystal Structure of Pim1 with Compound 3
  2282. 5a6o: Crystal Structure of The Apo Form of The Unphosphorylated Human Death Associated Protein Kinase 3 (dapk3)
  2283. 5a6n: Crystal Structure of Human Death Associated Protein Kinase 3 (dapk3) in Complex with Compound 2
  2284. 4ty1: Crystal Structure of Human Pim-1 Kinase in Complex with an Aminooxadiazole-indole Inhibitor.
  2285. 4waf: Crystal Structure of a Novel Tetrahydropyrazolo[1,5-a]pyrazine in an Engineered PI3K Alpha
  2286. 4wno: Structure of Ulk1 Bound to an Inhibitor
  2287. 4wnp: Structure of Ulk1 Bound to a Potent Inhibitor
  2288. 5a14: Human Cdk2 with Type II Inhibitor
  2289. 4wrs: Crystal Structure of Human Pim-1 Kinase in Complex with an Azaspiro Pyrazinyl-indazole Inhibitor.
  2290. 4wsy: Crystal Structure of Human Pim-1 Kinase in Complex with a Thiazolamine-indazole Inhibitor.
  2291. 4wt6: Crystal Structure of Human Pim-1 Kinase in Complex with a Thiadiazolamine-indole Inhibitor.
  2292. 4x3f: Crystal Structure of The Intracellular Domain of The M. Tuberculosis Ser/thr Kinase Pkna
  2293. 4zy6: Crystal Structure of P21-activated Kinase 1 in Complex with an Inhibitor Compound 29
  2294. 4zy5: Crystal Structure of P21-activated Kinase 1 in Complex with an Inhibitor Compound 17
  2295. 4zy4: Crystal Structure of P21 Activated Kinase 1 in Complex with an Inhibitor Compound 4
  2296. 4x7h: Co-crystal Structure of Perk Bound to N-{5-[(6,7-dimethoxyquinolin-4- Yl)oxy]pyridin-2-yl}-1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3- Dihydro-1h-pyrazole-4-carboxamide Inhibitor
  2297. 4x7j: Co-crystal Structure of Perk with 2-amino-n-[4-methoxy-3- (trifluoromethyl)phenyl]-4-methyl-3-[2-(methylamino)quinazolin-6- Yl]benzamide Inhibitor
  2298. 4x7k: Co-crystal Structure of Perk Bound to 4-{2-amino-3-[5-fluoro-2- (methylamino)quinazolin-6-yl]-4-methylbenzoyl}-1-methyl-2,5-diphenyl- 1,2-dihydro-3h-pyrazol-3-one Inhibitor
  2299. 4x7l: Co-crystal Structure of Perk Bound to 4-{2-amino-4-methyl-3-[2- (methylamino)-1,3-benzothiazol-6-yl]benzoyl}-1-methyl-2,5-diphenyl-1, 2-dihydro-3h-pyrazol-3-one Inhibitor
  2300. 4x7n: Co-crystal Structure of Perk Bound to 4-[2-amino-4-methyl-3-(2- Methylquinolin-6-yl)benzoyl]-1-methyl-2,5-diphenyl-1,2-dihydro-3h- Pyrazol-3-one Inhibitor
  2301. 4x7o: Co-crystal Structure of Perk Bound to 1-[5-(4-amino-2,7-dimethyl-7h- Pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1h-indol-1-yl]-2-[3-fluoro- 5-(trifluoromethyl)phenyl]ethanone Inhibitor
  2302. 4x7q: Pim2 Kinase in Complex with Compound 1s
  2303. 4xhk: Pim1 Kinase in Complex with Compound 1s
  2304. 4zts: Human Aurora a Catalytic Domain Bound to Fk1142
  2305. 4ztr: Human Aurora a Catalytic Domain Bound to Fk1141
  2306. 4ztq: Human Aurora a Catalytic Domain Bound to Fk932
  2307. 4ztn: Irak4-inhibitor Co-structure
  2308. 4ztm: Irak4-inhibitor Co-structure
  2309. 4ztl: Irak4-inhibitor Co-structure
  2310. 4zs0: Human Aurora a Catalytic Domain Bound to Sb-6-oh
  2311. 4zp5: MAP4K4 in Complex with Inhibitor
  2312. 4zop: Co-crystal Structure of Lipid Kinase PI3K Alpha with a Selective Phosphatidylinositol-3 Kinase Alpha Inhibitor
  2313. 4zlo: Serine/threonine-protein Kinase Pak1 Complexed with a Dibenzodiazepine: Identification of an Allosteric Site on Pak1
  2314. 4zk5: MAP4K4 in Complex with Inhibitor Gne-495
  2315. 4zjj: Pak1 in Complex with (s)-n-(tert-butyl)-3-((2-chloro-5-ethyl-8-fluoro- Dibenzodiazepin-11-yl)amino)pyrrolidine-1-carboxamide
  2316. 4zji: Pak1 in Complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin- 1-yl)-dibenzodiazepine
  2317. 4zhx: Novel Binding Site for Allosteric Activation of Ampk
  2318. 5aik: Human DYRK1A in Complex with Ldn-211898
  2319. 4z8l: Crystal Structure of Dcaf1/siv-mnd Vpx/mnd Samhd1 Ntd Ternary Complex
  2320. 4z64: The Plant Peptide Hormone Receptor Complex in Arabidopsis
  2321. 4z63: The Plant Peptide Hormone Receptor in Arabidopsis
  2322. 4z62: The Plant Peptide Hormone Free Receptor
  2323. 4z61: The Plant Peptide Hormone Receptor Complex
  2324. 4z5w: The Plant Peptide Hormone Receptor
  2325. 4yzd: Crystal Structure of Human Phosphorylated IRE1ALPHA in Complex with Adp-mg
  2326. 4yzc: Crystal Structure of PIRE1ALPHA in Complex with Staurosporine
  2327. 4yz9: Crystal Structure of Human Phosphorylated IRE1ALPHA in Complex with a Type III Kinase Inhibitor (GSK2850163A)
  2328. 5ajq: Human Lok (stk10) in Complex with Bosutinib
  2329. 4rbl: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Mitoxantrone Derivatives
  2330. 4rc2: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Mitoxantrone Derivatives
  2331. 4rc3: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Mitoxantrone Derivatives
  2332. 4rc4: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Mitoxantrone Derivatives
  2333. 4u8z: Crystal Structure of Mst3 with a Pyrrolopyrimidine Inhibitor (pf- 06447475)
  2334. 4w8d: Crystal Structure of Mst3 with a Pyrrolopyrimidine Inhibitor (pf- 06454589).
  2335. 4w8e: Structure of Mst3 with a Pyrrolopyrimidine Inhibitor (pf-06645342)
  2336. 4ww5: Crystal Structure of Binary Complex Bud32-cgi121 in Complex with Ampp
  2337. 4ww7: Crystal Structure of Binary Complex Bud32-cgi121 in Complex with Amp
  2338. 4ww9: Crystal Structure of Binary Complex Bud32-cgi121 in Complex with Adp
  2339. 4wwa: Crystal Structure of Binary Complex Bud32-cgi121
  2340. 5air: Structural Analysis of Mouse GSK3BETA Fused with Lrp6 Peptide.
  2341. 4ptc: Structure of a Carboxamide Compound (3) (2-{2-[(cyclopropylcarbonyl) Amino]pyridin-4-yl}-4-oxo-4h-1lambda~4~,3-thiazole-5-carboxamide) to GSK3B
  2342. 4pte: Structure of a Carvoxamide Compound (15) (n-[4-(isoquinolin-7-yl) Pyridin-2-yl]cyclopropanecarboxamide) to GSK3B
  2343. 4ptg: Structure of a Carboxamine Compound (26) (2-{2-[(cyclopropylcarbonyl) Amino]pyridin-4-yl}-4-methoxypyrimidine-5-carboxamide) to GSK3B
  2344. 4yve: Rock 1 Bound to Methoxyphenyl Thiazole Inhibitor
  2345. 4yvc: Rock 1 Bound to Thiazole Inhibitor
  2346. 4y8d: Crystal Structure of Cyclin-g Associated Kinase (gak) Complexed with Selective 12i Inhibitor
  2347. 4ykn: PI3K Alpha Lipid Kinase with Active Site Inhibitor
  2348. 4yht: Braf Complexed with an Inhibitor
  2349. 4yg7: Structure of Fl Autorepression Promoter Complex
  2350. 4yfi: TNNI3K Complexed with Inhibitor 1
  2351. 4yff: TNNI3K Complexed with Inhibitor 2
  2352. 4rvt: MAP4K4 in Complex with a Pyridin-2(1h)-one Derivative
  2353. 4wot: Rock2 in Complex with 1426382-07-1
  2354. 4xs2: Irak4-inhibitor Co-structure
  2355. 4y0x: Crystal Structure of The S/t Protein Kinase Pkng from Mycobacterium Tuberculosis in Complex with Adp
  2356. 4y12: Crystal Structure of The S/t Protein Kinase Pkng from Mycobacterium Tuberculosis in Complex with Ags
  2357. 4y73: Crystal Structure of Irak4 Kinase Domain with Inhibitor
  2358. 4yo4: Crystal Structure of Dapk1 Catalytic Domain in Complex with The Hinge Binding Fragment Phthalazine
  2359. 4yo6: Irak4-inhibitor Co-structure
  2360. 4yp8: Irak4-inhibitor Co-structure
  2361. 4ypd: Crystal Structure of Dapk1 Catalytic Domain in Complex with The Hinge Binding Fragment 4-methylpyridazine
  2362. 4yzm: Humanized Roco4 Bound to Lrrk2-in1
  2363. 4yzn: Humanized Roco4 Bound to Compound 19
  2364. 4yzs: Crystal Structures Reveal Transient Perk Luminal Domain Tetramerization in Er Stress Signaling
  2365. 4yzy: Crystal Structures Reveal Transient Perk Luminal Domain Tetramerization in Er Stress Signaling
  2366. 4z7g: Crystal Structure of Human Ire1 Cytoplasmic Kinase-rnase Region - Apo
  2367. 4z7h: Crystal Structure of Human Ire1 Cytoplasmic Kinase-rnase Region - Complex with Imidazopyridine Compound 3
  2368. 5aja: Crystal Structure of Mandrill Samhd1 (amino Acid Residues 1-114) Bound to Vpx Isolated from Mandrill and Human Dcaf1 (amino Acid Residues 1058-1396)
  2369. 2mwc: Solution Structure of Human Obscurin Ig58
  2370. 2n56: Ig59 Domain of Human Obscurin a
  2371. 2n7z: Solution Structure of Rip2 Card
  2372. 2n83: P75NTR Dd:rip2 Card
  2373. 3jbz: Crystal Structure of Mtor Docked into Em Map of Dimeric Atm Kinase
  2374. 3wws: Crystal Structure of Serine/threonine-protein Kinase 3
  2375. 4qeg: Crystal Structure of Domain I10 from Titin (space Group P41)
  2376. 4qml: Mst3 in Complex with Amp-pnp
  2377. 4qmm: Mst3 in Complex with At-9283, 4-[(2-{4-[(cyclopropylcarbamoyl)amino]- 1h-pyrazol-3-yl}-1h-benzimidazol-6-yl)methyl]morpholin-4-ium
  2378. 4qmn: Mst3 in Complex with Bosutinib
  2379. 4qmo: Mst3 in Complex with Imidazolo-oxindole Pkr Inhibitor C16
  2380. 4qmp: Mst3 in Complex with Cdk1/2 Inhibitor Iii, 5-amino-3-{[4- (aminosulfonyl)phenyl]amino}-n-(2,6-difluorophenyl)-1h-1,2,4- Triazole-1-carbothioamide
  2381. 4qmq: Mst3 in Complex with Cp-673451
  2382. 4qms: Mst3 in Complex with Dasatinib
  2383. 4qmt: Mst3 in Complex with Hesperadin
  2384. 4qmu: Mst3 in Complex with Jnj-7706621, 4-({5-amino-1-[(2,6-difluorophenyl) Carbonyl]-1h-1,2,4-triazol-3-yl}amino)benzenesulfonamide
  2385. 4qmv: Mst3 in Complex with Pf-03814735, N-{2-[(1s,4r)-6-{[4- (cyclobutylamino)-5-(trifluoromethyl)pyrimidin-2-yl]amino}-1,2,3,4- Tetrahydro-1,4-epiminonaphthalen-9-yl]-2-oxoethyl}acetamide
  2386. 4qmw: Mst3 in Complex with Pp-121, 1-cyclopentyl-3-(1h-pyrrolo[2,3- B]pyridin-5-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine
  2387. 4qmx: Mst3 in Complex with Saracatinib
  2388. 4qmy: Mst3 in Complex with Staurosporine
  2389. 4qmz: Mst3 in Complex with Sunitinib
  2390. 4qna: Mst3 in Complex with 2-(4,6-diamino-1,3,5-triazin-2-yl)phenol
  2391. 4qo9: Mst3 in Complex with Danusertib
  2392. 4r5y: The Complex Structure of Braf V600E Kinase Domain with a Novel Braf Inhibitor
  2393. 4rmz: Crystal Structure of Irak-4
  2394. 4rsv: Human Obscurin Ig58 Domain
  2395. 4rvk: Chk1 Kinase Domain with Diazacarbazole Compound 8: N-[3-(6-cyano-9h- Pyrrolo[2,3-b:5,4-c']dipyridin-3-yl)phenyl]acetamide
  2396. 4rvl: Chk1 Kinase Domain with Diazacarbazole Compound 7: 3-(2- Hydroxyphenyl)-9h-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile
  2397. 4rvm: Chk1 Kinase Domain with Diazacarbazole Compound 19
  2398. 4rzv: Crystal Structure of The Braf (R509H) Kinase Domain Monomer Bound to Vemurafenib
  2399. 4rzw: Crystal Structure of Braf (R509H) Kinase Domain Bound to Az628
  2400. 4tl0: Crystal Structure of Death-associated Protein Kinase 1 with a Crucial Phosphomimicking Mutation
  2401. 4tl6: Crystal Structure of N-terminal Domain of Kaic
  2402. 4tl7: Crystal Structure of N-terminal C1 Domain of Kaic
  2403. 4tl8: Crystal Structure of N-terminal C1 Domain of Kaic
  2404. 4tl9: Crystal Structure of N-terminal C1 Domain of Kaic
  2405. 4tla: Crystal Structure of N-terminal C1 Domain of Kaic
  2406. 4tlb: Crystal Structure of N-terminal C1 Domain of Kaic
  2407. 4tlc: Crystal Structure of N-terminal C1 Domain of Kaic
  2408. 4tld: Crystal Structure of N-terminal C1 Domain of Kaic
  2409. 4tle: Crystal Structure of N-terminal C1 Domain of Kaic
  2410. 4tn6: CK1D in Complex with Inhibitor
  2411. 4tyh: Ternary Complex of P38 and Mk2 with a P38 Inhibitor
  2412. 4u3y: Apo Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4)
  2413. 4u3z: Apo MAP4K4 T181E Phosphomimetic Mutant
  2414. 4u40: Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Bound to Amppnp
  2415. 4u41: MAP4K4 Bound to Inhibitor Compound 1
  2416. 4u42: MAP4K4 T181E Mutant Bound to Inhibitor Compound 1
  2417. 4ub7: High-salt Structure of Protein Kinase Ck2 Catalytic Subunit with 4'- Carboxy-6,8-bromo-flavonol (flc26) Showing an Extreme Distortion of The Atp-binding Loop Combined with a Pi-halogen Bond
  2418. 4uba: Low-salt Structure of Protein Kinase Ck2 Catalytic Subunit with 4'- Carboxy-6,8-bromo-flavonol (flc26)
  2419. 4usd: Human Stk10 (lok) with Sb-633825
  2420. 4use: Human Stk10 (lok) with Sb-633825
  2421. 4usf: Human Slk with Sb-440719
  2422. 4uv0: Structure of a Semisynthetic Phosphorylated Dapk
  2423. 4wua: Crystal Structure of Human Srpk1 Complexed to an Inhibitor Srpin340
  2424. 4wzx: Ulk3 Regulates Cytokinetic Abscission by Phosphorylating Escrt-iii Proteins
  2425. 4xbr: In Cellulo Crystal Structure of Pak4 in Complex with Inka
  2426. 4xbu: In Vitro Crystal Structure of Pak4 in Complex with Inka Peptide
  2427. 4xh0: Structure of C. Glabrata Hrr25 Bound to Adp (so4 Condition)
  2428. 4xh6: Crystal Structure of Proto-oncogene Kinase Pim1 Bound to Hispidulin
  2429. 4xhl: Structure of S. Cerevisiae Hrr25 1-394 (K38R Mutant)
  2430. 4xv1: B-raf Kinase V600E Oncogenic Mutant in Complex with Plx7904
  2431. 4xv2: B-raf Kinase V600E Oncogenic Mutant in Complex with Dabrafenib
  2432. 4xv3: B-raf Kinase V600E Oncogenic Mutant in Complex with Plx7922
  2433. 4xv9: B-raf Kinase Domain in Complex with Plx5568
  2434. 4xx5: Structure of PI3K Gamma in Complex with an Inhibitor
  2435. 4xx9: Crystal Structure of Pdk1 in Complex with Atp and The Pif-pocket Ligand Rf4
  2436. 4xz4: Structure of PI3K Gamma in Complex with an Inhibitor
  2437. 6lph: The Sufu-fu Complex Crystal Structure
  2438. 6wjq: Crystal Structure of Wdr5 in Complex with The Win Peptide of Pdpk1
  2439. 6xgu: Crystal Structure of KRAS-Q61R (gmppnp-bound) in Complex with Ras- Binding Domain (rbd) and Cysteine-rich Domain (crd) of Raf1/craf
  2440. 6xgv: Crystal Structure of KRAS-G13D (gmppnp-bound) in Complex with Ras- Binding Domain (rbd) and Cysteine-rich Domain (crd) of Raf1/craf
  2441. 6xha: Crystal Structure of KRAS-G12V (gmppnp-bound) in Complex with Ras- Binding Domain (rbd) and Cysteine-rich Domain (crd) of Raf1/craf
  2442. 6xhb: Crystal Structure of Wild-type Kras (gmppnp-bound) in Complex with Ras-binding Domain (rbd) and Cysteine-rich Domain (crd) of Raf1/craf (crystal Form Ii)
  2443. 6xi7: Crystal Structure of Wild-type Kras (gmppnp-bound) in Complex with Ras-binding Domain (rbd) and Cysteine-rich Domain (crd) of Raf1/craf (crystal Form I)
  2444. 7ayh: Crystal Structure of Aurora a in Complex with 7-(2-anilinopyrimidin-4- Yl)-1-benzazepin-2-one Derivative (compound 2c)
  2445. 7ayi: Crystal Structure of Aurora a in Complex with 7-(2-anilinopyrimidin-4- Yl)-1-benzazepin-2-one Derivative (compound 2a)
  2446. 7ccu: Crystal Structure of Death-associated Protein Kinase 1 in Complex with Resveratrol
  2447. 7ccv: Crystal Structure of Death-associated Protein Kinase 1 in Complex with Piceatannol
  2448. 7ccw: Crystal Structure of Death-associated Protein Kinase 1 in Complex with Resveratrol and Mes
  2449. 7k0y: Cryo-em Structure of Activated-form Dna-pk (complex Vi)
  2450. 7k10: Cryoem Structure of Activated-form Fatkin Domain of Dna-pk
  2451. 7k11: Cryoem Structure of Inactivated-form Fatkin Domain of Dna-pk
  2452. 7k17: Re-refined Crystal Structure of Dna-dependent Protein Kinase Catalytic Subunit Complexed with Ku80 C-terminal Helix
  2453. 7k19: Cryoem Structure of Dna-pk Catalytic Subunit Complexed with Dna (complex I)
  2454. 7k1b: Cryoem Structure of Dna-pk Catalytic Subunit Complexed with Dna (complex Ii)
  2455. 7k1j: Cryoem Structure of Inactivated-form Dna-pk (complex Iii)
  2456. 7k1k: Cryoem Structure of Inactivated-form Dna-pk (complex Iv)
  2457. 7k1n: Cryoem Structure of Inactivated-form Dna-pk (complex V)
  2458. 7k6m: Crystal Structure of PI3KALPHA Selective Inhibitor Pf-06843195
  2459. 7k6n: Crystal Structure of PI3KALPHA Selective Inhibitor 11-1575
  2460. 7k6o: Crystal Structure of PI3KALPHA Inhibitor 10-5429
  2461. 7k71: Crystal Structure of PI3KALPHA Inhibitor 4-0686
  2462. 7kac: Crystal Structure of Hpk1 (MAP4K1) Kinase in Complex with 5-{[4- {[(1s)-2-hydroxy-1-phenylethyl]amino}-5-(1,3,4-oxadiazol-2-yl) Pyrimidin-2-yl]amino}-3,3-dimethyl-2-benzofuran-1(3h)-one
  2463. 7jjh: Crystal Structure of The Unliganded Tandem Bromodomain (bd1, Bd2) of Human Taf1
  2464. 6vo7: Crystal Structure of PI3K-ALPHA Ras Binding Domain (rbd)
  2465. 7b8h: Monoclinic Structure of Human Protein Kinase Ck2 Catalytic Subunit in Complex with a Heparin Oligo Saccharide
  2466. 7b8i: Tetragonal Structure of Human Protein Kinase Ck2 Catalytic Subunit in Complex with a Heparin Oligo Saccharide
  2467. 6vqm: Crystal Structure Analysis of Human Ack1
  2468. 6wqx: Human Prpk-tprkb Complex
  2469. 6vxu: Structure of Human Vaccinia-related Kinase 1 (vrk1) Bound to Ach471
  2470. 7ncf: Crystal Structure of Hipk2 in Complex with Mu135 (compound 21e)
  2471. 7nip: Titin N2A Unique Sequence (UN2A) Core
  2472. 7b1f: Orthorhombic P212121 Structure of Human Mad1 C-terminal Domain in Complex with Phosphorylated Bub1 Cd1 Domain
  2473. 7b1h: Monoclinic P21 Structure of Human Mad1 C-terminal Domain in Complex with Phosphorylated Bub1 Cd1 Domain
  2474. 7b1j: Orthorhombic P21212 Structure of Human Mad1 C-terminal Domain in Complex with Phosphorylated Bub1 Cd1 Domain
  2475. 7e2k: Crystal Structure of The Rwd Domain of Human Gcn2 - 1
  2476. 7e2m: Crystal Structure of The Rwd Domain of Human Gcn2 - 2
  2477. 7jwe: Gedatolisib Bound to The PI3KG Catalytic Subunit P110 Gamma
  2478. 7jwz: Ipi-549 Bound to The PI3KG Catalytic Subunit P110 Gamma
  2479. 7jx0: Nvs-pi3-4 Bound to The PI3KG Catalytic Subunit P110 Gamma
  2480. 7l24: Hpk1 in Complex with Compound 11
  2481. 7l25: Hpk1 in Complex with Compound 18
  2482. 7l26: Hpk1 in Complex with Compound 38
  2483. 6z1c: Crystal Structure of Arabidopsis Thaliana Ck2-alpha-1 in Complex with Ttp-22
  2484. 7ahs: TITIN-N2A Ig81-ig83
  2485. 7kke: Phosphoinositide 3-kinase Gamma Bound to a Thiazole Inhibitor
  2486. 6l23: Crystal Structure of CK2A1 V116I with Hematein
  2487. 6ygn: Titin Kinase and Its Flanking Domains
  2488. 7bu4: Crystal Structure of CK2A1 Complexed with Ky49
  2489. 7m0k: Hpk1 in Complex with Compound 1
  2490. 7m0l: Hpk1 in Complex with Compound 1
  2491. 7m0m: Hpk1 in Complex with Compound 1
  2492. 6yj0: Solution Nmr Structure of Titin N2A Region Ig Domain I83
  2493. 7akm: Crystal Structure of Chk1 Kinase Domain in Complex with Atpys
  2494. 7ako: Crystal Structure of Chk1 Kinase Domain in Complex with a Claspin Phosphopeptide
  2495. 7lt3: Nhej Long-range Synaptic Complex
  2496. 6xdb: Crystal Structure of IRE1A in Complex with G-6904
  2497. 6xdd: Crystal Structure of Ire1 in Complex with G-3053
  2498. 6xdf: Crystal Structure of IRE1A in Complex with G-4100
  2499. 7aby: Crystal Structure of ILOV-Q489K Mutant
  2500. 7dd1: Crystal Structure of Srpk1 in Complex with a Peptide Inhibitor
  2501. 7m0t: Crystal Structure of The Braf:mek1 Kinases in Complex with Amppnp and Selumetinib
  2502. 7m0u: Crystal Structure of The Braf:mek1 Kinases in Complex with Amppnp and Binimetinib
  2503. 7m0v: Crystal Structure of The Braf:mek1 Kinases in Complex with Amppnp and Cobimetinib
  2504. 7m0w: Crystal Structure of The Braf:mek1 Kinases in Complex with Amppnp and Pimasertib
  2505. 7m0x: Crystal Structure of The Braf:mek1 Kinases in Complex with Amppnp and Pd0325901
  2506. 7m0y: Crystal Structure of The Braf:mek1 Kinases in Complex with Amppnp and Trametinib
  2507. 7m0z: Crystal Structure of The Braf:mek1 Kinases in Complex with Amppnp and Ch5126766
  2508. 7da4: Cryo-em Structure of Amyloid Fibril Formed by Human Ripk3
  2509. 7dac: Human Ripk3 Amyloid Fibril Revealed by Solid-state Nmr
  2510. 7o94: The Mark3 Kinase Domain Bound to Aa-cs-1-008
  2511. 7edx: P53-bound Tfiid-based Core Pic on Hdm2 Promoter
  2512. 7eg7: Tfiid-based Core Pic on Scp Promoter
  2513. 7eg8: Tfiid-based Core Pic on Puma Promoter
  2514. 7eg9: Tfiid-based Intermediate Pic on Scp Promoter
  2515. 7ega: Tfiid-based Intermediate Pic on Puma Promoter
  2516. 6zv6: Human Rio1(kd)-stha Late Pre-40s Particle, Structural State B (post 18s Rrna Cleavage)
  2517. 7egd: Scp Promoter-bound Tfiid-tfiia in Initial Tbp-loading State
  2518. 7ege: Tfiid in Canonical Conformation
  2519. 7egh: Tfiid Lobe C Subcomplex
  2520. 7egi: Tfiid in Rearranged Conformation
  2521. 7egj: Scp Promoter-bound Tfiid-tfiia in post Tbp-loading State
  2522. 6yzh: Crystal Structure of P8C9 Bound to CK2ALPHA
  2523. 7jxx: Structure of Ttbk1 Kinase Domain in Complex with Compound 3
  2524. 7jxy: Structure of Ttbk1 Kinase Domain in Complex with Compound 18
  2525. 7oai: Crystal Structure of Pseudokinase Cask in Complex with Pfe-pkis12
  2526. 7oaj: Crystal Structure of Pseudokinase Cask in Complex with Compound 7
  2527. 7oak: Crystal Structure of Pseudokinase Cask in Complex with Compound 26
  2528. 7oal: Crystal Structure of Pseudokinase Cask in Complex with Compound 25
  2529. 6z19: Crystal Structure of P8C9 Bound to CK2ALPHA
  2530. 7k0v: Crystal Structure of Braf in Complex with Inhibitor Gne-0749
  2531. 7m10: Phf2 Phd Domain Complexed with Peptide from N-terminus of Vrk1
  2532. 6x61: Crystal Structure of The N-terminal Thioredoxin Domain of Sasa in Complex with The N-terminal Ci Domain of Kaic from Thermosynchococcus Elongatus
  2533. 6xaf: 1.9a Crystal Structure of The Gtpase Domain of Parkinson's Disease- Associated Protein Lrrk2 Carrying R1398H
  2534. 7n42: Crystal Structure of The Tandem Bromodomain of Human Taf1 (taf1-t) Bound to Zs1-681
  2535. 7lht: Structure of The Lrrk2 Dimer
  2536. 7lhw: Structure of The Lrrk2 Monomer
  2537. 7li3: Structure of The Lrrk2 G2019S Mutant
  2538. 7li4: Structure of Lrrk2 after Symmetry Expansion
  2539. 7mck: Structure of Chk1 10-pt. Mutant Complex with Lrrk2 Inhibitor 18
  2540. 7jiu: Human PI3KDELTA in Complex with Compound 2f
  2541. 7l6x: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 Bound to Gne-371
  2542. 7bjd: Crystal Structure of Chk1-10pt-mutant Complex with Compound 3
  2543. 7bje: Crystal Structure of Chk1-10pt-mutant Complex with Adenine
  2544. 7bjh: Crystal Structure of Chk1-10pt-mutant Complex with Compound 8
  2545. 7bjj: Crystal Structure of Chk1-10pt-mutant Complex with Compound 9
  2546. 7bjm: Crystal Structure of Chk1-10pt-mutant Complex with Compound 10
  2547. 7bjo: Crystal Structure of Chk1-10pt-mutant Complex with Compound 13
  2548. 7bjr: Crystal Structure of Chk1-10pt-mutant Complex with Compound 18
  2549. 7bjx: Crystal Structure of Chk1-10pt-mutant Complex with Compound 26
  2550. 7bk1: Crystal Structure of Chk1-10pt-mutant Complex with Compound 32
  2551. 7bk2: Crystal Structure of Chk1-10pt-mutant Complex with Compound 44
  2552. 7bk3: Crystal Structure of Chk1-10pt-mutant Complex with Compound 45
  2553. 7bkn: Crystal Structure of Chk1 Complex with Adenine
  2554. 7bko: Crystal Structure of Chk1 Complex with Compound 9
  2555. 7cjb: Vhl Recognizes Hydroxyproline in Ripk1
  2556. 7lb0: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 Bound to Zs1-295
  2557. 7lb1: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 Bound to Zs1-585
  2558. 7lb2: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 Bound to Zs1-589
  2559. 7mez: Structure of The Phosphoinositide 3-kinase P110 Gamma (PIK3CG) P101 (PIK3R5) Complex
  2560. 7p1l: The Mark3 Kinase Domain Bound to Aa-cs-1-008
  2561. 6zx9: Crystal Structure of Siv Vpr,fused to T4 Lysozyme, Isolated from Moustached Monkey, Bound to Human Ddb1 and Human Dcaf1 (amino Acid Residues 1046-1396)
  2562. 7jhg: Cryo-em Structure of Atp-bound Fully Inactive Ampk in Complex with Dorsomorphin (compound C) and Fab-nanobody
  2563. 7jhh: Cryo-em Structure of Atp-bound Fully Inactive Ampk in Complex with Fab and Nanobody
  2564. 7ops: Crystal Structure of Haspin in Complex with Zw282 (compound 2a)
  2565. 6zue: Crystal Structure of Human Ddb1 Bound to Human Dcaf1 (amino Acid Residues 1046-1396)
  2566. 7cmb: Crystal Structure of Pak4 in Complex with Inhibitor 41
  2567. 7jij: Atp-bound Amp-activated Protein Kinase
  2568. 7jjg: Crystal Structure of The Second Bromodomain (bd2) of Human Taf1 Bound to Atr Kinase Inhibitor Az20
  2569. 7lvh: Crystal Structure of Ap2 Associated Kinase 1 Isoform 1 Complexed with Ligand N-[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]-3-(propan-2-yl) Piperidine-2-carboxamide
  2570. 7lvi: Crystal Structure of Ap2 Associated Kinase 1 Isoform 1 Complexed with Ligand (2r)-2-amino-n-[3-methoxy-4- (1,3-oxazol-5-yl)phenyl]-4- Methylpentanamide
  2571. 7at5: Structure of Protein Kinase Ck2 Catalytic Subunit (CSNK2A1 Gene Product) in Complex with The Bivalent Inhibitor Kn2
  2572. 7at9: Structure of Protein Kinase Ck2 Catalytic Subunit (CSNK2A2 Gene Product) in Complex with The Atp-competitive Inhibitor Mb002 and The Alphad-pocket Ligand 3,4-dichlorophenethylamine
  2573. 7atv: Structure of Protein Kinase Ck2 Catalytic Subunit (CSNK2A2 Gene Product) in Complex with The Bivalent Inhibitor Kn2
  2574. 7naa: Crystal Structure of Mycobacterium Tuberculosis H37RV Pknf Kinase Domain
  2575. 7oov: Crystal Structure of Pim1 in Complex with Arc-1411
  2576. 7oow: Crystal Structure of Pim1 in Complex with Arc-1415
  2577. 7oox: Crystal Structure of Pim1 in Complex with Arc-3126
  2578. 7cp3: Crystal Structure of Pak4 in Complex with Inhibitor 47
  2579. 7cp4: Crystal Structure of Pak4 in Complex with Inhibitor 55
  2580. 7l1x: Structure of Human Ck2 Alpha Kinase (catalytic Subunit) with The Inhibitor 108600.
  2581. 7lwh: Human Neurofibromin 2/merlin Residues 1-339 in Complex with Lats1
  2582. 7f3g: Crystal Structure of Dclk1 Kinase Domain in Complex with Ruxolitinib
  2583. 7nfc: Cryo-em Structure of Nhej Super-complex (dimer)
  2584. 7nfe: Cryo-em Structure of Nhej Super-complex (monomer)
  2585. 7apj: Structure of Autoinhibited Akt1 Reveals Mechanism of Pip3-mediated Activation
  2586. 7jsp: Crystal Structure of The Second Bromodomain (bd2) of Human Taf1 Bound to Atr Kinase Inhibitor Azd6738
  2587. 7jtc: Crystal Structure of The Second Bromodomain (bd2) of Human Taf1 Bound to Zs1-322
  2588. 7ni4: Human Atm Kinase Domain with Bound M4076 Inhibitor
  2589. 7ni5: Human Atm Kinase with Bound Inhibitor Ku-55933
  2590. 7ni6: Human Atm Kinase with Bound Atpys
  2591. 7nh4: Co-crystal Structure of Akt1 in Complex with Covalent-allosteric Akt Inhibitor 3
  2592. 7nh5: Co-crystal Structure of Akt1 in Complex with Covalent-allosteric Akt Inhibitor 6
  2593. 7owg: Human Deptor in a Complex with Mutant Human Mtorc1 A1459P
  2594. 7pe8: Cryo-em Structure of Deptor Bound to Human Mtor Complex 2, Focussed on One Protomer
  2595. 7pe9: Cryo-em Structure of Deptor Bound to Human Mtor Complex 2, Dept-bound Subset Local Refinement
  2596. 7pea: Cryo-em Structure of Deptor Bound to Human Mtor Complex 1, Overall Refinement
  2597. 7peb: Cryo-em Structure of Deptor Bound to Human Mtor Complex 1, Focussed on One Protomer
  2598. 7pec: Cryo-em Structure of Deptor Bound to Human Mtor Complex 1, Dept-bound Subset Local Refinement
  2599. 7o3b: Crystal Structure of The Ttbk2-cep164 Complex Bound to a Camelid Nanobody
  2600. 7pe7: Cryo-em Structure of Deptor Bound to Human Mtor Complex 2, Overall Refinement
  2601. 7k03: Crystal Structure of The Tandem Bromodomain (bd1 and Bd2) of Human Taf1 Bound to Atr Kinase Inhibitor Azd6738
  2602. 7k0d: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 Bound to Mtorc1/2 Inhibitor Azd3147
  2603. 7k0u: Crystal Structure of The Second Bromodomain (bd2) of Human Taf1 Bound to Plk1 Kinase Inhibitor Bi2536
  2604. 7k1p: Crystal Structure of The Second Bromodomain (bd2) of Human Taf1 Bound to Bromosporine
  2605. 7k27: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 Bound to Atr Inhibitor Az20
  2606. 7k3o: Crystal Structure of The Unliganded Second Bromodomain (bd2) of Human Taf1
  2607. 7k42: Crystal Structure of The Second Bromodomain (bd2) of Human Taf1 Bound to Dioxane
  2608. 7k6f: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 in Complex with Mes (2-(n-morpholino)ethanesulfonic Acid)
  2609. 7kx6: Crystal Structure of Dclk1-kd in Complex with Xmd8-85
  2610. 7kx8: Crystal Structure of Dclk1-cter in Complex with Fmf-03-055-1
  2611. 7kxw: Crystal Structure of Dclk1-kd in Complex with Dclk1-in-1
  2612. 7o86: 1.73a X-ray Crystal Structure of The Conserved C-terminal (cct) of Human Spak
  2613. 7okw: 1.62a X-ray Crystal Structure of The Conserved C-terminal (cct) of Human Osr1
  2614. 7s65: Compressed Conformation of Nighttime State Kaic
  2615. 7s66: Extended Conformation of Nighttime State Kaic
  2616. 7s67: Extended Conformation of Daytime State Kaic
  2617. 7bmk: Atp-competitive Partial Antagonists-'pair's-rheostatically Modulate IRE1ALPHA'S Kinase Helix-alphac to Segregate Its Rnase-mediated Biological Outputs
  2618. 7okq: Cryo-em Structure of The DDB1-DCAF1-CUL4A-RBX1 Complex
  2619. 7p4s: Bromodomain of Human Taf1 (2) with Naphthyridinone Compound
  2620. 7o2v: Aurora Kinase a in Complex with The Aur-a/pdk1 Inhibitor Vi8
© Copyright 2008-2009 by enzymes.me.uk